1	Rescue	rescue	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Progeria	progeria	NN	_	2	PMOD
4	in	in	IN	_	1	NMOD
5	Trichothiodystrophy	trichothiodystrophy	NN	_	4	PMOD
6	by	by	IN	_	1	NMOD
7	Homozygous	homozygous	JJ	_	10	NMOD
8	Lethal	lethal	JJ	_	10	NMOD
9	Xpd	xpd	NN	_	10	NMOD
10	Alleles	allele	NNS	_	6	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Although	although	IN	_	31	ADV
2	compound	compound	NN	_	3	NMOD
3	heterozygosity	heterozygosity	NN	_	18	SBJ
4	,	,	,	_	3	P
5	or	or	CC	_	3	COORD
6	the	the	DT	_	7	NMOD
7	presence	presence	NN	_	5	CONJ
8	of	of	IN	_	7	NMOD
9	two	two	CD	_	12	NMOD
10	different	different	JJ	_	12	NMOD
11	mutant	mutant	JJ	_	12	NMOD
12	alleles	allele	NNS	_	8	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	same	same	JJ	_	16	NMOD
16	gene	gene	NN	_	13	PMOD
17	,	,	,	_	18	P
18	is	be	VBZ	_	1	SUB
19	common	common	JJ	_	18	PRD
20	in	in	IN	_	18	ADV
21	human	human	JJ	_	23	NMOD
22	recessive	recessive	JJ	_	23	NMOD
23	disease	disease	NN	_	20	PMOD
24	,	,	,	_	31	P
25	its	its	PRP$	_	26	NMOD
26	potential	potential	NN	_	31	SBJ
27	to	to	TO	_	26	NMOD
28	impact	impact	VB	_	27	IM
29	disease	disease	NN	_	30	NMOD
30	outcome	outcome	NN	_	28	OBJ
31	has	have	VBZ	_	0	ROOT
32	not	not	RB	_	31	ADV
33	been	be	VBN	_	31	VC
34	well	well	RB	_	33	ADV
35	documented	document	VBN	_	33	VC
36	.	.	.	_	31	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	most	most	RBS	_	4	AMOD
4	likely	likely	RB	_	5	PMOD
5	because	because	IN	_	2	PRP
6	of	of	IN	_	5	PMOD
7	the	the	DT	_	9	NMOD
8	inherent	inherent	JJ	_	9	NMOD
9	difficulty	difficulty	NN	_	5	PMOD
10	in	in	IN	_	9	NMOD
11	distinguishing	distinguish	VBG	_	10	PMOD
12	specific	specific	JJ	_	14	NMOD
13	biallelic	biallelic	JJ	_	14	NMOD
14	effects	effect	NNS	_	11	OBJ
15	from	from	IN	_	11	ADV
16	differences	difference	NNS	_	15	PMOD
17	in	in	IN	_	16	NMOD
18	environment	environment	NN	_	17	PMOD
19	or	or	CC	_	18	COORD
20	genetic	genetic	JJ	_	21	NMOD
21	background	background	NN	_	19	CONJ
22	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	addressed	address	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	potential	potential	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	different	different	JJ	_	8	NMOD
7	recessive	recessive	JJ	_	8	NMOD
8	alleles	allele	NNS	_	5	PMOD
9	to	to	TO	_	4	NMOD
10	contribute	contribute	VB	_	9	IM
11	to	to	IN	_	10	ADV
12	the	the	DT	_	14	NMOD
13	enigmatic	enigmatic	JJ	_	14	NMOD
14	pleiotropy	pleiotropy	NN	_	11	PMOD
15	associated	associate	VBN	_	14	NMOD
16	with	with	IN	_	15	ADV
17	XPD	xpd	NN	_	19	NMOD
18	recessive	recessive	JJ	_	19	NMOD
19	disorders	disorder	NNS	_	16	PMOD
20	in	in	IN	_	15	LOC
21	compound	compound	NN	_	24	NMOD
22	heterozygous	heterozygous	JJ	_	24	NMOD
23	mouse	mouse	NN	_	24	NMOD
24	models	model	NNS	_	20	PMOD
25	.	.	.	_	2	P

1	Alterations	alteration	NNS	_	17	SBJ
2	in	in	IN	_	1	NMOD
3	this	this	DT	_	5	NMOD
4	essential	essential	JJ	_	5	NMOD
5	helicase	helicase	NN	_	2	PMOD
6	,	,	,	_	5	P
7	with	with	IN	_	5	NMOD
8	functions	function	NNS	_	7	PMOD
9	in	in	IN	_	8	NMOD
10	both	both	CC	_	12	COORD
11	DNA	dna	NN	_	12	NMOD
12	repair	repair	NN	_	9	PMOD
13	and	and	CC	_	12	COORD
14	basal	basal	JJ	_	15	NMOD
15	transcription	transcription	NN	_	13	CONJ
16	,	,	,	_	17	P
17	result	result	VBP	_	0	ROOT
18	in	in	IN	_	17	ADV
19	diverse	diverse	JJ	_	20	NMOD
20	pathologies	pathology	NNS	_	18	PMOD
21	ranging	range	VBG	_	20	NMOD
22	from	from	IN	_	21	ADV
23	elevated	elevate	VBN	_	25	NMOD
24	UV	uv	NN	_	25	NMOD
25	sensitivity	sensitivity	NN	_	22	PMOD
26	and	and	CC	_	25	COORD
27	cancer	cancer	NN	_	28	NMOD
28	predisposition	predisposition	NN	_	26	CONJ
29	to	to	IN	_	22	PMOD
30	accelerated	accelerate	VBN	_	32	NMOD
31	segmental	segmental	JJ	_	32	NMOD
32	progeria	progeria	NN	_	29	PMOD
33	.	.	.	_	17	P

1	We	we	PRP	_	2	SBJ
2	report	report	VBP	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	variety	variety	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	biallelic	biallelic	JJ	_	7	NMOD
7	effects	effect	NNS	_	5	PMOD
8	on	on	IN	_	7	NMOD
9	organismal	organismal	JJ	_	10	NMOD
10	phenotype	phenotype	NN	_	8	PMOD
11	attributable	attributable	JJ	_	7	NMOD
12	to	to	IN	_	11	AMOD
13	combinations	combination	NNS	_	12	PMOD
14	of	of	IN	_	13	NMOD
15	recessive	recessive	JJ	_	17	NMOD
16	Xpd	xpd	NN	_	17	NMOD
17	alleles	allele	NNS	_	14	PMOD
18	,	,	,	_	4	P
19	including	include	VBG	_	4	NMOD
20	the	the	DT	_	21	NMOD
21	following	following	NN	_	27	NMOD
22	:	:	:	_	27	P
23	(	(	-LRB-	_	24	P
24	i	i	LS	_	27	NMOD
25	)	)	-RRB-	_	24	P
26	the	the	DT	_	27	NMOD
27	ability	ability	NN	_	19	PMOD
28	of	of	IN	_	27	NMOD
29	homozygous	homozygous	JJ	_	32	NMOD
30	lethal	lethal	JJ	_	32	NMOD
31	Xpd	xpd	NN	_	32	NMOD
32	alleles	allele	NNS	_	28	PMOD
33	to	to	TO	_	27	NMOD
34	ameliorate	ameliorate	VB	_	33	IM
35	a	a	DT	_	36	NMOD
36	variety	variety	NN	_	34	OBJ
37	of	of	IN	_	36	NMOD
38	disease	disease	NN	_	39	NMOD
39	symptoms	symptom	NNS	_	37	PMOD
40	when	when	WRB	_	47	TMP
41	their	their	PRP$	_	45	NMOD
42	essential	essential	JJ	_	45	NMOD
43	basal	basal	JJ	_	45	NMOD
44	transcription	transcription	NN	_	45	NMOD
45	function	function	NN	_	46	SBJ
46	is	be	VBZ	_	34	TMP
47	supplied	supply	VBN	_	46	VC
48	by	by	IN	_	47	LGS
49	a	a	DT	_	54	NMOD
50	different	different	JJ	_	54	NMOD
51	disease	disease	NN	_	53	AMOD
52	-	-	HYPH	_	51	P
53	causing	cause	VBG	_	54	NMOD
54	allele	allele	NN	_	48	PMOD
55	,	,	,	_	27	P
56	(	(	-LRB-	_	57	P
57	ii	ii	LS	_	65	NMOD
58	)	)	-RRB-	_	57	P
59	differential	differential	JJ	_	60	AMOD
60	developmental	developmental	JJ	_	65	NMOD
61	and	and	CC	_	60	COORD
62	tissue	tissue	NN	_	64	AMOD
63	-	-	HYPH	_	62	P
64	specific	specific	JJ	_	61	CONJ
65	functions	function	NNS	_	27	CONJ
66	of	of	IN	_	65	NMOD
67	distinct	distinct	JJ	_	70	NMOD
68	Xpd	xpd	NN	_	69	NMOD
69	allele	allele	NN	_	70	NMOD
70	products	product	NNS	_	66	PMOD
71	,	,	,	_	65	P
72	and	and	CC	_	65	COORD
73	(	(	-LRB-	_	74	P
74	iii	iii	LS	_	77	NMOD
75	)	)	-RRB-	_	74	P
76	interallelic	interallelic	JJ	_	77	NMOD
77	complementation	complementation	NN	_	72	CONJ
78	,	,	,	_	77	P
79	a	a	DT	_	80	NMOD
80	phenomenon	phenomenon	NN	_	77	APPO
81	rarely	rarely	RB	_	82	ADV
82	reported	report	VBN	_	80	NMOD
83	at	at	IN	_	82	LOC
84	clinically	clinically	RB	_	85	AMOD
85	relevant	relevant	JJ	_	86	NMOD
86	loci	locus	NNS	_	83	PMOD
87	in	in	IN	_	86	LOC
88	mammals	mammal	NNS	_	87	PMOD
89	.	.	.	_	2	P

1	Our	our	PRP$	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	a	a	DT	_	5	NMOD
5	re-evaluation	re-evaluation	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	contribution	contribution	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	“	“	``	_	9	P
11	null	null	JJ	_	13	NMOD
12	”	”	''	_	13	P
13	alleles	allele	NNS	_	9	PMOD
14	to	to	IN	_	8	NMOD
15	XPD	xpd	NN	_	16	NMOD
16	disorders	disorder	NNS	_	14	PMOD
17	and	and	CC	_	3	COORD
18	highlight	highlight	VBP	_	17	CONJ
19	the	the	DT	_	20	NMOD
20	potential	potential	NN	_	18	OBJ
21	of	of	IN	_	20	NMOD
22	combinations	combination	NNS	_	21	PMOD
23	of	of	IN	_	22	NMOD
24	recessive	recessive	JJ	_	25	NMOD
25	alleles	allele	NNS	_	23	PMOD
26	to	to	TO	_	20	NMOD
27	affect	affect	VB	_	26	IM
28	both	both	CC	_	33	COORD
29	normal	normal	JJ	_	33	NMOD
30	and	and	CC	_	29	COORD
31	pathological	pathological	JJ	_	30	CONJ
32	phenotypic	phenotypic	JJ	_	33	NMOD
33	plasticity	plasticity	NN	_	27	OBJ
34	in	in	IN	_	27	LOC
35	mammals	mammal	NNS	_	34	PMOD
36	.	.	.	_	3	P

1	Introduction	introduction	NN	_	0	ROOT

1	Interallelic	interallelic	JJ	_	2	NMOD
2	complementation	complementation	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	defined	define	VBN	_	3	VC
5	as	as	IN	_	4	MNR
6	the	the	DT	_	7	NMOD
7	ability	ability	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	two	two	CD	_	12	NMOD
10	differentially	differentially	RB	_	11	AMOD
11	mutated	mutate	VBN	_	12	NMOD
12	alleles	allele	NNS	_	8	PMOD
13	to	to	TO	_	7	NMOD
14	function	function	VB	_	13	IM
15	better	well	RBR	_	14	ADV
16	together	together	RB	_	14	ADV
17	than	than	IN	_	15	AMOD
18	either	either	DT	_	19	SBJ
19	can	can	MD	_	17	SUB
20	on	on	IN	_	19	ADV
21	its	its	PRP$	_	22	NMOD
22	own	own	JJ	_	20	PMOD
23	.	.	.	_	3	P

1	Despite	despite	IN	_	22	ADV
2	its	its	PRP$	_	4	NMOD
3	near	near	JJ	_	4	NMOD
4	universality	universality	NN	_	1	PMOD
5	in	in	IN	_	4	LOC
6	lower	low	JJR	_	7	NMOD
7	organisms	organism	NNS	_	5	PMOD
8	[	[	-LRB-	_	9	P
9	1	0	CD	_	7	PRN
10	]	]	-RRB-	_	9	P
11	,	,	,	_	22	P
12	its	its	PRP$	_	13	NMOD
13	potential	potential	NN	_	22	SBJ
14	to	to	TO	_	13	NMOD
15	contribute	contribute	VB	_	14	IM
16	to	to	IN	_	15	ADV
17	clinical	clinical	JJ	_	18	NMOD
18	heterogeneity	heterogeneity	NN	_	16	PMOD
19	in	in	IN	_	18	NMOD
20	human	human	JJ	_	21	NMOD
21	disease	disease	NN	_	19	PMOD
22	is	be	VBZ	_	0	ROOT
23	seldom	seldom	RB	_	22	TMP
24	considered	consider	VBN	_	22	VC
25	.	.	.	_	22	P

1	Evidence	evidence	NN	_	9	SBJ
2	of	of	IN	_	1	NMOD
3	interallelic	interallelic	JJ	_	4	NMOD
4	complementation	complementation	NN	_	2	PMOD
5	at	at	IN	_	4	LOC
6	clinically	clinically	RB	_	7	AMOD
7	relevant	relevant	JJ	_	8	NMOD
8	loci	locus	NNS	_	5	PMOD
9	is	be	VBZ	_	0	ROOT
10	limited	limit	VBN	_	9	VC
11	to	to	IN	_	10	ADV
12	biochemical	biochemical	JJ	_	17	NMOD
13	and	and	CC	_	12	COORD
14	cell	cell	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	based	base	VBN	_	13	CONJ
17	studies	study	NNS	_	11	PMOD
18	of	of	IN	_	17	NMOD
19	a	a	DT	_	20	NMOD
20	handful	handful	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	metabolic	metabolic	JJ	_	23	NMOD
23	disorders	disorder	NNS	_	21	PMOD
24	with	with	IN	_	23	NMOD
25	defects	defect	NNS	_	24	PMOD
26	in	in	IN	_	25	NMOD
27	enzymes	enzyme	NNS	_	26	PMOD
28	including	include	VBG	_	27	NMOD
29	propinyl	propinyl	NN	_	31	NMOD
30	-	-	HYPH	_	29	P
31	CoA	coa	NN	_	32	NMOD
32	carboxylase	carboxylase	NN	_	28	PMOD
33	[	[	-LRB-	_	34	P
34	2	0	CD	_	32	PRN
35	]	]	-RRB-	_	34	P
36	,	,	,	_	32	P
37	argininosuccinate	argininosuccinate	NN	_	38	NMOD
38	lyase	lyase	NN	_	32	CONJ
39	[	[	-LRB-	_	40	P
40	3	0	CD	_	38	PRN
41	]	]	-RRB-	_	40	P
42	,	,	,	_	38	P
43	galactose	galactose	NN	_	47	NMOD
44	-	-	HYPH	_	43	P
45	1	0	CD	_	47	NMOD
46	-	-	HYPH	_	45	P
47	phosphate	phosphate	NN	_	48	NMOD
48	uridylyltransferase	uridylyltransferase	NN	_	38	CONJ
49	[	[	-LRB-	_	50	P
50	4	0	CD	_	48	PRN
51	]	]	-RRB-	_	50	P
52	,	,	,	_	48	P
53	and	and	CC	_	48	COORD
54	methylmalonyl	methylmalonyl	NN	_	56	NMOD
55	CoA	coa	NN	_	56	NMOD
56	mutase	mutase	NN	_	53	CONJ
57	[	[	-LRB-	_	58	P
58	5	0	CD	_	56	PRN
59	]	]	-RRB-	_	58	P
60	.	.	.	_	9	P

1	Compound	compound	JJ	_	2	NMOD
2	heterozygotes	heterozygote	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	individuals	individual	NNS	_	3	PRD
5	carrying	carry	VBG	_	4	NMOD
6	two	two	CD	_	9	NMOD
7	different	different	JJ	_	9	NMOD
8	mutant	mutant	JJ	_	9	NMOD
9	alleles	allele	NNS	_	5	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	same	same	JJ	_	13	NMOD
13	gene	gene	NN	_	10	PMOD
14	.	.	.	_	3	P

1	In	in	IN	_	32	ADV
2	the	the	DT	_	3	NMOD
3	absence	absence	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	a	a	DT	_	15	NMOD
6	dominant	dominant	JJ	_	15	NMOD
7	(	(	-LRB-	_	15	P
8	wild	wild	JJ	_	10	NMOD
9	-	-	HYPH	_	8	P
10	type	type	NN	_	12	NMOD
11	[	[	-LRB-	_	12	P
12	wt	wt	NN	_	15	NMOD
13	]	]	-RRB-	_	15	P
14	)	)	-RRB-	_	15	P
15	allele	allele	NN	_	4	PMOD
16	,	,	,	_	32	P
17	genetic	genetic	JJ	_	18	NMOD
18	interactions	interaction	NNS	_	32	SBJ
19	between	between	IN	_	18	NMOD
20	recessive	recessive	JJ	_	21	NMOD
21	alleles	allele	NNS	_	19	PMOD
22	(	(	-LRB-	_	18	P
23	referred	refer	VBN	_	18	NMOD
24	to	to	IN	_	23	ADV
25	here	here	RB	_	23	ADV
26	as	as	IN	_	23	MNR
27	“	“	``	_	26	P
28	biallelic	biallelic	JJ	_	30	NMOD
29	”	”	''	_	30	P
30	effects	effect	NNS	_	26	PMOD
31	)	)	-RRB-	_	32	P
32	could	could	MD	_	0	ROOT
33	result	result	VB	_	32	VC
34	in	in	IN	_	33	ADV
35	different	different	JJ	_	37	NMOD
36	phenotypic	phenotypic	JJ	_	37	NMOD
37	outcomes	outcome	NNS	_	34	PMOD
38	including	include	VBG	_	37	NMOD
39	interallelic	interallelic	JJ	_	40	NMOD
40	complementation	complementation	NN	_	38	PMOD
41	.	.	.	_	32	P

1	Although	although	IN	_	32	ADV
2	amelioration	amelioration	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	disease	disease	NN	_	5	NMOD
5	symptoms	symptom	NNS	_	3	PMOD
6	by	by	IN	_	2	NMOD
7	interallelic	interallelic	JJ	_	8	NMOD
8	complementation	complementation	NN	_	6	PMOD
9	would	would	MD	_	1	SUB
10	create	create	VB	_	9	VC
11	an	an	DT	_	13	NMOD
12	ascertainment	ascertainment	NN	_	13	NMOD
13	bias	bias	NN	_	10	OBJ
14	in	in	IN	_	10	LOC
15	the	the	DT	_	16	NMOD
16	clinic	clinic	NN	_	14	PMOD
17	,	,	,	_	32	P
18	the	the	DT	_	19	NMOD
19	lack	lack	NN	_	32	SBJ
20	of	of	IN	_	19	NMOD
21	evidence	evidence	NN	_	20	PMOD
22	concerning	concern	VBG	_	21	NMOD
23	interallelic	interallelic	JJ	_	24	NMOD
24	complementation	complementation	NN	_	22	PMOD
25	or	or	CC	_	24	COORD
26	other	other	JJ	_	28	NMOD
27	biallelic	biallelic	JJ	_	28	NMOD
28	effects	effect	NNS	_	25	CONJ
29	in	in	IN	_	24	NMOD
30	human	human	JJ	_	31	NMOD
31	disease	disease	NN	_	29	PMOD
32	is	be	VBZ	_	0	ROOT
33	likely	likely	RB	_	32	ADV
34	caused	cause	VBN	_	32	VC
35	by	by	IN	_	34	LGS
36	the	the	DT	_	37	NMOD
37	difficulty	difficulty	NN	_	35	PMOD
38	in	in	IN	_	37	NMOD
39	distinguishing	distinguish	VBG	_	38	PMOD
40	such	such	JJ	_	41	NMOD
41	effects	effect	NNS	_	39	OBJ
42	from	from	IN	_	39	ADV
43	environment	environment	NN	_	42	PMOD
44	and	and	CC	_	43	COORD
45	genetic	genetic	JJ	_	46	NMOD
46	background	background	NN	_	44	CONJ
47	.	.	.	_	32	P

1	XPD	xpd	NN	_	2	SBJ
2	encodes	encode	VBZ	_	0	ROOT
3	one	one	CD	_	27	NMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	two	two	CD	_	8	NMOD
7	helicase	helicase	NN	_	8	NMOD
8	components	component	NNS	_	4	PMOD
9	of	of	IN	_	8	NMOD
10	basal	basal	JJ	_	18	NMOD
11	transcription	transcription	NN	_	14	NMOD
12	/	/	HYPH	_	11	P
13	DNA	dna	NN	_	14	NMOD
14	repair	repair	NN	_	16	NMOD
15	factor	factor	NN	_	16	NMOD
16	IIH	iih	NN	_	18	NMOD
17	(	(	-LRB-	_	18	P
18	TFIIH	tfiih	NN	_	9	PMOD
19	)	)	-RRB-	_	27	P
20	,	,	,	_	27	P
21	a	a	DT	_	27	NMOD
22	ten	ten	CD	_	24	NMOD
23	-	-	HYPH	_	22	P
24	subunit	subunit	NN	_	27	NMOD
25	,	,	,	_	27	P
26	multifunctional	multifunctional	JJ	_	27	NMOD
27	complex	complex	NN	_	2	OBJ
28	that	that	WDT	_	29	SBJ
29	is	be	VBZ	_	27	NMOD
30	essential	essential	JJ	_	29	PRD
31	for	for	IN	_	30	AMOD
32	multiple	multiple	JJ	_	33	NMOD
33	processes	process	NNS	_	31	PMOD
34	,	,	,	_	33	P
35	including	include	VBG	_	33	NMOD
36	basal	basal	JJ	_	38	NMOD
37	transcription	transcription	NN	_	38	NMOD
38	initiation	initiation	NN	_	35	PMOD
39	and	and	CC	_	38	COORD
40	DNA	dna	NN	_	42	NMOD
41	damage	damage	NN	_	42	NMOD
42	repair	repair	NN	_	39	CONJ
43	via	via	IN	_	42	NMOD
44	the	the	DT	_	51	NMOD
45	nucleotide	nucleotide	NN	_	47	NMOD
46	excision	excision	NN	_	47	NMOD
47	repair	repair	NN	_	49	NMOD
48	(	(	-LRB-	_	49	P
49	NER	ner	NN	_	51	NMOD
50	)	)	-RRB-	_	51	P
51	pathway	pathway	NN	_	43	PMOD
52	[	[	-LRB-	_	55	P
53	6	0	CD	_	55	NMOD
54	,	,	,	_	55	P
55	7	0	CD	_	27	PRN
56	]	]	-RRB-	_	55	P
57	.	.	.	_	2	P

1	Alterations	alteration	NNS	_	9	SBJ
2	in	in	IN	_	1	NMOD
3	XPD	xpd	NN	_	2	PMOD
4	resulting	result	VBG	_	1	NMOD
5	in	in	IN	_	4	ADV
6	defective	defective	JJ	_	8	NMOD
7	TFIIH	tfiih	NN	_	8	NMOD
8	function	function	NN	_	5	PMOD
9	are	be	VBP	_	0	ROOT
10	associated	associate	VBN	_	9	VC
11	with	with	IN	_	10	ADV
12	UV	uv	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	sensitive	sensitive	JJ	_	17	NMOD
15	,	,	,	_	17	P
16	multisystem	multisystem	JJ	_	17	NMOD
17	disorders	disorder	NNS	_	11	PMOD
18	including	include	VBG	_	17	NMOD
19	xeroderma	xeroderma	NN	_	20	NMOD
20	pigmentosum	pigmentosum	NN	_	22	NMOD
21	(	(	-LRB-	_	22	P
22	XP	xp	NN	_	18	PMOD
23	)	)	-RRB-	_	22	P
24	,	,	,	_	22	P
25	XP	xp	NN	_	22	CONJ
26	combined	combine	VBN	_	25	NMOD
27	with	with	IN	_	26	ADV
28	Cockayne	cockayne	NN	_	29	NMOD
29	syndrome	syndrome	NN	_	31	NMOD
30	(	(	-LRB-	_	31	P
31	CS	c	NN	_	27	PMOD
32	)	)	-RRB-	_	25	P
33	,	,	,	_	25	P
34	and	and	CC	_	25	COORD
35	trichothiodystrophy	trichothiodystrophy	NN	_	37	NMOD
36	(	(	-LRB-	_	37	P
37	TTD	ttd	NN	_	34	CONJ
38	)	)	-RRB-	_	10	P
39	[	[	-LRB-	_	40	P
40	8	0	CD	_	10	PRN
41	–	–	SYM	_	42	P
42	10	0	CD	_	40	NMOD
43	]	]	-RRB-	_	40	P
44	.	.	.	_	9	P

1	XP	xp	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	marked	mark	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	sun	sun	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	induced	induce	VBN	_	9	NMOD
8	pigmentation	pigmentation	NN	_	9	NMOD
9	anomalies	anomaly	NNS	_	4	PMOD
10	and	and	CC	_	9	COORD
11	a	a	DT	_	17	NMOD
12	greater	great	JJR	_	17	NMOD
13	than	than	IN	_	12	QMOD
14	1,000	0	CD	_	12	QMOD
15	-	-	HYPH	_	12	P
16	fold	fold	RB	_	12	QMOD
17	elevation	elevation	NN	_	10	CONJ
18	in	in	IN	_	17	NMOD
19	skin	skin	NN	_	20	NMOD
20	cancer	cancer	NN	_	21	NMOD
21	risk	risk	NN	_	18	PMOD
22	.	.	.	_	2	P

1	Severe	severe	JJ	_	2	NMOD
2	cases	case	NNS	_	3	SBJ
3	can	can	MD	_	0	ROOT
4	also	also	RB	_	3	ADV
5	present	present	VB	_	3	VC
6	with	with	IN	_	5	MNR
7	growth	growth	NN	_	8	NMOD
8	retardation	retardation	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	primary	primary	JJ	_	11	NMOD
11	neurodegeneration	neurodegeneration	NN	_	9	CONJ
12	[	[	-LRB-	_	13	P
13	11	0	CD	_	5	PRN
14	]	]	-RRB-	_	13	P
15	.	.	.	_	3	P

1	CS	c	NN	_	10	SBJ
2	and	and	CC	_	1	COORD
3	TTD	ttd	NN	_	2	CONJ
4	,	,	,	_	10	P
5	on	on	IN	_	10	ADV
6	the	the	DT	_	8	NMOD
7	other	other	JJ	_	8	NMOD
8	hand	hand	NN	_	5	PMOD
9	,	,	,	_	10	P
10	are	be	VBP	_	0	ROOT
11	segmental	segmental	JJ	_	13	NMOD
12	progeroid	progeroid	JJ	_	13	NMOD
13	disorders	disorder	NNS	_	10	PRD
14	characterised	characterise	VBN	_	13	NMOD
15	by	by	IN	_	14	LGS
16	progressive	progressive	JJ	_	19	NMOD
17	post-natal	post-natal	JJ	_	19	NMOD
18	growth	growth	NN	_	19	NMOD
19	failure	failure	NN	_	15	PMOD
20	and	and	CC	_	19	COORD
21	primary	primary	JJ	_	22	NMOD
22	demyelination	demyelination	NN	_	20	CONJ
23	resulting	result	VBG	_	22	NMOD
24	in	in	IN	_	23	ADV
25	severe	severe	JJ	_	26	NMOD
26	neurodysfunction	neurodysfunction	NN	_	24	PMOD
27	,	,	,	_	10	P
28	but	but	CC	_	29	COORD
29	without	without	IN	_	10	DEP
30	a	a	DT	_	33	NMOD
31	clear	clear	JJ	_	33	NMOD
32	cancer	cancer	NN	_	33	NMOD
33	predisposition	predisposition	NN	_	29	PMOD
34	[	[	-LRB-	_	35	P
35	12	0	CD	_	10	PRN
36	–	–	SYM	_	37	P
37	15	0	CD	_	35	NMOD
38	]	]	-RRB-	_	35	P
39	.	.	.	_	10	P

1	Patients	patient	NNS	_	5	SBJ
2	with	with	IN	_	1	NMOD
3	TTD	ttd	NN	_	2	PMOD
4	additionally	additionally	RB	_	5	ADV
5	display	display	VBP	_	0	ROOT
6	hallmark	hallmark	NN	_	11	NMOD
7	sulphur	sulphur	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	deficient	deficient	JJ	_	11	NMOD
10	brittle	brittle	JJ	_	11	NMOD
11	hair	hair	NN	_	5	OBJ
12	and	and	CC	_	11	COORD
13	nails	nail	NNS	_	12	CONJ
14	and	and	CC	_	11	COORD
15	scaling	scaling	JJ	_	16	NMOD
16	skin	skin	NN	_	14	CONJ
17	[	[	-LRB-	_	18	P
18	13	0	CD	_	11	PRN
19	]	]	-RRB-	_	18	P
20	,	,	,	_	11	P
21	resulting	result	VBG	_	11	NMOD
22	from	from	IN	_	21	ADV
23	a	a	DT	_	26	NMOD
24	basal	basal	JJ	_	26	NMOD
25	transcription	transcription	NN	_	26	NMOD
26	defect	defect	NN	_	22	PMOD
27	in	in	IN	_	26	LOC
28	specific	specific	JJ	_	30	NMOD
29	cell	cell	NN	_	30	NMOD
30	types	type	NNS	_	27	PMOD
31	[	[	-LRB-	_	34	P
32	16	0	CD	_	34	NMOD
33	,	,	,	_	34	P
34	17	0	CD	_	5	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	5	P

1	A	a	DT	_	3	NMOD
2	related	related	JJ	_	3	NMOD
3	disorder	disorder	NN	_	24	SBJ
4	with	with	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	cancer	cancer	NN	_	7	NMOD
7	predisposition	predisposition	NN	_	4	PMOD
8	of	of	IN	_	7	NMOD
9	XP	xp	NN	_	8	PMOD
10	combined	combine	VBN	_	7	NMOD
11	with	with	IN	_	10	ADV
12	the	the	DT	_	14	NMOD
13	neurodevelopmental	neurodevelopmental	JJ	_	14	NMOD
14	complications	complication	NNS	_	11	PMOD
15	of	of	IN	_	14	NMOD
16	CS	c	NN	_	15	PMOD
17	(	(	-LRB-	_	18	P
18	XPCS	xpcs	NN	_	16	PRN
19	)	)	-RRB-	_	18	P
20	,	,	,	_	24	P
21	although	although	IN	_	24	ADV
22	rare	rare	JJ	_	21	SUB
23	,	,	,	_	24	P
24	has	have	VBZ	_	0	ROOT
25	also	also	RB	_	24	ADV
26	been	be	VBN	_	24	VC
27	described	describe	VBN	_	26	VC
28	[	[	-LRB-	_	29	P
29	18	0	CD	_	27	PRN
30	]	]	-RRB-	_	29	P
31	.	.	.	_	24	P

1	Many	many	JJ	_	3	NMOD
2	XPD	xpd	NN	_	3	NMOD
3	mutations	mutation	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	associated	associate	VBN	_	4	VC
6	with	with	IN	_	5	ADV
7	an	an	DT	_	10	NMOD
8	exclusive	exclusive	JJ	_	10	NMOD
9	disease	disease	NN	_	10	NMOD
10	phenotype	phenotype	NN	_	6	PMOD
11	(	(	-LRB-	_	14	P
12	e.g.	e.g.	FW	_	14	NMOD
13	,	,	,	_	14	P
14	XPDR722W	xpdr0w	NN	_	10	PRN
15	with	with	IN	_	14	NMOD
16	TTD	ttd	NN	_	15	PMOD
17	and	and	CC	_	14	COORD
18	XPDR683W	xpdr0w	NN	_	17	CONJ
19	with	with	IN	_	18	NMOD
20	XP	xp	NN	_	19	PMOD
21	)	)	-RRB-	_	14	P
22	and	and	CC	_	4	COORD
23	are	be	VBP	_	22	CONJ
24	thus	thus	RB	_	23	ADV
25	viewed	view	VBN	_	23	VC
26	as	as	IN	_	25	ADV
27	causative	causative	JJ	_	26	PMOD
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	31	NMOD
30	corresponding	correspond	VBG	_	31	NMOD
31	syndromes	syndrome	NNS	_	28	PMOD
32	.	.	.	_	4	P

1	Alleles	allele	NNS	_	8	SBJ
2	not	not	RB	_	3	ADV
3	associated	associate	VBN	_	1	NMOD
4	exclusively	exclusively	RB	_	3	ADV
5	with	with	IN	_	3	ADV
6	one	one	CD	_	7	NMOD
7	disorder	disorder	NN	_	5	PMOD
8	are	be	VBP	_	0	ROOT
9	considered	consider	VBN	_	8	VC
10	“	“	``	_	14	P
11	likely	likely	RB	_	12	AMOD
12	null	null	JJ	_	14	NMOD
13	”	”	''	_	14	P
14	alleles	allele	NNS	_	9	OPRD
15	[	[	-LRB-	_	18	P
16	19	0	CD	_	18	NMOD
17	,	,	,	_	18	P
18	20	0	CD	_	9	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	8	P

1	Some	some	DT	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	these	these	DT	_	4	NMOD
4	alleles	allele	NNS	_	2	PMOD
5	fail	fail	VBP	_	0	ROOT
6	to	to	TO	_	5	OPRD
7	support	support	VB	_	6	IM
8	viability	viability	NN	_	7	OBJ
9	in	in	IN	_	7	LOC
10	a	a	DT	_	15	NMOD
11	haploid	haploid	JJ	_	15	NMOD
12	Schizosaccharomyces	schizosaccharomyces	NNP	_	15	NMOD
13	pombe	pombe	NNP	_	15	NMOD
14	yeast	yeast	NN	_	15	NMOD
15	strain	strain	NN	_	9	PMOD
16	with	with	IN	_	15	NMOD
17	a	a	DT	_	19	NMOD
18	null	null	JJ	_	19	NMOD
19	mutation	mutation	NN	_	16	PMOD
20	in	in	IN	_	19	LOC
21	the	the	DT	_	24	NMOD
22	XPD	xpd	NN	_	24	NMOD
23	homologue	homologue	NN	_	24	NMOD
24	rad15	rad0	NN	_	20	PMOD
25	and	and	CC	_	5	COORD
26	are	be	VBP	_	25	CONJ
27	thus	thus	RB	_	26	ADV
28	considered	consider	VBN	_	26	VC
29	devoid	devoid	JJ	_	28	OPRD
30	of	of	IN	_	29	AMOD
31	significant	significant	JJ	_	33	NMOD
32	biological	biological	JJ	_	33	NMOD
33	activity	activity	NN	_	30	PMOD
34	[	[	-LRB-	_	35	P
35	19	0	CD	_	28	PRN
36	]	]	-RRB-	_	35	P
37	.	.	.	_	5	P

1	This	this	DT	_	2	NMOD
2	classification	classification	NN	_	11	SBJ
3	of	of	IN	_	2	NMOD
4	alleles	allele	NNS	_	3	PMOD
5	as	as	IN	_	2	NMOD
6	either	either	CC	_	7	COORD
7	causative	causative	JJ	_	5	PMOD
8	or	or	CC	_	7	COORD
9	null	null	JJ	_	8	CONJ
10	currently	currently	RB	_	11	TMP
11	defines	define	VBZ	_	0	ROOT
12	what	what	WP	_	15	PMOD
13	we	we	PRP	_	14	SBJ
14	refer	refer	VBP	_	11	OBJ
15	to	to	IN	_	14	ADV
16	as	as	IN	_	14	ADV
17	a	a	DT	_	21	NMOD
18	“	“	``	_	21	P
19	monoallelic	monoallelic	JJ	_	21	NMOD
20	”	”	''	_	21	P
21	paradigm	paradigm	NN	_	16	PMOD
22	of	of	IN	_	21	NMOD
23	XPD	xpd	NN	_	24	NMOD
24	disease	disease	NN	_	22	PMOD
25	.	.	.	_	11	P

1	However	however	RB	_	30	ADV
2	,	,	,	_	30	P
3	the	the	DT	_	4	NMOD
4	identification	identification	NN	_	30	SBJ
5	in	in	IN	_	4	TMP
6	recent	recent	JJ	_	7	NMOD
7	years	year	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	XP	xp	NN	_	13	NMOD
10	complementation	complementation	NN	_	13	NMOD
11	group	group	NN	_	12	NMOD
12	D	d	NN	_	13	NMOD
13	patients	patient	NNS	_	8	PMOD
14	with	with	IN	_	13	NMOD
15	atypical	atypical	JJ	_	17	NMOD
16	disease	disease	NN	_	17	NMOD
17	presentation	presentation	NN	_	14	PMOD
18	,	,	,	_	17	P
19	including	include	VBG	_	17	NMOD
20	symptoms	symptom	NNS	_	19	PMOD
21	of	of	IN	_	20	NMOD
22	both	both	CC	_	23	COORD
23	XP	xp	NN	_	21	PMOD
24	and	and	CC	_	23	COORD
25	TTD	ttd	NN	_	24	CONJ
26	[	[	-LRB-	_	27	P
27	8	0	CD	_	4	PRN
28	]	]	-RRB-	_	27	P
29	,	,	,	_	30	P
30	casts	cast	VBZ	_	0	ROOT
31	doubt	doubt	NN	_	30	OBJ
32	on	on	IN	_	30	ADV
33	the	the	DT	_	34	NMOD
34	ability	ability	NN	_	32	PMOD
35	of	of	IN	_	34	NMOD
36	such	such	JJ	_	39	NMOD
37	a	a	DT	_	39	NMOD
38	monoallelic	monoallelic	JJ	_	39	NMOD
39	paradigm	paradigm	NN	_	35	PMOD
40	to	to	TO	_	34	NMOD
41	explain	explain	VB	_	40	IM
42	clinical	clinical	JJ	_	43	NMOD
43	heterogeneity	heterogeneity	NN	_	41	OBJ
44	in	in	IN	_	41	LOC
45	compound	compound	NN	_	46	NMOD
46	heterozygotes	heterozygote	NNS	_	44	PMOD
47	.	.	.	_	30	P

1	Previously	previously	RB	_	4	TMP
2	,	,	,	_	4	P
3	we	we	PRP	_	4	SBJ
4	generated	generate	VBD	_	0	ROOT
5	a	a	DT	_	8	NMOD
6	TTD	ttd	NN	_	8	NMOD
7	mouse	mouse	NN	_	8	NMOD
8	model	model	NN	_	4	OBJ
9	(	(	-LRB-	_	10	P
10	XPDR722W	xpdr0w	NN	_	8	PRN
11	)	)	-RRB-	_	10	P
12	that	that	WDT	_	13	SBJ
13	phenocopies	phenocopies	VBZ	_	8	NMOD
14	the	the	DT	_	16	NMOD
15	human	human	JJ	_	16	NMOD
16	syndrome	syndrome	NN	_	13	OBJ
17	[	[	-LRB-	_	20	P
18	15	0	CD	_	20	NMOD
19	,	,	,	_	20	P
20	21	0	CD	_	4	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	4	P

1	Here	here	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	report	report	VBP	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	generation	generation	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	additional	additional	JJ	_	10	NMOD
8	mutant	mutant	JJ	_	10	NMOD
9	Xpd	xpd	NN	_	10	NMOD
10	alleles	allele	NNS	_	6	PMOD
11	that	that	WDT	_	12	SBJ
12	fail	fail	VBP	_	10	NMOD
13	to	to	TO	_	12	OPRD
14	support	support	VB	_	13	IM
15	viability	viability	NN	_	14	OBJ
16	on	on	IN	_	14	ADV
17	their	their	PRP$	_	18	NMOD
18	own	own	NN	_	16	PMOD
19	but	but	CC	_	12	COORD
20	nevertheless	nevertheless	RB	_	21	ADV
21	ameliorate	ameliorate	VBP	_	19	CONJ
22	TTD	ttd	NN	_	24	AMOD
23	-	-	HYPH	_	22	P
24	associated	associate	VBN	_	27	NMOD
25	premature	premature	JJ	_	27	NMOD
26	segmental	segmental	JJ	_	27	NMOD
27	ageing	ageing	NN	_	21	OBJ
28	,	,	,	_	27	P
29	cutaneous	cutaneous	JJ	_	30	NMOD
30	features	feature	NNS	_	27	CONJ
31	,	,	,	_	30	P
32	cellular	cellular	JJ	_	35	NMOD
33	DNA	dna	NN	_	34	NMOD
34	repair	repair	NN	_	35	NMOD
35	capacity	capacity	NN	_	30	CONJ
36	,	,	,	_	35	P
37	and	and	CC	_	35	COORD
38	UV	uv	NN	_	39	NMOD
39	survival	survival	NN	_	37	CONJ
40	when	when	WRB	_	41	TMP
41	present	present	JJ	_	21	TMP
42	in	in	IN	_	41	AMOD
43	a	a	DT	_	46	NMOD
44	compound	compound	JJ	_	46	NMOD
45	heterozygote	heterozygote	NN	_	46	NMOD
46	state	state	NN	_	42	PMOD
47	.	.	.	_	3	P

1	Results	result	NNS	_	0	ROOT

1	Generation	generation	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Xpd	xpd	NN	_	5	NMOD
4	Compound	compound	NN	_	5	NMOD
5	Heterozygotes	heterozygote	NNS	_	2	PMOD

1	We	we	PRP	_	2	SBJ
2	generated	generate	VBD	_	0	ROOT
3	an	an	DT	_	8	NMOD
4	Xpd	xpd	NN	_	8	NMOD
5	knock	knock	VB	_	8	NMOD
6	-	-	HYPH	_	5	P
7	in	in	RP	_	5	AMOD
8	allele	allele	NN	_	2	OBJ
9	with	with	IN	_	8	NMOD
10	a	a	DT	_	12	NMOD
11	point	point	NN	_	12	NMOD
12	mutation	mutation	NN	_	9	PMOD
13	encoding	encode	VBG	_	12	NMOD
14	a	a	DT	_	18	NMOD
15	single	single	JJ	_	18	NMOD
16	amino	amino	NN	_	17	NMOD
17	acid	acid	NN	_	18	NMOD
18	change	change	NN	_	13	OBJ
19	(	(	-LRB-	_	20	P
20	XPDG602D	xpdg0d	NN	_	18	PRN
21	)	)	-RRB-	_	20	P
22	found	find	VBN	_	18	NMOD
23	in	in	IN	_	22	LOC
24	the	the	DT	_	26	NMOD
25	XPCS	xpcs	NN	_	26	NMOD
26	patient	patient	NN	_	27	NMOD
27	XPCS2	xpcs0	NN	_	23	PMOD
28	(	(	-LRB-	_	30	P
29	Figure	figure	NN	_	30	NMOD
30	1A	0a	NN	_	2	PRN
31	–	–	SYM	_	32	P
32	1C	0c	NN	_	30	NMOD
33	)	)	-RRB-	_	30	P
34	.	.	.	_	2	P

1	mRNA	mrna	NN	_	2	NMOD
2	expression	expression	NN	_	7	SBJ
3	from	from	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	targeted	target	VBN	_	6	NMOD
6	allele	allele	NN	_	3	PMOD
7	could	could	MD	_	0	ROOT
8	be	be	VB	_	7	VC
9	detected	detect	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	embryonic	embryonic	JJ	_	13	NMOD
12	stem	stem	NN	_	13	NMOD
13	cells	cell	NNS	_	10	PMOD
14	by	by	IN	_	9	MNR
15	RT	rt	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	PCR	pcr	NN	_	14	PMOD
18	(	(	-LRB-	_	20	P
19	Figure	figure	NN	_	20	NMOD
20	1D	0d	NN	_	9	PRN
21	)	)	-RRB-	_	20	P
22	,	,	,	_	9	P
23	although	although	IN	_	9	ADV
24	expression	expression	NN	_	25	SBJ
25	was	be	VBD	_	23	SUB
26	reduced	reduce	VBN	_	25	VC
27	approximately	approximately	RB	_	28	NMOD
28	5	0	CD	_	26	EXT
29	-	-	HYPH	_	28	P
30	fold	fold	RB	_	28	QMOD
31	relative	relative	JJ	_	26	ADV
32	to	to	IN	_	31	AMOD
33	wt	wt	NN	_	36	NMOD
34	mRNA	mrna	NN	_	36	NMOD
35	transcript	transcript	NN	_	36	NMOD
36	levels	level	NNS	_	32	PMOD
37	as	as	IN	_	26	ADV
38	determined	determine	VBN	_	37	SUB
39	by	by	IN	_	38	MNR
40	Northern	northern	NNP	_	39	PMOD
41	blotting	blot	VBG	_	40	NMOD
42	of	of	IN	_	40	NMOD
43	RNA	rna	NN	_	42	PMOD
44	from	from	IN	_	43	NMOD
45	the	the	DT	_	46	NMOD
46	testis	testis	NN	_	44	PMOD
47	of	of	IN	_	46	NMOD
48	heterozygous	heterozygous	JJ	_	49	NMOD
49	animals	animal	NNS	_	47	PMOD
50	(	(	-LRB-	_	52	P
51	Figure	figure	NN	_	52	NMOD
52	1E	0e	NN	_	9	PRN
53	)	)	-RRB-	_	52	P
54	.	.	.	_	7	P

1	Because	because	IN	_	23	PRP
2	patient	patient	NN	_	3	NMOD
3	XPCS2	xpcs0	NN	_	4	SBJ
4	was	be	VBD	_	1	SUB
5	a	a	DT	_	6	NMOD
6	hemizygote	hemizygote	NN	_	4	PRD
7	with	with	IN	_	6	NMOD
8	mutant	mutant	JJ	_	10	NMOD
9	XPD	xpd	NN	_	10	NMOD
10	protein	protein	NN	_	7	PMOD
11	(	(	-LRB-	_	12	P
12	XPDG602D	xpdg0d	NN	_	10	PRN
13	)	)	-RRB-	_	12	P
14	expressed	express	VBN	_	10	NMOD
15	from	from	IN	_	14	ADV
16	a	a	DT	_	18	NMOD
17	single	single	JJ	_	18	NMOD
18	allele	allele	NN	_	15	PMOD
19	,	,	,	_	23	P
20	the	the	DT	_	22	NMOD
21	corresponding	correspond	VBG	_	22	NMOD
22	mutation	mutation	NN	_	23	SBJ
23	was	be	VBD	_	0	ROOT
24	expected	expect	VBN	_	23	VC
25	to	to	TO	_	24	OPRD
26	be	be	VB	_	25	IM
27	viable	viable	JJ	_	26	PRD
28	in	in	IN	_	26	ADV
29	the	the	DT	_	31	NMOD
30	homozygous	homozygous	JJ	_	31	NMOD
31	state	state	NN	_	28	PMOD
32	.	.	.	_	23	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	homozygous	homozygous	JJ	_	5	NMOD
4	mutant	mutant	JJ	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	not	not	RB	_	6	ADV
8	observed	observe	VBN	_	6	VC
9	,	,	,	_	8	P
10	neither	neither	CC	_	11	COORD
11	amongst	amongst	IN	_	8	ADV
12	live	live	JJ	_	13	NMOD
13	births	birth	NNS	_	11	PMOD
14	nor	nor	CC	_	13	COORD
15	embryonic	embryonic	JJ	_	16	NMOD
16	day	day	NN	_	19	NMOD
17	13.5	0	CD	_	16	NMOD
18	(	(	-LRB-	_	19	P
19	E13.5	e0	NN	_	23	NMOD
20	)	)	-RRB-	_	19	P
21	or	or	CC	_	19	COORD
22	E3.5	e0	NN	_	21	CONJ
23	embryos	embryo	NNS	_	14	CONJ
24	(	(	-LRB-	_	25	P
25	Table	table	NN	_	8	PRN
26	1	0	CD	_	25	NMOD
27	)	)	-RRB-	_	25	P
28	.	.	.	_	6	P

1	The	the	DT	_	6	NMOD
2	corresponding	correspond	VBG	_	6	NMOD
3	hypomorphic	hypomorphic	JJ	_	6	NMOD
4	,	,	,	_	6	P
5	mutant	mutant	JJ	_	6	NMOD
6	allele	allele	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	thus	thus	RB	_	7	ADV
9	designated	designate	VBN	_	7	VC
10	as	as	IN	_	9	MNR
11	homozygous	homozygous	JJ	_	12	NMOD
12	lethal	lethal	JJ	_	10	PMOD
13	(	(	-LRB-	_	14	P
14	†XPCS	†xpcs	NN	_	12	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	7	P

1	Homozygous	homozygous	JJ	_	2	NMOD
2	lethality	lethality	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	XPCS	xpcs	NN	_	6	NMOD
6	allele	allele	NN	_	3	PMOD
7	is	be	VBZ	_	0	ROOT
8	likely	likely	RB	_	9	PMOD
9	due	due	IN	_	7	PRP
10	to	to	IN	_	9	PMOD
11	reduced	reduce	VBN	_	12	NMOD
12	levels	level	NNS	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	expression	expression	NN	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	this	this	DT	_	18	NMOD
17	essential	essential	JJ	_	18	NMOD
18	protein	protein	NN	_	15	PMOD
19	as	as	IN	_	12	NMOD
20	a	a	DT	_	21	NMOD
21	result	result	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	gene	gene	NN	_	24	NMOD
24	targeting	targeting	NN	_	22	PMOD
25	(	(	-LRB-	_	27	P
26	Figure	figure	NN	_	27	NMOD
27	1A	0a	NN	_	24	PRN
28	)	)	-RRB-	_	27	P
29	rather	rather	JJ	_	30	DEP
30	than	than	IN	_	10	COORD
31	to	to	IN	_	30	CONJ
32	the	the	DT	_	33	NMOD
33	mutation	mutation	NN	_	34	NMOD
34	itself	itself	PRP	_	31	PMOD
35	.	.	.	_	7	P

1	Xpd	xpd	NN	_	2	NMOD
2	ablation	ablation	NN	_	8	SBJ
3	(	(	-LRB-	_	6	P
4	XpdKO	xpdko	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	KO	ko	NN	_	2	PRN
7	)	)	-RRB-	_	6	P
8	is	be	VBZ	_	0	ROOT
9	similarly	similarly	RB	_	10	AMOD
10	incompatible	incompatible	JJ	_	8	PRD
11	with	with	IN	_	10	AMOD
12	life	life	NN	_	11	PMOD
13	beyond	beyond	IN	_	12	TMP
14	the	the	DT	_	16	NMOD
15	earliest	early	JJS	_	16	NMOD
16	stages	stage	NNS	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	embryogenesis	embryogenesis	NN	_	17	PMOD
19	[	[	-LRB-	_	20	P
20	22	0	CD	_	8	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	8	P

1	Consistent	consistent	JJ	_	26	ADV
2	with	with	IN	_	1	AMOD
3	this	this	DT	_	4	NMOD
4	interpretation	interpretation	NN	_	2	PMOD
5	,	,	,	_	26	P
6	a	a	DT	_	10	NMOD
7	different	different	JJ	_	10	NMOD
8	targeted	target	VBN	_	10	NMOD
9	Xpd	xpd	NN	_	10	NMOD
10	mutation	mutation	NN	_	26	SBJ
11	encoding	encode	VBG	_	10	NMOD
12	XPDR683W	xpdr0w	NN	_	11	OBJ
13	,	,	,	_	12	P
14	which	which	WDT	_	15	SBJ
15	is	be	VBZ	_	12	NMOD
16	associated	associate	VBN	_	15	VC
17	with	with	IN	_	16	ADV
18	XP	xp	NN	_	17	PMOD
19	in	in	IN	_	16	ADV
20	the	the	DT	_	22	NMOD
21	homozygous	homozygous	JJ	_	22	NMOD
22	state	state	NN	_	19	PMOD
23	in	in	IN	_	16	LOC
24	humans	human	NNS	_	23	PMOD
25	,	,	,	_	26	P
26	was	be	VBD	_	0	ROOT
27	similarly	similarly	RB	_	28	AMOD
28	underexpressed	underexpressed	JJ	_	26	PRD
29	and	and	CC	_	28	COORD
30	lethal	lethal	JJ	_	29	CONJ
31	in	in	IN	_	26	ADV
32	the	the	DT	_	34	NMOD
33	homozygous	homozygous	JJ	_	34	NMOD
34	state	state	NN	_	31	PMOD
35	(	(	-LRB-	_	36	P
36	designated	designate	VBN	_	26	PRN
37	as	as	IN	_	36	ADV
38	†XP	†xp	NN	_	39	NMOD
39	allele	allele	NN	_	37	PMOD
40	)	)	-RRB-	_	36	P
41	(	(	-LRB-	_	51	P
42	Figure	figure	NN	_	43	NMOD
43	1A	0a	NN	_	51	NMOD
44	–	–	SYM	_	45	P
45	1C	0c	NN	_	43	NMOD
46	;	;	:	_	51	P
47	Table	table	NN	_	51	NMOD
48	1	0	CD	_	47	NMOD
49	;	;	:	_	51	P
50	unpublished	unpublished	JJ	_	51	NMOD
51	data	datum	NNS	_	26	PRN
52	)	)	-RRB-	_	51	P
53	.	.	.	_	26	P

1	Also	also	RB	_	23	ADV
2	,	,	,	_	23	P
3	a	a	DT	_	6	NMOD
4	different	different	JJ	_	6	NMOD
5	targeting	targeting	NN	_	6	NMOD
6	approach	approach	NN	_	23	SBJ
7	leading	lead	VBG	_	6	NMOD
8	to	to	IN	_	7	ADV
9	the	the	DT	_	10	NMOD
10	use	use	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	16	NMOD
13	native	native	JJ	_	16	NMOD
14	3	0	CD	_	16	NMOD
15	′	′	SYM	_	14	P
16	UTR	utr	NN	_	11	PMOD
17	and	and	CC	_	10	COORD
18	removal	removal	NN	_	17	CONJ
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	neo	neo	NN	_	22	NMOD
22	gene	gene	NN	_	19	PMOD
23	resulted	result	VBD	_	0	ROOT
24	in	in	IN	_	23	ADV
25	normalisation	normalisation	NN	_	24	PMOD
26	of	of	IN	_	25	NMOD
27	XpdXPCS	xpdxpcs	NN	_	29	NMOD
28	mRNA	mrna	NN	_	29	NMOD
29	levels	level	NNS	_	26	PMOD
30	and	and	CC	_	25	COORD
31	viable	viable	JJ	_	41	NMOD
32	homozygous	homozygous	JJ	_	41	NMOD
33	XpdXPCS	xpdxpcs	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	XPCS	xpcs	NN	_	41	NMOD
36	(	(	-LRB-	_	39	P
37	XPDG602D	xpdg0d	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	G602D	g0d	NN	_	35	PRN
40	)	)	-RRB-	_	39	P
41	animals	animal	NNS	_	30	CONJ
42	[	[	-LRB-	_	43	P
43	23	0	CD	_	23	PRN
44	]	]	-RRB-	_	43	P
45	.	.	.	_	23	P

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Targeting	targeting	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	6	NMOD
4	Mouse	mouse	NN	_	6	NMOD
5	Xpd	xpd	NN	_	6	NMOD
6	Gene	gene	NN	_	2	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Schematic	schematic	JJ	_	5	NMOD
5	representation	representation	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	structure	structure	NN	_	6	PMOD
10	and	and	CC	_	5	COORD
11	partial	partial	JJ	_	13	NMOD
12	restriction	restriction	NN	_	13	NMOD
13	map	map	NN	_	10	CONJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	21	NMOD
16	wt	wt	NN	_	21	NMOD
17	and	and	CC	_	16	COORD
18	targeted	target	VBN	_	17	CONJ
19	mouse	mouse	NN	_	21	NMOD
20	Xpd	xpd	NN	_	21	NMOD
21	loci	locus	NNS	_	14	PMOD
22	.	.	.	_	5	P

1	For	for	IN	_	24	ADV
2	the	the	DT	_	5	NMOD
3	wt	wt	NN	_	5	NMOD
4	Xpd	xpd	NN	_	5	NMOD
5	allele	allele	NN	_	1	PMOD
6	,	,	,	_	24	P
7	shaded	shaded	JJ	_	8	NMOD
8	boxes	box	NNS	_	9	SBJ
9	represent	represent	VBP	_	24	DEP
10	coding	code	VBG	_	11	NMOD
11	regions	region	NNS	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	exons	exon	NNS	_	14	NMOD
14	12	0	CD	_	12	PMOD
15	and	and	CC	_	14	COORD
16	19	0	CD	_	15	CONJ
17	–	–	SYM	_	18	P
18	23	0	CD	_	16	NMOD
19	;	;	:	_	24	P
20	the	the	DT	_	23	NMOD
21	3	0	CD	_	23	NMOD
22	′	′	SYM	_	21	P
23	UTR	utr	NN	_	24	SBJ
24	is	be	VBZ	_	0	ROOT
25	represented	represent	VBN	_	24	VC
26	by	by	IN	_	25	LGS
27	an	an	DT	_	29	NMOD
28	open	open	JJ	_	29	NMOD
29	box	box	NN	_	26	PMOD
30	.	.	.	_	24	P

1	TGA	tga	NN	_	2	SBJ
2	indicates	indicate	VBZ	_	9	DEP
3	the	the	DT	_	6	NMOD
4	translational	translational	JJ	_	6	NMOD
5	stop	stop	NN	_	6	NMOD
6	codon	codon	NN	_	2	OBJ
7	;	;	:	_	9	P
8	PolyA	polya	NN	_	9	SBJ
9	indicates	indicate	VBZ	_	0	ROOT
10	the	the	DT	_	12	NMOD
11	polyadenylation	polyadenylation	NN	_	12	NMOD
12	signal	signal	NN	_	9	OBJ
13	.	.	.	_	9	P

1	For	for	IN	_	23	ADV
2	the	the	DT	_	5	NMOD
3	XpdTTD	xpdttd	NN	_	5	NMOD
4	targeted	target	VBN	_	5	NMOD
5	allele	allele	NN	_	1	PMOD
6	,	,	,	_	23	P
7	the	the	DT	_	18	NMOD
8	194	0	CD	_	13	NMOD
9	–	–	HYPH	_	8	P
10	base	base	NN	_	11	NMOD
11	pair	pair	NN	_	13	NMOD
12	(	(	-LRB-	_	13	P
13	bp	bp	NN	_	18	NMOD
14	)	)	-RRB-	_	18	P
15	human	human	JJ	_	18	NMOD
16	XPD	xpd	NN	_	18	NMOD
17	cDNA	cdna	NN	_	18	NMOD
18	fragment	fragment	NN	_	23	SBJ
19	fused	fuse	VBN	_	18	NMOD
20	to	to	IN	_	19	ADV
21	exon	exon	NN	_	20	PMOD
22	22	0	CD	_	21	NMOD
23	is	be	VBZ	_	0	ROOT
24	indicated	indicate	VBN	_	23	VC
25	as	as	IN	_	24	MNR
26	a	a	DT	_	28	NMOD
27	striped	stripe	VBN	_	28	NMOD
28	box	box	NN	_	25	PMOD
29	including	include	VBG	_	18	NMOD
30	the	the	DT	_	35	NMOD
31	TTD	ttd	NN	_	35	NMOD
32	(	(	-LRB-	_	33	P
33	R722W	r0w	NN	_	31	PRN
34	)	)	-RRB-	_	33	P
35	mutation	mutation	NN	_	29	PMOD
36	indicated	indicate	VBN	_	35	NMOD
37	by	by	IN	_	36	LGS
38	a	a	DT	_	40	NMOD
39	vertical	vertical	JJ	_	40	NMOD
40	arrow	arrow	NN	_	37	PMOD
41	.	.	.	_	23	P

1	Chicken	chicken	NN	_	6	NMOD
2	β	β	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	globin	globin	NN	_	6	NMOD
5	exons	exon	NNS	_	6	NMOD
6	2	0	CD	_	14	SBJ
7	and	and	CC	_	6	COORD
8	3	0	CD	_	7	CONJ
9	including	include	VBG	_	6	NMOD
10	the	the	DT	_	13	NMOD
11	3	0	CD	_	13	NMOD
12	′	′	HYPH	_	11	P
13	UTR	utr	NN	_	9	PMOD
14	are	be	VBP	_	0	ROOT
15	indicated	indicate	VBN	_	14	VC
16	as	as	IN	_	15	MNR
17	black	black	JJ	_	18	NMOD
18	boxes	box	NNS	_	16	PMOD
19	with	with	IN	_	18	NMOD
20	corresponding	correspond	VBG	_	22	NMOD
21	Roman	roman	NNP	_	22	NMOD
22	numerals	numeral	NNS	_	19	PMOD
23	followed	follow	VBN	_	22	NMOD
24	by	by	IN	_	23	LGS
25	the	the	DT	_	30	NMOD
26	β	β	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	globin	globin	NN	_	30	NMOD
29	polyadenylation	polyadenylation	NN	_	30	NMOD
30	signal	signal	NN	_	24	PMOD
31	(	(	-LRB-	_	32	P
32	PolyA*	polya*	NN	_	30	PRN
33	)	)	-RRB-	_	32	P
34	.	.	.	_	14	P

1	For	for	IN	_	11	ADV
2	the	the	DT	_	7	NMOD
3	Xpd†XP	xpd†xp	NN	_	7	NMOD
4	and	and	CC	_	3	COORD
5	Xpd†XPCS	xpd†xpcs	NN	_	4	CONJ
6	targeted	target	VBN	_	7	NMOD
7	alleles	allele	NNS	_	1	PMOD
8	,	,	,	_	11	P
9	vertical	vertical	JJ	_	10	NMOD
10	arrows	arrow	NNS	_	11	SBJ
11	indicate	indicate	VBP	_	0	ROOT
12	XPCS	xpcs	NN	_	25	NMOD
13	(	(	-LRB-	_	16	P
14	G602D	g0d	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	encoding	encode	VBG	_	12	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	12	COORD
19	XP	xp	NN	_	18	CONJ
20	(	(	-LRB-	_	23	P
21	R683W	r0w	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	encoding	encode	VBG	_	19	PRN
24	)	)	-RRB-	_	23	P
25	mutations	mutation	NNS	_	11	OBJ
26	in	in	IN	_	25	LOC
27	exons	exon	NNS	_	28	NMOD
28	19	0	CD	_	26	PMOD
29	and	and	CC	_	28	COORD
30	22	0	CD	_	29	CONJ
31	,	,	,	_	11	P
32	respectively	respectively	RB	_	11	ADV
33	.	.	.	_	11	P

1	The	the	DT	_	5	NMOD
2	unique	unique	JJ	_	5	NMOD
3	3	0	CD	_	5	NMOD
4	′	′	SYM	_	3	P
5	probe	probe	NN	_	11	SBJ
6	located	locate	VBN	_	5	NMOD
7	outside	outside	IN	_	6	LOC
8	the	the	DT	_	10	NMOD
9	targeting	target	VBG	_	10	NMOD
10	construct	construct	NN	_	7	PMOD
11	is	be	VBZ	_	0	ROOT
12	marked	mark	VBN	_	11	VC
13	by	by	IN	_	12	LGS
14	a	a	DT	_	17	NMOD
15	thick	thick	JJ	_	17	NMOD
16	black	black	JJ	_	17	NMOD
17	line	line	NN	_	13	PMOD
18	.	.	.	_	11	P

1	Restriction	restriction	NN	_	2	NMOD
2	sites	site	NNS	_	24	NMOD
3	:	:	:	_	24	P
4	B	b	NN	_	24	NMOD
5	,	,	,	_	4	P
6	BamHI	bamhi	NN	_	4	APPO
7	;	;	:	_	24	P
8	C	c	NN	_	24	NMOD
9	,	,	,	_	8	P
10	ClaI	clai	NN	_	8	APPO
11	;	;	:	_	24	P
12	E	e	NN	_	24	NMOD
13	,	,	,	_	12	P
14	EcoRI	ecori	NN	_	12	APPO
15	;	;	:	_	24	P
16	H	h	NN	_	24	NMOD
17	,	,	,	_	16	P
18	HindIII	hindiii	NN	_	16	APPO
19	;	;	:	_	24	P
20	Hp	hp	NN	_	24	NMOD
21	,	,	,	_	20	P
22	HpaI	hpai	NN	_	20	APPO
23	;	;	:	_	24	P
24	Sf	sf	NN	_	0	ROOT
25	,	,	,	_	24	P
26	SfiI	sfii	NN	_	24	APPO
27	.	.	.	_	24	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Southern	southern	NNP	_	5	NMOD
5	blot	blot	NN	_	6	NMOD
6	analysis	analysis	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	EcoRI	ecori	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	digested	digest	VBN	_	12	NMOD
11	genomic	genomic	JJ	_	12	NMOD
12	DNA	dna	NN	_	7	PMOD
13	from	from	IN	_	12	NMOD
14	wt	wt	NN	_	28	NMOD
15	,	,	,	_	14	P
16	Xpd†XPCS	xpd†xpcs	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	wt	wt	NN	_	14	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	Xpd†XP	xpd†xp	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	wt	wt	NN	_	20	CONJ
24	recombinant	recombinant	JJ	_	28	NMOD
25	embryonic	embryonic	JJ	_	27	NMOD
26	stem	stem	NN	_	27	NMOD
27	cell	cell	NN	_	28	NMOD
28	clones	clone	NNS	_	13	PMOD
29	hybridised	hybridise	VBN	_	28	NMOD
30	with	with	IN	_	29	MNR
31	the	the	DT	_	34	NMOD
32	3	0	CD	_	34	NMOD
33	′	′	SYM	_	32	P
34	probe	probe	NN	_	30	PMOD
35	depicted	depict	VBN	_	34	NMOD
36	in	in	IN	_	35	ADV
37	(	(	-LRB-	_	36	P
38	A	a	NN	_	36	PMOD
39	)	)	-RRB-	_	6	P
40	.	.	.	_	6	P

1	The	the	DT	_	3	NMOD
2	wt	wt	NN	_	3	NMOD
3	allele	allele	NN	_	4	SBJ
4	yields	yield	VBZ	_	0	ROOT
5	a	a	DT	_	12	NMOD
6	6.5	0	CD	_	10	NMOD
7	-	-	HYPH	_	6	P
8	kilobase	kilobase	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	kb	kb	NN	_	12	NMOD
11	)	)	-RRB-	_	12	P
12	fragment	fragment	NN	_	4	OBJ
13	,	,	,	_	4	P
14	whereas	whereas	IN	_	4	ADV
15	both	both	CC	_	20	COORD
16	targeted	target	VBN	_	20	NMOD
17	Xpd†XP	xpd†xp	NN	_	20	NMOD
18	and	and	CC	_	17	COORD
19	Xpd†XPCS	xpd†xpcs	NN	_	18	CONJ
20	alleles	allele	NNS	_	21	SBJ
21	yield	yield	VBP	_	14	SUB
22	a	a	DT	_	26	NMOD
23	5.1	0	CD	_	25	NMOD
24	-	-	HYPH	_	23	P
25	kb	kb	NN	_	26	NMOD
26	fragment	fragment	NN	_	21	OBJ
27	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Genotyping	genotyping	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	wt	wt	NN	_	9	NMOD
7	and	and	CC	_	6	COORD
8	targeted	target	VBN	_	7	CONJ
9	alleles	allele	NNS	_	5	PMOD
10	by	by	IN	_	4	NMOD
11	PCR	pcr	NN	_	10	PMOD
12	using	use	VBG	_	4	NMOD
13	primers	primer	NNS	_	14	NMOD
14	F2	f0	NN	_	12	OBJ
15	,	,	,	_	14	P
16	R1	r0	NN	_	14	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	mR	mr	NN	_	18	CONJ
20	as	as	IN	_	12	ADV
21	indicated	indicate	VBN	_	20	SUB
22	in	in	IN	_	12	ADV
23	(	(	-LRB-	_	24	P
24	A	a	LS	_	27	NMOD
25	)	)	-RRB-	_	24	P
26	yields	yield	VBZ	_	27	NMOD
27	fragments	fragment	NNS	_	22	PMOD
28	of	of	IN	_	27	NMOD
29	399	0	CD	_	30	NMOD
30	bp	bp	NN	_	28	PMOD
31	and	and	CC	_	30	COORD
32	468	0	CD	_	33	NMOD
33	bp	bp	NN	_	31	CONJ
34	,	,	,	_	12	P
35	respectively	respectively	RB	_	12	ADV
36	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	42	DEP
3	)	)	-RRB-	_	2	P
4	RT	rt	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	PCR	pcr	NN	_	7	NMOD
7	detection	detection	NN	_	42	SBJ
8	of	of	IN	_	7	NMOD
9	mRNA	mrna	NN	_	10	NMOD
10	expression	expression	NN	_	8	PMOD
11	originating	originate	VBG	_	10	NMOD
12	from	from	IN	_	11	ADV
13	the	the	DT	_	18	NMOD
14	targeted	target	VBN	_	18	NMOD
15	†XP	†xp	NN	_	18	NMOD
16	and	and	CC	_	15	COORD
17	†XPCS	†xpcs	NN	_	16	CONJ
18	alleles	allele	NNS	_	12	PMOD
19	in	in	IN	_	7	LOC
20	embryonic	embryonic	JJ	_	22	NMOD
21	stem	stem	NN	_	22	NMOD
22	cell	cell	NN	_	23	NMOD
23	clones	clone	NNS	_	19	PMOD
24	using	use	VBG	_	7	NMOD
25	primers	primer	NNS	_	26	NMOD
26	F1	f0	NN	_	24	OBJ
27	(	(	-LRB-	_	28	P
28	hybridising	hybridise	VBG	_	26	PRN
29	outside	outside	IN	_	28	ADV
30	the	the	DT	_	32	NMOD
31	targeting	target	VBG	_	32	NMOD
32	construct	construct	NN	_	29	PMOD
33	)	)	-RRB-	_	28	P
34	and	and	CC	_	26	COORD
35	mR	mr	NN	_	34	CONJ
36	as	as	IN	_	24	ADV
37	indicated	indicate	VBN	_	36	SUB
38	in	in	IN	_	37	ADV
39	(	(	-LRB-	_	38	P
40	A	a	NN	_	38	PMOD
41	)	)	-RRB-	_	42	P
42	results	result	VBZ	_	0	ROOT
43	in	in	IN	_	42	ADV
44	a	a	DT	_	48	NMOD
45	1,416	0	CD	_	47	NMOD
46	-	-	HYPH	_	45	P
47	bp	bp	NN	_	48	NMOD
48	fragment	fragment	NN	_	43	PMOD
49	.	.	.	_	42	P

1	(	(	-LRB-	_	2	P
2	E	e	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Northern	northern	NNP	_	5	NMOD
5	blot	blot	NN	_	6	NMOD
6	analysis	analysis	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	total	total	JJ	_	9	NMOD
9	RNA	rna	NN	_	7	PMOD
10	isolated	isolate	VBN	_	9	NMOD
11	from	from	IN	_	10	ADV
12	testis	testis	NN	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	homozygous	homozygous	JJ	_	15	NMOD
15	wt	wt	NN	_	36	NMOD
16	and	and	CC	_	15	COORD
17	XpdTTD	xpdttd	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	TTD	ttd	NN	_	16	CONJ
20	,	,	,	_	15	P
21	heterozygous	heterozygous	JJ	_	24	NMOD
22	Xpd†XPCS	xpd†xpcs	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	wt	wt	NN	_	15	CONJ
25	and	and	CC	_	24	COORD
26	XpdTTD	xpdttd	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	wt	wt	NN	_	25	CONJ
29	,	,	,	_	24	P
30	and	and	CC	_	24	COORD
31	compound	compound	JJ	_	35	NMOD
32	heterozygous	heterozygous	JJ	_	35	NMOD
33	Xpd†XPCS	xpd†xpcs	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	TTD	ttd	NN	_	30	CONJ
36	mice	mouse	NNS	_	13	PMOD
37	as	as	IN	_	10	ADV
38	indicated	indicate	VBN	_	37	SUB
39	.	.	.	_	6	P

1	Hybridisation	hybridisation	NN	_	11	SBJ
2	with	with	IN	_	1	NMOD
3	a	a	DT	_	10	NMOD
4	1.4	0	CD	_	6	NMOD
5	-	-	HYPH	_	4	P
6	kb	kb	NN	_	10	NMOD
7	mouse	mouse	NN	_	10	NMOD
8	Xpd	xpd	NN	_	10	NMOD
9	cDNA	cdna	NN	_	10	NMOD
10	probe	probe	NN	_	2	PMOD
11	detects	detect	VBZ	_	0	ROOT
12	mRNAs	mrna	NNS	_	11	OBJ
13	of	of	IN	_	12	NMOD
14	4	0	CD	_	20	NMOD
15	,	,	,	_	14	P
16	3.3	0	CD	_	14	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	2.7	0	CD	_	18	CONJ
20	kb	kb	NN	_	13	PMOD
21	from	from	IN	_	12	NMOD
22	wt	wt	NN	_	28	NMOD
23	,	,	,	_	22	P
24	Xpd†XPCS	xpd†xpcs	NN	_	22	CONJ
25	,	,	,	_	24	P
26	and	and	CC	_	24	COORD
27	XpdTTD	xpdttd	NN	_	26	CONJ
28	alleles	allele	NNS	_	21	PMOD
29	,	,	,	_	12	P
30	respectively	respectively	RB	_	12	NMOD
31	.	.	.	_	11	P

1	An	an	DT	_	9	NMOD
2	ethidium	ethidium	NN	_	3	NMOD
3	bromide	bromide	NN	_	5	NMOD
4	(	(	-LRB-	_	5	P
5	EtBr	etbr	NN	_	8	AMOD
6	)	)	-RRB-	_	8	P
7	–	–	HYPH	_	5	P
8	stained	stain	VBN	_	9	NMOD
9	gel	gel	NN	_	17	SBJ
10	showing	show	VBG	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	amount	amount	NN	_	10	OBJ
13	of	of	IN	_	12	NMOD
14	total	total	JJ	_	15	NMOD
15	RNA	rna	NN	_	13	PMOD
16	loaded	load	VBN	_	15	NMOD
17	is	be	VBZ	_	0	ROOT
18	shown	show	VBN	_	17	VC
19	below	below	RB	_	18	ADV
20	.	.	.	_	17	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Frequency	frequency	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Xpd†XP	xpd†xp	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	†XP	†xp	NN	_	17	NMOD
6	,	,	,	_	5	P
7	Xpd†XPCS	xpd†xpcs	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	†XPCS	†xpcs	NN	_	5	CONJ
10	,	,	,	_	9	P
11	and	and	CC	_	9	COORD
12	Compound	compound	NN	_	16	NMOD
13	Heterozygous	heterozygous	JJ	_	16	NMOD
14	Xpd†XP	xpd†xp	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	†XPCS	†xpcs	NN	_	11	CONJ
17	Embryos	embryo	NNS	_	2	PMOD
18	and	and	CC	_	17	COORD
19	Offspring	offspring	NN	_	18	CONJ

1	“	“	``	_	4	P
2	Null	null	JJ	_	4	NMOD
3	”	”	''	_	4	P
4	Allele	allele	NN	_	5	SBJ
5	Can	can	MD	_	0	ROOT
6	Alleviate	alleviate	VB	_	5	VC
7	Developmental	developmental	JJ	_	8	NMOD
8	Delay	delay	NN	_	6	OBJ
9	,	,	,	_	8	P
10	Skin	skin	NN	_	14	NMOD
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	Hair	hair	NN	_	12	CONJ
14	Features	feature	NNS	_	8	APPO
15	of	of	IN	_	14	NMOD
16	TTD	ttd	NN	_	15	PMOD

1	To	to	TO	_	21	PRP
2	test	test	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	potential	potential	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	a	a	DT	_	12	NMOD
7	homozygous	homozygous	JJ	_	12	NMOD
8	lethal	lethal	JJ	_	12	NMOD
9	“	“	``	_	12	P
10	null	null	JJ	_	12	NMOD
11	”	”	''	_	12	P
12	allele	allele	NN	_	5	PMOD
13	to	to	TO	_	4	NMOD
14	nevertheless	nevertheless	RB	_	13	ADV
15	contribute	contribute	VB	_	13	IM
16	to	to	IN	_	15	ADV
17	organismal	organismal	JJ	_	18	NMOD
18	phenotype	phenotype	NN	_	16	PMOD
19	,	,	,	_	21	P
20	we	we	PRP	_	21	SBJ
21	combined	combine	VBD	_	0	ROOT
22	an	an	DT	_	24	NMOD
23	Xpd†XPCS	xpd†xpcs	NN	_	24	NMOD
24	allele	allele	NN	_	21	OBJ
25	with	with	IN	_	24	NMOD
26	a	a	DT	_	29	NMOD
27	viable	viable	JJ	_	29	NMOD
28	XpdTTD	xpdttd	NN	_	29	NMOD
29	allele	allele	NN	_	25	PMOD
30	by	by	IN	_	21	MNR
31	crossing	cross	VBG	_	30	PMOD
32	the	the	DT	_	35	NMOD
33	corresponding	correspond	VBG	_	35	NMOD
34	heterozygous	heterozygous	JJ	_	35	NMOD
35	animals	animal	NNS	_	31	OBJ
36	.	.	.	_	21	P

1	Similar	similar	JJ	_	24	ADV
2	to	to	IN	_	1	AMOD
3	hemizygous	hemizygous	JJ	_	5	NMOD
4	TTD	ttd	NN	_	5	NMOD
5	mice	mouse	NNS	_	2	PMOD
6	carrying	carry	VBG	_	5	NMOD
7	one	one	CD	_	11	NMOD
8	true	true	JJ	_	11	NMOD
9	Xpd	xpd	NN	_	10	NMOD
10	knockout	knockout	NN	_	11	NMOD
11	allele	allele	NN	_	6	OBJ
12	(	(	-LRB-	_	15	P
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	KO	ko	NN	_	11	PRN
16	)	)	-RRB-	_	15	P
17	,	,	,	_	24	P
18	compound	compound	NN	_	23	NMOD
19	heterozygous	heterozygous	JJ	_	23	NMOD
20	XpdTTD	xpdttd	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	†XPCS	†xpcs	NN	_	23	NMOD
23	mice	mouse	NNS	_	24	SBJ
24	were	be	VBD	_	0	ROOT
25	born	bear	VBN	_	24	VC
26	at	at	IN	_	25	ADV
27	the	the	DT	_	30	NMOD
28	expected	expect	VBN	_	30	NMOD
29	Mendelian	mendelian	JJ	_	30	NMOD
30	frequencies	frequency	NNS	_	26	PMOD
31	.	.	.	_	24	P

1	Expression	expression	NN	_	6	SBJ
2	from	from	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	Xpd†XPCS	xpd†xpcs	NN	_	5	NMOD
5	allele	allele	NN	_	2	PMOD
6	was	be	VBD	_	0	ROOT
7	also	also	RB	_	6	ADV
8	reduced	reduce	VBN	_	6	VC
9	in	in	IN	_	8	LOC
10	the	the	DT	_	11	NMOD
11	testis	testis	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	compound	compound	NN	_	15	NMOD
14	heterozygous	heterozygous	JJ	_	15	NMOD
15	animals	animal	NNS	_	12	PMOD
16	,	,	,	_	8	P
17	whereas	whereas	IN	_	8	ADV
18	expression	expression	NN	_	23	SBJ
19	from	from	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	XpdTTD	xpdttd	NN	_	22	NMOD
22	allele	allele	NN	_	19	PMOD
23	was	be	VBD	_	17	SUB
24	increased	increase	VBN	_	23	VC
25	relative	relative	JJ	_	24	ADV
26	to	to	IN	_	25	AMOD
27	wt	wt	NN	_	26	PMOD
28	by	by	IN	_	24	EXT
29	~	~	SYM	_	30	P
30	5-fold	0-fold	RB	_	28	PMOD
31	(	(	-LRB-	_	33	P
32	Figure	figure	NN	_	33	NMOD
33	1E	0e	NN	_	24	PRN
34	)	)	-RRB-	_	33	P
35	.	.	.	_	6	P

1	Because	because	IN	_	28	PRP
2	of	of	IN	_	1	PMOD
3	a	a	DT	_	4	NMOD
4	lack	lack	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	available	available	JJ	_	7	NMOD
7	antibodies	antibody	NNS	_	5	PMOD
8	and	and	CC	_	7	COORD
9	the	the	DT	_	10	NMOD
10	inability	inability	NN	_	8	CONJ
11	to	to	TO	_	10	NMOD
12	distinguish	distinguish	VB	_	11	IM
13	amongst	amongst	IN	_	12	ADV
14	various	various	JJ	_	16	NMOD
15	mutant	mutant	JJ	_	16	NMOD
16	forms	form	NNS	_	13	PMOD
17	of	of	IN	_	16	NMOD
18	XPD	xpd	NN	_	17	PMOD
19	differing	differ	VBG	_	16	NMOD
20	only	only	RB	_	19	ADV
21	by	by	IN	_	19	ADV
22	single	single	JJ	_	25	NMOD
23	amino	amino	NN	_	24	NMOD
24	acid	acid	NN	_	25	NMOD
25	substitutions	substitution	NNS	_	21	PMOD
26	,	,	,	_	28	P
27	we	we	PRP	_	28	SBJ
28	were	be	VBD	_	0	ROOT
29	unable	unable	JJ	_	28	PRD
30	to	to	TO	_	29	AMOD
31	ascertain	ascertain	VB	_	30	IM
32	the	the	DT	_	34	NMOD
33	relative	relative	JJ	_	34	NMOD
34	amount	amount	NN	_	31	OBJ
35	of	of	IN	_	34	NMOD
36	XPD	xpd	NN	_	37	NMOD
37	protein	protein	NN	_	35	PMOD
38	from	from	IN	_	37	NMOD
39	the	the	DT	_	41	NMOD
40	different	different	JJ	_	41	NMOD
41	alleles	allele	NNS	_	38	PMOD
42	.	.	.	_	28	P

1	Despite	despite	IN	_	13	ADV
2	reduced	reduce	VBN	_	3	NMOD
3	levels	level	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	mRNA	mrna	NN	_	6	NMOD
6	expression	expression	NN	_	4	PMOD
7	,	,	,	_	13	P
8	the	the	DT	_	12	NMOD
9	homozygous	homozygous	JJ	_	12	NMOD
10	lethal	lethal	JJ	_	12	NMOD
11	Xpd†XPCS	xpd†xpcs	NN	_	12	NMOD
12	allele	allele	NN	_	13	SBJ
13	ameliorated	ameliorate	VBD	_	0	ROOT
14	multiple	multiple	JJ	_	19	NMOD
15	XpdTTD	xpdttd	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	associated	associated	JJ	_	19	NMOD
18	disease	disease	NN	_	19	NMOD
19	symptoms	symptom	NNS	_	13	OBJ
20	in	in	IN	_	13	LOC
21	compound	compound	JJ	_	26	NMOD
22	heterozygous	heterozygous	JJ	_	26	NMOD
23	XpdTTD	xpdttd	NN	_	25	NMOD
24	/	/	HYPH	_	23	P
25	†XPCS	†xpcs	NN	_	26	NMOD
26	animals	animal	NNS	_	20	PMOD
27	including	include	VBG	_	13	ADV
28	the	the	DT	_	31	NMOD
29	hallmark	hallmark	NN	_	31	NMOD
30	brittle	brittle	JJ	_	31	NMOD
31	hair	hair	NN	_	27	PMOD
32	and	and	CC	_	31	COORD
33	cutaneous	cutaneous	JJ	_	34	NMOD
34	features	feature	NNS	_	32	CONJ
35	fully	fully	RB	_	36	AMOD
36	penetrant	penetrant	JJ	_	31	NMOD
37	in	in	IN	_	36	LOC
38	homo	homo	AFX	_	43	NMOD
39	-	-	HYPH	_	38	P
40	and	and	CC	_	38	COORD
41	hemizygous	hemizygous	JJ	_	40	CONJ
42	TTD	ttd	NN	_	43	NMOD
43	mice	mouse	NNS	_	37	PMOD
44	(	(	-LRB-	_	46	P
45	Figure	figure	NN	_	46	NMOD
46	2A	0a	NN	_	13	PRN
47	–	–	SYM	_	48	P
48	2C	0c	NN	_	46	NMOD
49	)	)	-RRB-	_	46	P
50	.	.	.	_	13	P

1	In	in	IN	_	44	ADV
2	marked	marked	JJ	_	3	NMOD
3	contrast	contrast	NN	_	1	PMOD
4	to	to	IN	_	3	NMOD
5	XpdTTD	xpdttd	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	TTD	ttd	NN	_	14	NMOD
8	(	(	-LRB-	_	7	P
9	and	and	CC	_	7	COORD
10	XpdTTD	xpdttd	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	KO	ko	NN	_	9	CONJ
13	)	)	-RRB-	_	14	P
14	mice	mouse	NNS	_	4	PMOD
15	,	,	,	_	14	P
16	which	which	WDT	_	17	SBJ
17	display	display	VBP	_	14	NMOD
18	complete	complete	JJ	_	20	NMOD
19	hair	hair	NN	_	20	NMOD
20	loss	loss	NN	_	17	OBJ
21	in	in	IN	_	20	NMOD
22	the	the	DT	_	25	NMOD
23	first	$#ORD#$	JJ	_	25	NMOD
24	hair	hair	NN	_	25	NMOD
25	cycle	cycle	NN	_	21	PMOD
26	and	and	CC	_	20	COORD
27	partial	partial	JJ	_	29	NMOD
28	hair	hair	NN	_	29	NMOD
29	loss	loss	NN	_	26	CONJ
30	in	in	IN	_	29	NMOD
31	subsequent	subsequent	JJ	_	32	NMOD
32	cycles	cycle	NNS	_	30	PMOD
33	throughout	throughout	IN	_	17	TMP
34	their	their	PRP$	_	35	NMOD
35	lives	life	NNS	_	33	PMOD
36	[	[	-LRB-	_	37	P
37	21	0	CD	_	17	PRN
38	]	]	-RRB-	_	37	P
39	,	,	,	_	44	P
40	compound	compound	NN	_	43	NMOD
41	heterozygous	heterozygous	JJ	_	43	NMOD
42	XpdTTD/†XPCS	xpdttd/†xpcs	NN	_	43	NMOD
43	mice	mouse	NNS	_	44	SBJ
44	displayed	display	VBD	_	0	ROOT
45	some	some	DT	_	47	NMOD
46	hair	hair	NN	_	47	NMOD
47	loss	loss	NN	_	44	OBJ
48	only	only	RB	_	49	PMOD
49	during	during	IN	_	44	ADV
50	the	the	DT	_	53	NMOD
51	first	$#ORD#$	JJ	_	53	NMOD
52	hair	hair	NN	_	53	NMOD
53	cycle	cycle	NN	_	49	PMOD
54	and	and	CC	_	49	COORD
55	only	only	RB	_	56	AMOD
56	locally	locally	RB	_	57	PMOD
57	at	at	IN	_	54	CONJ
58	the	the	DT	_	59	NMOD
59	back	back	NN	_	57	PMOD
60	(	(	-LRB-	_	62	P
61	Figure	figure	NN	_	62	NMOD
62	2A	0a	NN	_	44	PRN
63	)	)	-RRB-	_	62	P
64	.	.	.	_	44	P

1	Scanning	scanning	NN	_	3	NMOD
2	electron	electron	NN	_	3	NMOD
3	microscope	microscope	NN	_	4	NMOD
4	analysis	analysis	NN	_	10	SBJ
5	of	of	IN	_	4	NMOD
6	XpdTTD	xpdttd	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	†XPCS	†xpcs	NN	_	9	NMOD
9	hair	hair	NN	_	5	PMOD
10	revealed	reveal	VBD	_	0	ROOT
11	an	an	DT	_	14	NMOD
12	almost	almost	RB	_	13	AMOD
13	normal	normal	JJ	_	14	NMOD
14	appearance	appearance	NN	_	10	OBJ
15	,	,	,	_	14	P
16	with	with	IN	_	14	NMOD
17	TTD	ttd	NN	_	19	AMOD
18	-	-	HYPH	_	17	P
19	like	like	JJ	_	20	NMOD
20	features	feature	NNS	_	16	PMOD
21	such	such	JJ	_	22	PMOD
22	as	as	IN	_	20	NMOD
23	broken	broken	JJ	_	24	NMOD
24	hairs	hair	NNS	_	22	PMOD
25	found	find	VBN	_	20	NMOD
26	only	only	RB	_	27	PMOD
27	at	at	IN	_	25	ADV
28	very	very	RB	_	29	AMOD
29	low	low	JJ	_	30	NMOD
30	frequency	frequency	NN	_	27	PMOD
31	(	(	-LRB-	_	33	P
32	unpublished	unpublished	JJ	_	33	NMOD
33	data	datum	NNS	_	10	PRN
34	)	)	-RRB-	_	33	P
35	.	.	.	_	10	P

1	Amino	amino	NN	_	2	NMOD
2	acid	acid	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	confirmed	confirm	VBD	_	0	ROOT
5	that	that	IN	_	4	OBJ
6	cysteine	cysteine	NN	_	7	NMOD
7	levels	level	NNS	_	17	SBJ
8	in	in	IN	_	7	LOC
9	the	the	DT	_	10	NMOD
10	hair	hair	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	16	NMOD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	†XPCS	†xpcs	NN	_	16	NMOD
16	mice	mouse	NNS	_	11	PMOD
17	were	be	VBD	_	5	SUB
18	significantly	significantly	RB	_	19	AMOD
19	higher	high	JJR	_	17	PRD
20	than	than	IN	_	19	AMOD
21	in	in	IN	_	20	LOC
22	XpdTTD	xpdttd	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	TTD	ttd	NN	_	25	NMOD
25	animals	animal	NNS	_	21	PMOD
26	,	,	,	_	17	P
27	but	but	CC	_	17	COORD
28	remained	remain	VBD	_	27	CONJ
29	below	below	IN	_	28	PRD
30	the	the	DT	_	32	NMOD
31	wt	wt	NN	_	32	NMOD
32	level	level	NN	_	29	PMOD
33	(	(	-LRB-	_	35	P
34	Figure	figure	NN	_	35	NMOD
35	2C	0c	NN	_	4	PRN
36	)	)	-RRB-	_	35	P
37	.	.	.	_	4	P

1	TTD	ttd	NN	_	2	NMOD
2	hemizygotes	hemizygotes	NNS	_	8	SBJ
3	(	(	-LRB-	_	6	P
4	XpdTTD	xpdttd	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	KO	ko	NN	_	2	PRN
7	)	)	-RRB-	_	6	P
8	do	do	VBP	_	0	ROOT
9	not	not	RB	_	8	ADV
10	display	display	VB	_	8	VC
11	significant	significant	JJ	_	12	NMOD
12	differences	difference	NNS	_	10	OBJ
13	in	in	IN	_	12	NMOD
14	cutaneous	cutaneous	JJ	_	15	NMOD
15	features	feature	NNS	_	13	PMOD
16	and	and	CC	_	15	COORD
17	longevity	longevity	NN	_	16	CONJ
18	relative	relative	JJ	_	12	NMOD
19	to	to	IN	_	18	AMOD
20	homozygous	homozygous	JJ	_	24	NMOD
21	XpdTTD	xpdttd	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	TTD	ttd	NN	_	24	NMOD
24	mice	mouse	NNS	_	19	PMOD
25	[	[	-LRB-	_	26	P
26	21	0	CD	_	10	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	8	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Partial	partial	JJ	_	2	NMOD
2	Rescue	rescue	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	TTD	ttd	NN	_	3	PMOD
5	Cutaneous	cutaneous	JJ	_	4	NMOD
6	,	,	,	_	4	P
7	Blood	blood	NN	_	4	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	Developmental	developmental	JJ	_	11	NMOD
11	Phenotypes	phenotype	NNS	_	9	CONJ
12	in	in	IN	_	2	NMOD
13	Compound	compound	NN	_	18	NMOD
14	Heterozygous	heterozygous	JJ	_	18	NMOD
15	XpdTTD	xpdttd	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	†XPCS	†xpcs	NN	_	18	NMOD
18	Mice	mouse	NNS	_	12	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Photographs	photograph	NNS	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	5	0	CD	_	8	NMOD
7	-	-	HYPH	_	6	P
8	mo	mo	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	old	old	JJ	_	24	NMOD
11	homozygous	homozygous	JJ	_	14	NMOD
12	XpdTTD	xpdttd	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	TTD	ttd	NN	_	24	NMOD
15	,	,	,	_	14	P
16	compound	compound	NN	_	20	NMOD
17	heterozygous	heterozygous	JJ	_	20	NMOD
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	†XPCS	†xpcs	NN	_	14	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	wt	wt	NN	_	22	CONJ
24	mice	mouse	NNS	_	5	PMOD
25	.	.	.	_	4	P

1	Insets	inset	NNS	_	3	NMOD
2	:	:	:	_	3	P
3	images	image	NNS	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	first	$#ORD#$	JJ	_	7	NMOD
6	-	-	HYPH	_	5	P
7	round	round	NN	_	9	NMOD
8	hair	hair	NN	_	9	NMOD
9	loss	loss	NN	_	4	PMOD
10	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Histological	histological	JJ	_	5	NMOD
5	analysis	analysis	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	skin	skin	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	XpdTTD	xpdttd	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	TTD	ttd	NN	_	20	NMOD
13	,	,	,	_	12	P
14	XpdTTD	xpdttd	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	†XPCS	†xpcs	NN	_	12	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	wt	wt	NN	_	18	CONJ
20	mice	mouse	NNS	_	9	PMOD
21	.	.	.	_	5	P

1	TTD	ttd	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	associated	associated	JJ	_	4	NMOD
4	acanthosis	acanthosis	NN	_	36	SBJ
5	(	(	-LRB-	_	7	P
6	thicker	thick	JJR	_	7	NMOD
7	epidermis	epidermis	NN	_	4	PRN
8	,	,	,	_	7	P
9	indicated	indicate	VBN	_	7	NMOD
10	by	by	IN	_	9	LGS
11	solid	solid	JJ	_	13	NMOD
12	vertical	vertical	JJ	_	13	NMOD
13	line	line	NN	_	10	PMOD
14	)	)	-RRB-	_	7	P
15	,	,	,	_	4	P
16	pronounced	pronounce	VBN	_	18	NMOD
17	granular	granular	JJ	_	18	NMOD
18	layer	layer	NN	_	4	CONJ
19	(	(	-LRB-	_	18	P
20	indicated	indicate	VBN	_	18	NMOD
21	by	by	IN	_	20	LGS
22	arrows	arrow	NNS	_	21	PMOD
23	)	)	-RRB-	_	18	P
24	,	,	,	_	18	P
25	and	and	CC	_	18	COORD
26	sebacious	sebacious	JJ	_	28	NMOD
27	gland	gland	NN	_	28	NMOD
28	hyperplasia	hyperplasia	NN	_	25	CONJ
29	(	(	-LRB-	_	28	P
30	indicated	indicate	VBN	_	28	NMOD
31	by	by	IN	_	30	LGS
32	dotted	dot	VBN	_	34	NMOD
33	vertical	vertical	JJ	_	34	NMOD
34	line	line	NN	_	31	PMOD
35	)	)	-RRB-	_	36	P
36	were	be	VBD	_	0	ROOT
37	absent	absent	JJ	_	36	PRD
38	in	in	IN	_	36	LOC
39	the	the	DT	_	40	NMOD
40	epidermis	epidermis	NN	_	38	PMOD
41	of	of	IN	_	40	NMOD
42	XpdTTD	xpdttd	NN	_	44	NMOD
43	/	/	HYPH	_	42	P
44	†XPCS	†xpcs	NN	_	47	NMOD
45	and	and	CC	_	44	COORD
46	wt	wt	NN	_	45	CONJ
47	mice	mouse	NNS	_	41	PMOD
48	.	.	.	_	36	P

1	Magnification	magnification	NN	_	2	NMOD
2	400	0	CD	_	0	ROOT
3	×	×	SYM	_	2	P
4	.	.	.	_	2	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Cysteine	cysteine	NN	_	5	NMOD
5	content	content	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	hair	hair	NN	_	6	PMOD
8	from	from	IN	_	7	NMOD
9	wt	wt	NN	_	19	NMOD
10	,	,	,	_	9	P
11	XpdTTD	xpdttd	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	TTD	ttd	NN	_	9	CONJ
14	,	,	,	_	13	P
15	and	and	CC	_	13	COORD
16	XpdTTD	xpdttd	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	†XPCS	†xpcs	NN	_	15	CONJ
19	mice	mouse	NNS	_	8	PMOD
20	.	.	.	_	5	P

1	The	the	DT	_	4	NMOD
2	p	p	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	value	value	NN	_	5	SBJ
5	indicates	indicate	VBZ	_	0	ROOT
6	significant	significant	JJ	_	7	NMOD
7	differences	difference	NNS	_	5	OBJ
8	between	between	IN	_	7	NMOD
9	mutants	mutant	NNS	_	8	PMOD
10	and	and	CC	_	9	COORD
11	wt	wt	NN	_	10	CONJ
12	,	,	,	_	8	P
13	as	as	RB	_	15	ADV
14	well	well	RB	_	15	ADV
15	as	as	IN	_	8	COORD
16	between	between	IN	_	15	CONJ
17	XpdTTD	xpdttd	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	TTD	ttd	NN	_	24	NMOD
20	and	and	CC	_	19	COORD
21	XpdTTD	xpdttd	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	†XPCS	†xpcs	NN	_	20	CONJ
24	mice	mouse	NNS	_	16	PMOD
25	.	.	.	_	5	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	standard	standard	JJ	_	5	NMOD
5	error	error	NN	_	10	NMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	mean	mean	NN	_	6	PMOD
9	(	(	-LRB-	_	10	P
10	SEM	sem	NN	_	3	OBJ
11	)	)	-RRB-	_	3	P
12	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Hematocrit	hematocrit	NN	_	5	NMOD
5	values	value	NNS	_	0	ROOT
6	from	from	IN	_	5	NMOD
7	blood	blood	NN	_	6	PMOD
8	of	of	IN	_	7	NMOD
9	XpdTTD	xpdttd	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	TTD	ttd	NN	_	16	NMOD
12	and	and	CC	_	11	COORD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	†XPCS	†xpcs	NN	_	12	CONJ
16	mice	mouse	NNS	_	8	PMOD
17	.	.	.	_	5	P

1	The	the	DT	_	4	NMOD
2	p	p	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	values	value	NNS	_	5	SBJ
5	indicate	indicate	VBP	_	0	ROOT
6	the	the	DT	_	7	NMOD
7	significance	significance	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	difference	difference	NN	_	8	PMOD
11	relative	relative	JJ	_	5	ADV
12	to	to	IN	_	11	AMOD
13	wt	wt	NN	_	12	PMOD
14	.	.	.	_	5	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	SEM	sem	NN	_	3	OBJ
5	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	E	e	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Body	body	NN	_	5	NMOD
5	weights	weight	NNS	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	developing	develop	VBG	_	15	NMOD
8	XpdTTD	xpdttd	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	TTD	ttd	NN	_	15	NMOD
11	and	and	CC	_	10	COORD
12	XpdTTD	xpdttd	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	†XPCS	†xpcs	NN	_	11	CONJ
15	mice	mouse	NNS	_	6	PMOD
16	after	after	IN	_	15	TMP
17	weaning	wean	VBG	_	16	PMOD
18	plotted	plot	VBN	_	5	NMOD
19	as	as	IN	_	18	MNR
20	a	a	DT	_	21	NMOD
21	percentage	percentage	NN	_	19	PMOD
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	weight	weight	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	age	age	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	matched	matched	JJ	_	36	NMOD
29	control	control	NN	_	36	NMOD
30	wt	wt	NN	_	36	NMOD
31	and	and	CC	_	30	COORD
32	heterozygote	heterozygote	NN	_	31	CONJ
33	(	(	-LRB-	_	34	P
34	hz	hz	NN	_	32	PRN
35	)	)	-RRB-	_	34	P
36	littermates	littermates	NNS	_	25	PMOD
37	(	(	-LRB-	_	38	P
38	set	set	VBN	_	21	PRN
39	at	at	IN	_	38	ADV
40	100	0	CD	_	41	NMOD
41	%	%	NN	_	39	PMOD
42	)	)	-RRB-	_	38	P
43	.	.	.	_	5	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	SEM	sem	NN	_	3	OBJ
5	.	.	.	_	3	P

1	Other	other	JJ	_	4	NMOD
2	prominent	prominent	JJ	_	4	NMOD
3	TTD	ttd	NN	_	4	NMOD
4	features	feature	NNS	_	49	SBJ
5	in	in	IN	_	4	LOC
6	the	the	DT	_	7	NMOD
7	epidermis	epidermis	NN	_	5	PMOD
8	,	,	,	_	4	P
9	including	include	VBG	_	4	NMOD
10	acanthosis	acanthosis	NN	_	9	PMOD
11	(	(	-LRB-	_	12	P
12	thickening	thicken	VBG	_	10	PRN
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	layer	layer	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	nucleated	nucleated	JJ	_	19	NMOD
19	cells	cell	NNS	_	16	PMOD
20	)	)	-RRB-	_	12	P
21	,	,	,	_	10	P
22	hyperkeratosis	hyperkeratosis	NN	_	10	CONJ
23	(	(	-LRB-	_	25	P
24	prominent	prominent	JJ	_	25	NMOD
25	thickening	thickening	NN	_	22	PRN
26	of	of	IN	_	25	NMOD
27	the	the	DT	_	29	NMOD
28	cornified	cornified	VBN	_	29	NMOD
29	layer	layer	NN	_	26	PMOD
30	)	)	-RRB-	_	25	P
31	,	,	,	_	22	P
32	and	and	CC	_	22	COORD
33	pronounced	pronounced	JJ	_	35	NMOD
34	granular	granular	JJ	_	35	NMOD
35	layer	layer	NN	_	32	CONJ
36	and	and	CC	_	35	COORD
37	sebacious	sebacious	JJ	_	38	NMOD
38	gland	gland	NN	_	39	NMOD
39	hyperplasia	hyperplasia	NN	_	36	CONJ
40	(	(	-LRB-	_	41	P
41	causing	cause	VBG	_	35	PRN
42	greasy	greasy	JJ	_	43	NMOD
43	appearance	appearance	NN	_	41	OBJ
44	of	of	IN	_	43	NMOD
45	the	the	DT	_	46	NMOD
46	hair	hair	NN	_	44	PMOD
47	)	)	-RRB-	_	41	P
48	,	,	,	_	49	P
49	were	be	VBD	_	0	ROOT
50	absent	absent	JJ	_	49	PRD
51	in	in	IN	_	49	LOC
52	the	the	DT	_	53	NMOD
53	skin	skin	NN	_	51	PMOD
54	of	of	IN	_	53	NMOD
55	XpdTTD	xpdttd	NN	_	57	NMOD
56	/	/	HYPH	_	55	P
57	†XPCS	†xpcs	NN	_	58	NMOD
58	mice	mouse	NNS	_	54	PMOD
59	,	,	,	_	49	P
60	as	as	IN	_	49	ADV
61	established	establish	VBN	_	60	SUB
62	by	by	IN	_	61	MNR
63	blind	blind	JJ	_	65	NMOD
64	microscopic	microscopic	JJ	_	65	NMOD
65	examination	examination	NN	_	62	PMOD
66	of	of	IN	_	65	NMOD
67	skin	skin	NN	_	68	NMOD
68	sections	section	NNS	_	66	PMOD
69	(	(	-LRB-	_	71	P
70	Figure	figure	NN	_	71	NMOD
71	2B	0b	NN	_	49	PRN
72	)	)	-RRB-	_	71	P
73	.	.	.	_	49	P

1	Furthermore	furthermore	RB	_	24	ADV
2	,	,	,	_	24	P
3	anaemia	anaemia	NN	_	24	SBJ
4	and	and	CC	_	3	COORD
5	developmental	developmental	JJ	_	6	NMOD
6	delay	delay	NN	_	4	CONJ
7	present	present	JJ	_	3	NMOD
8	in	in	IN	_	7	LOC
9	patients	patient	NNS	_	8	PMOD
10	with	with	IN	_	9	NMOD
11	TTD	ttd	NN	_	10	PMOD
12	[	[	-LRB-	_	13	P
13	24	0	CD	_	9	PRN
14	]	]	-RRB-	_	13	P
15	and	and	CC	_	8	COORD
16	in	in	IN	_	15	CONJ
17	XpdTTD	xpdttd	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	TTD	ttd	NN	_	20	NMOD
20	mice	mouse	NNS	_	16	PMOD
21	[	[	-LRB-	_	22	P
22	15	0	CD	_	20	PRN
23	]	]	-RRB-	_	22	P
24	were	be	VBD	_	0	ROOT
25	both	both	RB	_	24	ADV
26	partially	partially	RB	_	24	ADV
27	rescued	rescue	VBN	_	24	VC
28	in	in	IN	_	27	LOC
29	compound	compound	JJ	_	34	NMOD
30	heterozygous	heterozygous	JJ	_	34	NMOD
31	XpdTTD	xpdttd	NN	_	33	NMOD
32	/	/	HYPH	_	31	P
33	†XPCS	†xpcs	NN	_	34	NMOD
34	mice	mouse	NNS	_	28	PMOD
35	(	(	-LRB-	_	37	P
36	Figure	figure	NN	_	37	NMOD
37	2D	0d	NN	_	27	PRN
38	and	and	CC	_	37	COORD
39	2E	0e	NN	_	38	CONJ
40	)	)	-RRB-	_	37	P
41	.	.	.	_	24	P

1	Rescue	rescue	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Progeroid	progeroid	JJ	_	4	NMOD
4	Features	feature	NNS	_	2	PMOD
5	in	in	IN	_	1	LOC
6	TTD	ttd	NN	_	7	NMOD
7	Mice	mouse	NN	_	5	PMOD
8	by	by	IN	_	1	NMOD
9	Homozygous	homozygous	JJ	_	12	NMOD
10	Lethal	lethal	JJ	_	12	NMOD
11	Xpd	xpd	NN	_	12	NMOD
12	Alleles	allele	NNS	_	8	PMOD

1	Because	because	IN	_	37	PRP
2	patients	patient	NNS	_	20	SBJ
3	with	with	IN	_	2	NMOD
4	TTD	ttd	NN	_	3	PMOD
5	,	,	,	_	4	P
6	XPCS	xpcs	NN	_	4	CONJ
7	,	,	,	_	6	P
8	and	and	CC	_	6	COORD
9	CS	c	NN	_	8	CONJ
10	(	(	-LRB-	_	4	P
11	but	but	CC	_	4	COORD
12	not	not	RB	_	11	ADV
13	XP	xp	NN	_	11	CONJ
14	)	)	-RRB-	_	2	P
15	and	and	CC	_	2	COORD
16	the	the	DT	_	19	NMOD
17	corresponding	correspond	VBG	_	19	NMOD
18	mouse	mouse	NN	_	19	NMOD
19	models	model	NNS	_	15	CONJ
20	share	share	VBP	_	1	SUB
21	similar	similar	JJ	_	24	NMOD
22	accelerated	accelerate	VBN	_	24	NMOD
23	progeroid	progeroid	NN	_	24	NMOD
24	symptoms	symptom	NNS	_	20	OBJ
25	[	[	-LRB-	_	32	P
26	12	0	CD	_	32	NMOD
27	,	,	,	_	32	P
28	13	0	CD	_	32	NMOD
29	,	,	,	_	32	P
30	15	0	CD	_	32	NMOD
31	,	,	,	_	32	P
32	23	0	CD	_	20	PRN
33	]	]	-RRB-	_	32	P
34	,	,	,	_	37	P
35	we	we	PRP	_	37	SBJ
36	next	next	RB	_	37	ADV
37	addressed	address	VBD	_	0	ROOT
38	ageing	ageing	JJ	_	40	AMOD
39	-	-	HYPH	_	38	P
40	related	related	JJ	_	41	NMOD
41	parameters	parameter	NNS	_	37	OBJ
42	in	in	IN	_	41	LOC
43	compound	compound	JJ	_	45	NMOD
44	heterozygous	heterozygous	JJ	_	45	NMOD
45	mice	mouse	NNS	_	42	PMOD
46	(	(	-LRB-	_	47	P
47	Figure	figure	NN	_	37	PRN
48	3	0	CD	_	47	NMOD
49	)	)	-RRB-	_	47	P
50	.	.	.	_	37	P

1	Whereas	whereas	IN	_	39	ADV
2	XpdTTD	xpdttd	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	TTD	ttd	NN	_	5	NMOD
5	animals	animal	NNS	_	6	SBJ
6	show	show	VBP	_	1	SUB
7	reduced	reduce	VBN	_	10	NMOD
8	bone	bone	NN	_	9	NMOD
9	mineral	mineral	NN	_	10	NMOD
10	density	density	NN	_	6	OBJ
11	as	as	IN	_	6	ADV
12	an	an	DT	_	13	NMOD
13	indication	indication	NN	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	17	NMOD
16	early	early	JJ	_	17	NMOD
17	onset	onset	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	osteoporosis	osteoporosis	NN	_	18	PMOD
20	before	before	IN	_	17	TMP
21	~	~	SYM	_	22	P
22	14	0	CD	_	23	NMOD
23	mo	mo	NNS	_	20	PMOD
24	of	of	IN	_	23	NMOD
25	age	age	NN	_	24	PMOD
26	[	[	-LRB-	_	27	P
27	15	0	CD	_	6	PRN
28	]	]	-RRB-	_	27	P
29	,	,	,	_	39	P
30	tail	tail	NN	_	31	NMOD
31	vertebrae	vertebra	NNS	_	39	SBJ
32	from	from	IN	_	31	NMOD
33	compound	compound	NN	_	38	NMOD
34	heterozygous	heterozygous	JJ	_	38	NMOD
35	XpdTTD	xpdttd	NN	_	37	NMOD
36	/	/	HYPH	_	35	P
37	†XPCS	†xpcs	NN	_	38	NMOD
38	mice	mouse	NNS	_	32	PMOD
39	were	be	VBD	_	0	ROOT
40	comparable	comparable	JJ	_	39	PRD
41	to	to	IN	_	40	AMOD
42	wt	wt	NN	_	41	PMOD
43	even	even	RB	_	44	PMOD
44	at	at	IN	_	39	TMP
45	20	0	CD	_	46	NMOD
46	mo	mo	NNS	_	44	PMOD
47	of	of	IN	_	46	NMOD
48	age	age	NN	_	47	PMOD
49	(	(	-LRB-	_	51	P
50	Figure	figure	NN	_	51	NMOD
51	3B	0b	NN	_	39	PRN
52	and	and	CC	_	51	COORD
53	3C	0c	NN	_	52	CONJ
54	)	)	-RRB-	_	51	P
55	.	.	.	_	39	P

1	Furthermore	furthermore	RB	_	32	ADV
2	,	,	,	_	32	P
3	whereas	whereas	IN	_	32	ADV
4	XpdTTD	xpdttd	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	TTD	ttd	NN	_	7	NMOD
7	mice	mouse	NNS	_	8	SBJ
8	developed	develop	VBD	_	3	SUB
9	kyphosis	kyphosis	NN	_	8	OBJ
10	earlier	earlier	RBR	_	8	TMP
11	than	than	IN	_	10	AMOD
12	wt	wt	NN	_	13	NMOD
13	animals	animal	NNS	_	11	PMOD
14	(	(	-LRB-	_	15	P
15	onset	onset	NN	_	10	PRN
16	~	~	SYM	_	17	P
17	3	0	CD	_	18	NMOD
18	mo	mo	NNS	_	15	TMP
19	versus	versus	CC	_	18	COORD
20	12	0	CD	_	23	NMOD
21	–	–	SYM	_	20	P
22	20	0	CD	_	20	QMOD
23	mo	mo	NNS	_	19	CONJ
24	)	)	-RRB-	_	15	P
25	,	,	,	_	32	P
26	compound	compound	JJ	_	31	NMOD
27	heterozygous	heterozygous	JJ	_	31	NMOD
28	XpdTTD	xpdttd	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	†XPCS	†xpcs	NN	_	31	NMOD
31	mice	mouse	NNS	_	32	SBJ
32	did	do	VBD	_	0	ROOT
33	not	not	RB	_	32	ADV
34	(	(	-LRB-	_	36	P
35	Figure	figure	NN	_	36	NMOD
36	3B	0b	NN	_	32	DEP
37	)	)	-RRB-	_	36	P
38	.	.	.	_	32	P

1	Overall	overall	JJ	_	2	NMOD
2	appearance	appearance	NN	_	7	SBJ
3	and	and	CC	_	2	COORD
4	body	body	NN	_	5	NMOD
5	weight	weight	NN	_	6	NMOD
6	curves	curve	NNS	_	3	CONJ
7	revealed	reveal	VBD	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	TTD	ttd	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	associated	associated	JJ	_	16	NMOD
12	age	age	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	related	related	JJ	_	16	NMOD
15	premature	premature	JJ	_	16	NMOD
16	cachexia	cachexia	NN	_	22	SBJ
17	and	and	CC	_	16	COORD
18	lack	lack	NN	_	17	CONJ
19	of	of	IN	_	18	NMOD
20	general	general	JJ	_	21	NMOD
21	fitness	fitness	NN	_	19	PMOD
22	were	be	VBD	_	8	SUB
23	fully	fully	RB	_	22	ADV
24	rescued	rescue	VBN	_	22	VC
25	in	in	IN	_	24	LOC
26	compound	compound	JJ	_	31	NMOD
27	heterozygous	heterozygous	JJ	_	31	NMOD
28	XpdTTD	xpdttd	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	†XPCS	†xpcs	NN	_	31	NMOD
31	mice	mouse	NNS	_	25	PMOD
32	(	(	-LRB-	_	34	P
33	Figure	figure	NN	_	34	NMOD
34	3A	0a	NN	_	7	PRN
35	and	and	CC	_	34	COORD
36	3D	0d	NN	_	35	CONJ
37	)	)	-RRB-	_	34	P
38	.	.	.	_	7	P

1	Finally	finally	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	5	NMOD
4	life	life	NN	_	5	NMOD
5	span	span	NN	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	compound	compound	JJ	_	8	NMOD
8	heterozygotes	heterozygote	NNS	_	6	PMOD
9	was	be	VBD	_	0	ROOT
10	extended	extend	VBN	_	9	VC
11	relative	relative	JJ	_	10	ADV
12	to	to	IN	_	11	AMOD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	TTD	ttd	NN	_	16	NMOD
16	mice	mouse	NNS	_	12	PMOD
17	(	(	-LRB-	_	18	P
18	Table	table	NN	_	10	PRN
19	2	0	CD	_	18	NMOD
20	)	)	-RRB-	_	18	P
21	.	.	.	_	9	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Rescue	rescue	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	TTD	ttd	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	Associated	associated	JJ	_	8	NMOD
6	Segmental	segmental	JJ	_	8	NMOD
7	Progeroid	progeroid	JJ	_	8	NMOD
8	Features	feature	NNS	_	2	PMOD
9	in	in	IN	_	8	NMOD
10	Compound	compound	JJ	_	15	NMOD
11	Heterozygous	heterozygous	JJ	_	15	NMOD
12	Xpd TTD	xpd ttd	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	†XPCS	†xpcs	NN	_	15	NMOD
15	Mice	mouse	NNS	_	9	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Photographs	photograph	NNS	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	20	0	CD	_	8	NMOD
7	-	-	HYPH	_	6	P
8	mo	mo	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	old	old	JJ	_	24	NMOD
11	wt	wt	NN	_	24	NMOD
12	,	,	,	_	11	P
13	compound	compound	JJ	_	17	NMOD
14	heterozygous	heterozygous	JJ	_	17	NMOD
15	XpdTTD	xpdttd	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	†XPCS	†xpcs	NN	_	11	CONJ
18	,	,	,	_	17	P
19	and	and	CC	_	17	COORD
20	homozygous	homozygous	JJ	_	23	NMOD
21	XpdTTD	xpdttd	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	TTD	ttd	NN	_	19	CONJ
24	mice	mouse	NNS	_	5	PMOD
25	.	.	.	_	4	P

1	Note	note	VB	_	0	ROOT
2	the	the	DT	_	6	NMOD
3	extreme	extreme	JJ	_	6	NMOD
4	cachexia	cachexia	NN	_	6	NMOD
5	(	(	-LRB-	_	6	P
6	lack	lack	NN	_	1	OBJ
7	of	of	IN	_	6	NMOD
8	subcutaneous	subcutaneous	JJ	_	9	NMOD
9	fat	fat	NN	_	7	PMOD
10	)	)	-RRB-	_	6	P
11	in	in	IN	_	6	LOC
12	the	the	DT	_	16	NMOD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	TTD	ttd	NN	_	16	NMOD
16	mouse	mouse	NN	_	11	PMOD
17	and	and	CC	_	6	COORD
18	the	the	DT	_	19	NMOD
19	absence	absence	NN	_	17	CONJ
20	of	of	IN	_	19	NMOD
21	this	this	DT	_	22	NMOD
22	phenotype	phenotype	NN	_	20	PMOD
23	in	in	IN	_	19	LOC
24	wt	wt	NN	_	29	NMOD
25	and	and	CC	_	24	COORD
26	XpdTTD	xpdttd	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	†XPCS	†xpcs	NN	_	25	CONJ
29	mice	mouse	NNS	_	23	PMOD
30	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Radiographs	radiograph	NNS	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	20	0	CD	_	8	NMOD
7	-	-	HYPH	_	6	P
8	mo	mo	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	old	old	JJ	_	22	NMOD
11	male	male	JJ	_	22	NMOD
12	wt	wt	NN	_	22	NMOD
13	,	,	,	_	12	P
14	XpdTTD	xpdttd	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	†XPCS	†xpcs	NN	_	12	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	XpdTTD	xpdttd	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	TTD	ttd	NN	_	18	CONJ
22	mice	mouse	NNS	_	5	PMOD
23	.	.	.	_	4	P

1	Ageing	age	VBG	_	5	NMOD
2	XpdTTD	xpdttd	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	TTD	ttd	NN	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	develop	develop	VBP	_	0	ROOT
7	kyphosis	kyphosis	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	curvature	curvature	NN	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	spinal	spinal	JJ	_	13	NMOD
13	column	column	NN	_	10	PMOD
14	)	)	-RRB-	_	9	P
15	and	and	CC	_	9	COORD
16	reduction	reduction	NN	_	15	CONJ
17	of	of	IN	_	16	NMOD
18	bone	bone	NN	_	19	NMOD
19	mineral	mineral	NN	_	20	NMOD
20	density	density	NN	_	17	PMOD
21	as	as	IN	_	6	ADV
22	shown	show	VBN	_	21	SUB
23	in	in	IN	_	22	LOC
24	the	the	DT	_	28	NMOD
25	6	0	CD	_	28	NMOD
26	–	–	SYM	_	25	P
27	8	0	CD	_	25	QMOD
28	segment	segment	NN	_	23	PMOD
29	of	of	IN	_	28	NMOD
30	the	the	DT	_	32	NMOD
31	tail	tail	NN	_	32	NMOD
32	vertebrae	vertebra	NNS	_	29	PMOD
33	counted	count	VBN	_	28	NMOD
34	from	from	IN	_	33	ADV
35	the	the	DT	_	36	NMOD
36	pelvis	pelvis	NN	_	34	PMOD
37	(	(	-LRB-	_	38	P
38	see	see	VB	_	6	PRN
39	close	close	JJ	_	38	OBJ
40	-	-	HYPH	_	39	P
41	up	up	RP	_	39	NMOD
42	at	at	IN	_	39	NMOD
43	right	right	NN	_	42	PMOD
44	)	)	-RRB-	_	38	P
45	.	.	.	_	6	P

1	Note	note	VB	_	0	ROOT
2	the	the	DT	_	3	NMOD
3	absence	absence	NN	_	1	OBJ
4	of	of	IN	_	3	NMOD
5	these	these	DT	_	6	NMOD
6	features	feature	NNS	_	4	PMOD
7	in	in	IN	_	3	LOC
8	the	the	DT	_	12	NMOD
9	XpdTTD 	xpdttd 	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	 † XPCS	 † xpcs	NN	_	12	NMOD
12	mouse	mouse	NN	_	7	PMOD
13	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Quantification	quantification	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	relative	relative	JJ	_	9	NMOD
7	bone	bone	NN	_	8	NMOD
8	mineral	mineral	NN	_	9	NMOD
9	density	density	NN	_	5	PMOD
10	of	of	IN	_	9	NMOD
11	tail	tail	NN	_	12	NMOD
12	vertebrae	vertebra	NNS	_	10	PMOD
13	from	from	IN	_	12	NMOD
14	20	0	CD	_	16	NMOD
15	-	-	HYPH	_	14	P
16	mo	mo	NN	_	18	AMOD
17	-	-	HYPH	_	16	P
18	old	old	JJ	_	45	NMOD
19	male	male	JJ	_	45	NMOD
20	wt	wt	NN	_	45	NMOD
21	(	(	-LRB-	_	24	P
22	n	n	NN	_	24	SBJ
23	=	=	SYM	_	24	P
24	3	0	CD	_	20	PRN
25	)	)	-RRB-	_	24	P
26	,	,	,	_	20	P
27	XpdTTD	xpdttd	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	†XPCS	†xpcs	NN	_	20	CONJ
30	(	(	-LRB-	_	33	P
31	n	n	NN	_	33	SBJ
32	=	=	SYM	_	33	P
33	4	0	CD	_	29	PRN
34	)	)	-RRB-	_	33	P
35	,	,	,	_	29	P
36	and	and	CC	_	29	COORD
37	XpdTTD	xpdttd	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	TTD	ttd	NN	_	36	CONJ
40	(	(	-LRB-	_	43	P
41	n	n	NN	_	43	SBJ
42	=	=	SYM	_	43	P
43	3	0	CD	_	39	PRN
44	)	)	-RRB-	_	43	P
45	mice	mouse	NNS	_	13	PMOD
46	.	.	.	_	4	P

1	The	the	DT	_	4	NMOD
2	p	p	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	values	value	NNS	_	5	SBJ
5	indicate	indicate	VBP	_	0	ROOT
6	the	the	DT	_	7	NMOD
7	significance	significance	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	difference	difference	NN	_	8	PMOD
11	relative	relative	JJ	_	5	ADV
12	to	to	IN	_	11	AMOD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	TTD	ttd	NN	_	12	PMOD
16	.	.	.	_	5	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	SEM	sem	NN	_	3	OBJ
5	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Body	body	NN	_	5	NMOD
5	weight	weight	NN	_	6	NMOD
6	curves	curve	NNS	_	0	ROOT
7	as	as	IN	_	6	NMOD
8	a	a	DT	_	9	NMOD
9	function	function	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	time	time	NN	_	10	PMOD
12	.	.	.	_	6	P

1	Note	note	VB	_	0	ROOT
2	that	that	IN	_	1	OBJ
3	the	the	DT	_	7	NMOD
4	age	age	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	dependent	dependent	JJ	_	7	NMOD
7	cachexia	cachexia	NN	_	14	SBJ
8	observed	observe	VBN	_	7	NMOD
9	in	in	IN	_	8	LOC
10	XpdTTD	xpdttd	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	TTD	ttd	NN	_	13	NMOD
13	mice	mouse	NNS	_	9	PMOD
14	was	be	VBD	_	2	SUB
15	rescued	rescue	VBN	_	14	VC
16	in	in	IN	_	15	LOC
17	both	both	CC	_	18	COORD
18	male	male	JJ	_	24	NMOD
19	and	and	CC	_	18	COORD
20	female	female	JJ	_	19	CONJ
21	XpdTTD 	xpdttd 	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	 †XPCS	 †xpcs	NN	_	24	NMOD
24	mice	mouse	NNS	_	16	PMOD
25	.	.	.	_	1	P

1	Significant	significant	JJ	_	2	NMOD
2	differences	difference	NNS	_	18	SBJ
3	between	between	IN	_	2	NMOD
4	wt	wt	NN	_	3	PMOD
5	and	and	CC	_	4	COORD
6	XpdTTD	xpdttd	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	TTD	ttd	NN	_	5	CONJ
9	but	but	CC	_	3	COORD
10	not	not	RB	_	9	ADV
11	between	between	IN	_	9	CONJ
12	wt	wt	NN	_	17	NMOD
13	and	and	CC	_	12	COORD
14	XpdTTD	xpdttd	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	†XPCS	†xpcs	NN	_	13	CONJ
17	mice	mouse	NNS	_	11	PMOD
18	were	be	VBD	_	0	ROOT
19	observed	observe	VBN	_	18	VC
20	at	at	IN	_	19	TMP
21	9	0	CD	_	24	NMOD
22	and	and	CC	_	21	COORD
23	18	0	CD	_	22	CONJ
24	mo	mo	NNS	_	20	PMOD
25	of	of	IN	_	24	NMOD
26	age	age	NN	_	25	PMOD
27	as	as	IN	_	19	ADV
28	indicated	indicate	VBN	_	27	SUB
29	by	by	IN	_	28	LGS
30	asterisks	asterisk	NNS	_	29	PMOD
31	.	.	.	_	18	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	SEM	sem	NN	_	3	OBJ
5	.	.	.	_	3	P

1	Table	table	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Pleiotropic	pleiotropic	JJ	_	4	NMOD
2	Xpd	xpd	NN	_	4	NMOD
3	Biallelic	biallelic	JJ	_	4	NMOD
4	Effects	effect	NNS	_	0	ROOT
5	in	in	IN	_	4	LOC
6	Mice	mouse	NNS	_	5	PMOD
7	and	and	CC	_	6	COORD
8	Cells	cell	NNS	_	7	CONJ

1	To	to	TO	_	24	PRP
2	determine	determine	VB	_	1	IM
3	whether	whether	IN	_	2	OBJ
4	the	the	DT	_	8	NMOD
5	homozygous	homozygous	JJ	_	8	NMOD
6	lethal	lethal	JJ	_	8	NMOD
7	Xpd†XPCS	xpd†xpcs	NN	_	8	NMOD
8	allele	allele	NN	_	9	SBJ
9	was	be	VBD	_	3	SUB
10	unique	unique	JJ	_	9	PRD
11	in	in	IN	_	10	AMOD
12	its	its	PRP$	_	13	NMOD
13	ability	ability	NN	_	11	PMOD
14	to	to	TO	_	13	NMOD
15	ameliorate	ameliorate	VB	_	14	IM
16	symptoms	symptom	NNS	_	15	OBJ
17	associated	associate	VBN	_	16	NMOD
18	with	with	IN	_	17	ADV
19	the	the	DT	_	21	NMOD
20	XpdTTD	xpdttd	NN	_	21	NMOD
21	allele	allele	NN	_	18	PMOD
22	,	,	,	_	24	P
23	we	we	PRP	_	24	SBJ
24	generated	generate	VBD	_	0	ROOT
25	compound	compound	NN	_	30	NMOD
26	heterozygous	heterozygous	JJ	_	30	NMOD
27	XpdTTD	xpdttd	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	†XP	†xp	NN	_	30	NMOD
30	mice	mouse	NNS	_	24	OBJ
31	by	by	IN	_	24	MNR
32	crossing	cross	VBG	_	31	PMOD
33	the	the	DT	_	36	NMOD
34	corresponding	correspond	VBG	_	36	NMOD
35	heterozygous	heterozygous	JJ	_	36	NMOD
36	animals	animal	NNS	_	32	OBJ
37	.	.	.	_	24	P

1	Similar	similar	JJ	_	12	ADV
2	to	to	IN	_	1	AMOD
3	the	the	DT	_	5	NMOD
4	Xpd †XPCS	xpd †xpcs	NN	_	5	NMOD
5	allele	allele	NN	_	2	PMOD
6	,	,	,	_	12	P
7	the	the	DT	_	11	NMOD
8	homozygous	homozygous	JJ	_	11	NMOD
9	lethal	lethal	JJ	_	11	NMOD
10	Xpd †XP	xpd †xp	NN	_	11	NMOD
11	allele	allele	NN	_	12	SBJ
12	rescued	rescue	VBD	_	0	ROOT
13	cutaneous	cutaneous	JJ	_	14	NMOD
14	symptoms	symptom	NNS	_	12	OBJ
15	including	include	VBG	_	14	NMOD
16	hair	hair	NN	_	17	NMOD
17	loss	loss	NN	_	15	PMOD
18	(	(	-LRB-	_	27	P
19	except	except	IN	_	27	DEP
20	locally	locally	RB	_	19	PMOD
21	during	during	IN	_	20	TMP
22	the	the	DT	_	24	NMOD
23	first	$#ORD#$	JJ	_	24	NMOD
24	round	round	NN	_	21	PMOD
25	;	;	:	_	27	P
26	unpublished	unpublished	JJ	_	27	NMOD
27	data	datum	NNS	_	17	PRN
28	)	)	-RRB-	_	27	P
29	,	,	,	_	17	P
30	reduced	reduce	VBN	_	32	NMOD
31	cysteine	cysteine	NN	_	32	NMOD
32	content	content	NN	_	17	CONJ
33	(	(	-LRB-	_	50	P
34	cysteine	cysteine	NN	_	35	NMOD
35	index	index	NN	_	40	NMOD
36	9.3	0	CD	_	40	NMOD
37	±	±	SYM	_	40	P
38	0.9	0	CD	_	40	NMOD
39	standard	standard	JJ	_	40	NMOD
40	deviation	deviation	NN	_	50	DEP
41	[	[	-LRB-	_	43	P
42	87	0	CD	_	43	NMOD
43	%	%	NN	_	40	PRN
44	of	of	IN	_	43	NMOD
45	wt	wt	NN	_	44	PMOD
46	]	]	-RRB-	_	43	P
47	,	,	,	_	50	P
48	p	p	NN	_	50	SBJ
49	=	=	SYM	_	50	P
50	0.01	0	CD	_	32	PRN
51	versus	versus	CC	_	50	COORD
52	TTD	ttd	NN	_	51	CONJ
53	)	)	-RRB-	_	50	P
54	,	,	,	_	32	P
55	ageing	ageing	NN	_	57	AMOD
56	-	-	HYPH	_	55	P
57	associated	associate	VBN	_	59	NMOD
58	premature	premature	JJ	_	59	NMOD
59	cachexia	cachexia	NN	_	32	CONJ
60	(	(	-LRB-	_	64	P
61	males	male	NNS	_	64	SBJ
62	and	and	CC	_	61	COORD
63	females	female	NNS	_	62	CONJ
64	were	be	VBD	_	59	PRN
65	36.1	0	CD	_	67	NMOD
66	±	±	SYM	_	67	P
67	6.4	0	CD	_	68	NMOD
68	g	g	NNS	_	64	PRD
69	[	[	-LRB-	_	71	P
70	93	0	CD	_	71	NMOD
71	%	%	NN	_	68	PRN
72	of	of	IN	_	71	NMOD
73	wt	wt	NN	_	72	PMOD
74	]	]	-RRB-	_	71	P
75	and	and	CC	_	68	COORD
76	39.2	0	CD	_	78	NMOD
77	±	±	SYM	_	78	P
78	3.2	0	CD	_	79	NMOD
79	g	g	NNS	_	75	CONJ
80	[	[	-LRB-	_	82	P
81	116	0	CD	_	82	NMOD
82	%	%	NN	_	79	PRN
83	of	of	IN	_	82	NMOD
84	wt	wt	NN	_	83	PMOD
85	]	]	-RRB-	_	82	P
86	,	,	,	_	64	P
87	respectively	respectively	RB	_	64	ADV
88	)	)	-RRB-	_	64	P
89	,	,	,	_	59	P
90	and	and	CC	_	59	COORD
91	reduced	reduce	VBN	_	93	NMOD
92	life	life	NN	_	93	NMOD
93	span	span	NN	_	90	CONJ
94	(	(	-LRB-	_	95	P
95	Table	table	NN	_	12	PRN
96	2	0	CD	_	95	NMOD
97	)	)	-RRB-	_	95	P
98	.	.	.	_	12	P

1	Taken	take	VBN	_	6	ADV
2	together	together	RB	_	1	ADV
3	,	,	,	_	6	P
4	these	these	DT	_	5	NMOD
5	data	datum	NNS	_	6	SBJ
6	indicate	indicate	VBP	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	two	two	CD	_	10	NMOD
9	independent	independent	JJ	_	10	NMOD
10	alleles	allele	NNS	_	26	SBJ
11	,	,	,	_	10	P
12	which	which	WDT	_	16	SBJ
13	on	on	IN	_	16	ADV
14	their	their	PRP$	_	15	NMOD
15	own	own	NN	_	13	PMOD
16	are	be	VBP	_	10	NMOD
17	unable	unable	JJ	_	16	PRD
18	to	to	TO	_	17	AMOD
19	support	support	VB	_	18	IM
20	viability	viability	NN	_	19	OBJ
21	(	(	-LRB-	_	22	P
22	Table	table	NN	_	19	PRN
23	1	0	CD	_	22	NMOD
24	)	)	-RRB-	_	22	P
25	,	,	,	_	26	P
26	were	be	VBD	_	7	SUB
27	nonetheless	nonetheless	RB	_	26	ADV
28	able	able	JJ	_	26	PRD
29	to	to	TO	_	28	AMOD
30	ameliorate	ameliorate	VB	_	29	IM
31	TTD	ttd	NN	_	33	AMOD
32	-	-	HYPH	_	31	P
33	associated	associate	VBN	_	34	NMOD
34	phenotypes	phenotype	NNS	_	30	OBJ
35	in	in	FW	_	36	AMOD
36	vivo	vivo	FW	_	30	ADV
37	(	(	-LRB-	_	38	P
38	Table	table	NN	_	30	PRN
39	2	0	CD	_	38	NMOD
40	)	)	-RRB-	_	38	P
41	.	.	.	_	6	P

1	Molecular	molecular	JJ	_	2	NMOD
2	Mechanisms	mechanism	NNS	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	Biallelic	biallelic	JJ	_	5	NMOD
5	Effects	effect	NNS	_	3	PMOD

1	We	we	PRP	_	3	SBJ
2	next	next	RB	_	3	ADV
3	turned	turn	VBD	_	0	ROOT
4	to	to	IN	_	3	ADV
5	UV	uv	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	based	base	VBN	_	9	NMOD
8	cellular	cellular	JJ	_	9	NMOD
9	assays	assay	NNS	_	4	PMOD
10	including	include	VBG	_	9	NMOD
11	unscheduled	unscheduled	JJ	_	13	NMOD
12	DNA	dna	NN	_	13	NMOD
13	synthesis	synthesis	NN	_	10	PMOD
14	after	after	IN	_	13	TMP
15	UV	uv	NN	_	16	NMOD
16	irradiation	irradiation	NN	_	14	PMOD
17	(	(	-LRB-	_	20	P
18	UV	uv	NN	_	20	NMOD
19	-	-	HYPH	_	18	P
20	UDS	uds	NN	_	13	PRN
21	)	)	-RRB-	_	20	P
22	,	,	,	_	13	P
23	recovery	recovery	NN	_	13	CONJ
24	of	of	IN	_	23	NMOD
25	RNA	rna	NN	_	26	NMOD
26	synthesis	synthesis	NN	_	24	PMOD
27	after	after	IN	_	23	TMP
28	UV	uv	NN	_	29	NMOD
29	irradiation	irradiation	NN	_	27	PMOD
30	(	(	-LRB-	_	33	P
31	UV	uv	NN	_	33	NMOD
32	-	-	HYPH	_	31	P
33	RRS	rrs	NN	_	23	PRN
34	)	)	-RRB-	_	33	P
35	,	,	,	_	23	P
36	and	and	CC	_	23	COORD
37	UV	uv	NN	_	38	NMOD
38	survival	survival	NN	_	36	CONJ
39	,	,	,	_	13	P
40	which	which	WDT	_	41	SBJ
41	report	report	VBP	_	13	NMOD
42	on	on	IN	_	41	ADV
43	the	the	DT	_	45	NMOD
44	NER	ner	NN	_	45	NMOD
45	subpathways	subpathways	NNS	_	42	PMOD
46	(	(	-LRB-	_	49	P
47	global	global	JJ	_	49	NMOD
48	genome	genome	NN	_	49	NMOD
49	NER	ner	NN	_	45	PRN
50	and	and	CC	_	49	COORD
51	transcription	transcription	NN	_	53	AMOD
52	-	-	HYPH	_	51	P
53	coupled	couple	VBN	_	54	NMOD
54	NER	ner	NN	_	50	CONJ
55	)	)	-RRB-	_	49	P
56	and	and	CC	_	45	COORD
57	total	total	JJ	_	58	NMOD
58	NER	ner	NN	_	56	CONJ
59	,	,	,	_	41	P
60	respectively	respectively	RB	_	41	ADV
61	.	.	.	_	3	P

1	In	in	IN	_	6	ADV
2	none	none	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	these	these	DT	_	5	NMOD
5	assays	assay	NNS	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	the	the	DT	_	8	NMOD
8	response	response	NN	_	6	SBJ
9	to	to	IN	_	8	NMOD
10	UV	uv	NN	_	9	PMOD
11	improved	improve	VBN	_	6	VC
12	in	in	IN	_	11	LOC
13	compound	compound	NN	_	14	NMOD
14	heterozygotes	heterozygote	NNS	_	12	PMOD
15	relative	relative	JJ	_	11	ADV
16	to	to	IN	_	15	AMOD
17	TTD	ttd	NN	_	18	NMOD
18	homozygotes	homozygote	NNS	_	16	PMOD
19	(	(	-LRB-	_	21	P
20	Figure	figure	NN	_	21	NMOD
21	4A	0a	NN	_	11	PRN
22	–	–	SYM	_	23	P
23	4C	0c	NN	_	21	NMOD
24	)	)	-RRB-	_	21	P
25	.	.	.	_	6	P

1	However	however	RB	_	28	ADV
2	,	,	,	_	28	P
3	unlike	unlike	IN	_	28	ADV
4	the	the	DT	_	8	NMOD
5	in	in	FW	_	6	AMOD
6	vivo	vivo	FW	_	8	NMOD
7	TTD	ttd	NN	_	8	NMOD
8	phenotypes	phenotype	NNS	_	3	PMOD
9	described	describe	VBN	_	8	NMOD
10	above	above	RB	_	9	ADV
11	,	,	,	_	8	P
12	in	in	IN	_	22	ADV
13	which	which	WDT	_	12	PMOD
14	XpdTTD	xpdttd	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	TTD	ttd	NN	_	21	NMOD
17	and	and	CC	_	16	COORD
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	KO	ko	NN	_	17	CONJ
21	animals	animal	NNS	_	22	SBJ
22	were	be	VBD	_	8	NMOD
23	indistinguishable	indistinguishable	JJ	_	22	PRD
24	,	,	,	_	28	P
25	XpdTTD	xpdttd	NN	_	27	NMOD
26	dosage	dosage	NN	_	27	NMOD
27	effects	effect	NNS	_	28	SBJ
28	were	be	VBD	_	0	ROOT
29	observed	observe	VBN	_	28	VC
30	in	in	IN	_	29	ADV
31	UV	uv	NN	_	32	NMOD
32	survival	survival	NN	_	30	PMOD
33	,	,	,	_	32	P
34	UV	uv	NN	_	36	NMOD
35	-	-	HYPH	_	34	P
36	UDS	uds	NN	_	32	CONJ
37	,	,	,	_	36	P
38	and	and	CC	_	36	COORD
39	UV	uv	NN	_	41	NMOD
40	-	-	HYPH	_	39	P
41	RRS	rrs	NN	_	38	CONJ
42	,	,	,	_	29	P
43	indicating	indicate	VBG	_	29	ADV
44	that	that	IN	_	43	OBJ
45	cellular	cellular	JJ	_	46	NMOD
46	parameters	parameter	NNS	_	52	SBJ
47	as	as	IN	_	46	ADV
48	measured	measure	VBN	_	47	SUB
49	in	in	IN	_	48	LOC
50	fibroblasts	fibroblast	NNS	_	49	PMOD
51	here	here	RB	_	48	ADV
52	do	do	VBP	_	44	SUB
53	not	not	RB	_	52	ADV
54	always	always	RB	_	52	ADV
55	correlate	correlate	VB	_	52	VC
56	with	with	IN	_	55	ADV
57	the	the	DT	_	58	NMOD
58	phenotype	phenotype	NN	_	56	PMOD
59	at	at	IN	_	55	ADV
60	the	the	DT	_	61	NMOD
61	level	level	NN	_	59	PMOD
62	of	of	IN	_	61	NMOD
63	the	the	DT	_	65	NMOD
64	intact	intact	JJ	_	65	NMOD
65	organism	organism	NN	_	62	PMOD
66	.	.	.	_	28	P

1	XpdTTD	xpdttd	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	KO	ko	NN	_	5	NMOD
4	hemizygous	hemizygous	JJ	_	5	NMOD
5	cells	cell	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	thus	thus	RB	_	6	ADV
8	used	use	VBN	_	6	VC
9	as	as	IN	_	8	MNR
10	the	the	DT	_	11	NMOD
11	baseline	baseline	NN	_	9	PMOD
12	on	on	IN	_	15	MNR
13	which	which	WDT	_	12	PMOD
14	to	to	TO	_	11	NMOD
15	compare	compare	VB	_	14	IM
16	the	the	DT	_	17	NMOD
17	activity	activity	NN	_	15	OBJ
18	of	of	IN	_	17	NMOD
19	compound	compound	NN	_	21	NMOD
20	heterozygous	heterozygous	JJ	_	21	NMOD
21	cells	cell	NNS	_	18	PMOD
22	.	.	.	_	6	P

1	Relative	relative	JJ	_	11	ADV
2	to	to	IN	_	1	AMOD
3	XpdTTD	xpdttd	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	KO	ko	NN	_	7	NMOD
6	hemizygote	hemizygote	NN	_	7	NMOD
7	cells	cell	NNS	_	2	PMOD
8	,	,	,	_	11	P
9	UV	uv	NN	_	10	NMOD
10	survival	survival	NN	_	11	SBJ
11	was	be	VBD	_	0	ROOT
12	improved	improve	VBN	_	11	VC
13	by	by	IN	_	12	ADV
14	the	the	DT	_	18	NMOD
15	homozygous	homozygous	JJ	_	18	NMOD
16	lethal	lethal	JJ	_	18	NMOD
17	Xpd†XPCS	xpd†xpcs	NN	_	18	NMOD
18	allele	allele	NN	_	13	PMOD
19	in	in	IN	_	18	LOC
20	XpdTTD	xpdttd	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	†XPCS	†xpcs	NN	_	25	NMOD
23	compound	compound	NN	_	25	NMOD
24	heterozygous	heterozygous	JJ	_	25	NMOD
25	cells	cell	NNS	_	19	PMOD
26	and	and	CC	_	13	COORD
27	to	to	IN	_	31	EXT
28	a	a	DT	_	30	NMOD
29	lesser	less	JJR	_	30	NMOD
30	degree	degree	NN	_	27	PMOD
31	by	by	IN	_	26	CONJ
32	the	the	DT	_	34	NMOD
33	Xpd†XP	xpd†xp	NN	_	34	NMOD
34	allele	allele	NN	_	31	PMOD
35	(	(	-LRB-	_	37	P
36	Figure	figure	NN	_	37	NMOD
37	4A	0a	NN	_	12	PRN
38	)	)	-RRB-	_	37	P
39	.	.	.	_	11	P

1	Because	because	IN	_	9	PRP
2	of	of	IN	_	1	PMOD
3	embryonic	embryonic	JJ	_	6	NMOD
4	and	and	CC	_	3	COORD
5	cellular	cellular	JJ	_	4	CONJ
6	lethality	lethality	NN	_	1	PMOD
7	,	,	,	_	9	P
8	we	we	PRP	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	unable	unable	JJ	_	9	PRD
11	to	to	TO	_	10	AMOD
12	test	test	VB	_	11	IM
13	UV	uv	NN	_	14	NMOD
14	survival	survival	NN	_	12	OBJ
15	associated	associate	VBN	_	14	NMOD
16	exclusively	exclusively	RB	_	15	ADV
17	with	with	IN	_	15	ADV
18	the	the	DT	_	22	NMOD
19	Xpd†XPCS	xpd†xpcs	NN	_	22	NMOD
20	or	or	CC	_	19	COORD
21	Xpd†XP	xpd†xp	NN	_	20	CONJ
22	alleles	allele	NNS	_	17	PMOD
23	.	.	.	_	9	P

1	However	however	RB	_	16	ADV
2	,	,	,	_	16	P
3	homozygous	homozygous	JJ	_	4	NMOD
4	XPDXP	xpdxp	NN	_	15	NMOD
5	(	(	-LRB-	_	6	P
6	XPDR683W	xpdr0w	NN	_	4	PRN
7	)	)	-RRB-	_	6	P
8	and	and	CC	_	4	COORD
9	hemizygous	hemizygous	JJ	_	10	NMOD
10	XPDXPCS	xpdxpcs	NN	_	8	CONJ
11	(	(	-LRB-	_	12	P
12	XPDG602D	xpdg0d	NN	_	10	PRN
13	)	)	-RRB-	_	12	P
14	human	human	JJ	_	15	NMOD
15	cells	cell	NNS	_	16	SBJ
16	are	be	VBP	_	0	ROOT
17	known	know	VBN	_	16	VC
18	to	to	TO	_	17	OPRD
19	be	be	VB	_	18	IM
20	highly	highly	RB	_	21	AMOD
21	sensitive	sensitive	JJ	_	19	PRD
22	to	to	IN	_	21	AMOD
23	UV	uv	NN	_	22	PMOD
24	[	[	-LRB-	_	27	P
25	19	0	CD	_	27	NMOD
26	,	,	,	_	27	P
27	25	0	CD	_	19	PRN
28	]	]	-RRB-	_	27	P
29	,	,	,	_	17	P
30	as	as	IN	_	17	ADV
31	are	be	VBP	_	30	SUB
32	cells	cell	NNS	_	31	SBJ
33	from	from	IN	_	32	NMOD
34	a	a	DT	_	46	NMOD
35	homozygous	homozygous	JJ	_	46	NMOD
36	viable	viable	JJ	_	46	NMOD
37	XpdXPCS	xpdxpcs	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	XPCS	xpcs	NN	_	46	NMOD
40	(	(	-LRB-	_	43	P
41	XPDG602D	xpdg0d	NN	_	43	NMOD
42	/	/	HYPH	_	41	P
43	G602D	g0d	NN	_	39	PRN
44	)	)	-RRB-	_	43	P
45	mouse	mouse	NN	_	46	NMOD
46	model	model	NN	_	33	PMOD
47	(	(	-LRB-	_	49	P
48	Figure	figure	NN	_	49	NMOD
49	4A	0a	NN	_	31	PRN
50	,	,	,	_	49	P
51	dotted	dot	VBN	_	52	NMOD
52	line	line	NN	_	49	APPO
53	)	)	-RRB-	_	49	P
54	[	[	-LRB-	_	55	P
55	23	0	CD	_	17	PRN
56	]	]	-RRB-	_	55	P
57	.	.	.	_	16	P

1	Thus	thus	RB	_	17	ADV
2	,	,	,	_	17	P
3	the	the	DT	_	4	NMOD
4	survival	survival	NN	_	17	SBJ
5	of	of	IN	_	4	NMOD
6	XpdTTD	xpdttd	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	†XPCS	†xpcs	NN	_	15	NMOD
9	(	(	-LRB-	_	8	P
10	and	and	CC	_	8	COORD
11	XpdTTD	xpdttd	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	†XP	†xp	NN	_	10	CONJ
14	)	)	-RRB-	_	15	P
15	cells	cell	NNS	_	5	PMOD
16	likely	likely	RB	_	17	ADV
17	represents	represent	VBZ	_	0	ROOT
18	a	a	DT	_	19	NMOD
19	level	level	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	UV	uv	NN	_	22	NMOD
22	resistance	resistance	NN	_	20	PMOD
23	that	that	WDT	_	28	OBJ
24	neither	neither	CC	_	26	COORD
25	mutant	mutant	JJ	_	26	NMOD
26	allele	allele	NN	_	27	SBJ
27	can	can	MD	_	19	NMOD
28	impart	impart	VB	_	27	VC
29	on	on	IN	_	28	MNR
30	its	its	PRP$	_	31	NMOD
31	own	own	NN	_	29	PMOD
32	(	(	-LRB-	_	33	P
33	Table	table	NN	_	17	PRN
34	2	0	CD	_	33	NMOD
35	)	)	-RRB-	_	33	P
36	.	.	.	_	17	P

1	Significant	significant	JJ	_	2	NMOD
2	effects	effect	NNS	_	15	SBJ
3	of	of	IN	_	2	NMOD
4	compound	compound	NN	_	5	NMOD
5	heterozygosity	heterozygosity	NN	_	3	PMOD
6	on	on	IN	_	2	NMOD
7	NER	ner	NN	_	8	NMOD
8	subpathways	subpathways	NNS	_	6	PMOD
9	relative	relative	JJ	_	2	NMOD
10	to	to	IN	_	9	AMOD
11	XpdTTD	xpdttd	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	KO	ko	NN	_	14	NMOD
14	cells	cell	NNS	_	10	PMOD
15	were	be	VBD	_	0	ROOT
16	observed	observe	VBN	_	15	VC
17	in	in	IN	_	16	ADV
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	†XP	†xp	NN	_	21	NMOD
21	cells	cell	NNS	_	17	PMOD
22	but	but	CC	_	17	COORD
23	only	only	RB	_	24	PMOD
24	for	for	IN	_	22	CONJ
25	UV	uv	NN	_	27	NMOD
26	-	-	HYPH	_	25	P
27	UDS	uds	NN	_	28	NMOD
28	activity	activity	NN	_	24	PMOD
29	.	.	.	_	15	P

1	Finally	finally	RB	_	30	ADV
2	,	,	,	_	30	P
3	none	none	NN	_	30	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	mutant	mutant	JJ	_	8	NMOD
7	TFIIH	tfiih	NN	_	8	NMOD
8	combinations	combination	NNS	_	4	PMOD
9	(	(	-LRB-	_	8	P
10	carrying	carry	VBG	_	8	NMOD
11	alterations	alteration	NNS	_	10	OBJ
12	associated	associate	VBN	_	11	NMOD
13	with	with	IN	_	12	ADV
14	TTD	ttd	NN	_	13	PMOD
15	[	[	-LRB-	_	16	P
16	XPDR722W	xpdr0w	NN	_	14	PRN
17	]	]	-RRB-	_	16	P
18	,	,	,	_	14	P
19	XPCS	xpcs	NN	_	14	CONJ
20	[	[	-LRB-	_	21	P
21	XPDG602D	xpdg0d	NN	_	19	PRN
22	]	]	-RRB-	_	21	P
23	,	,	,	_	19	P
24	or	or	CC	_	19	COORD
25	XP	xp	NN	_	24	CONJ
26	[	[	-LRB-	_	27	P
27	XPDR683W	xpdr0w	NN	_	25	PRN
28	]	]	-RRB-	_	27	P
29	)	)	-RRB-	_	30	P
30	exhibited	exhibit	VBD	_	0	ROOT
31	synergism	synergism	NN	_	30	OBJ
32	in	in	IN	_	30	ADV
33	an	an	DT	_	37	NMOD
34	in	in	FW	_	35	AMOD
35	vitro	vitro	FW	_	37	NMOD
36	NER	ner	NN	_	37	NMOD
37	reaction	reaction	NN	_	32	PMOD
38	reconstituted	reconstitute	VBN	_	37	NMOD
39	with	with	IN	_	38	MNR
40	different	different	JJ	_	43	NMOD
41	mutant	mutant	JJ	_	43	NMOD
42	TFIIH	tfiih	NN	_	43	NMOD
43	complexes	complex	NNS	_	39	PMOD
44	(	(	-LRB-	_	46	P
45	Figure	figure	NN	_	46	NMOD
46	4D	0d	NN	_	30	PRN
47	)	)	-RRB-	_	46	P
48	.	.	.	_	30	P

1	Taken	take	VBN	_	6	ADV
2	together	together	RB	_	1	ADV
3	,	,	,	_	6	P
4	these	these	DT	_	5	NMOD
5	data	datum	NNS	_	6	SBJ
6	are	be	VBP	_	0	ROOT
7	consistent	consistent	JJ	_	6	PRD
8	with	with	IN	_	7	AMOD
9	interallelic	interallelic	JJ	_	10	NMOD
10	complementation	complementation	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	UV	uv	NN	_	13	NMOD
13	sensitivity	sensitivity	NN	_	11	PMOD
14	in	in	IN	_	10	LOC
15	cells	cell	NNS	_	14	PMOD
16	but	but	CC	_	6	COORD
17	underscore	underscore	VBP	_	16	CONJ
18	the	the	DT	_	19	NMOD
19	lack	lack	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	any	any	DT	_	22	NMOD
22	correlation	correlation	NN	_	20	PMOD
23	between	between	IN	_	22	NMOD
24	UV	uv	NN	_	26	AMOD
25	-	-	HYPH	_	24	P
26	related	relate	VBN	_	28	NMOD
27	repair	repair	NN	_	28	NMOD
28	characteristics	characteristic	NNS	_	23	PMOD
29	and	and	CC	_	28	COORD
30	TTD	ttd	NN	_	32	NMOD
31	progeroid	progeroid	NN	_	32	NMOD
32	phenotypes	phenotype	NNS	_	29	CONJ
33	in	in	IN	_	22	LOC
34	animal	animal	NN	_	35	NMOD
35	models	model	NNS	_	33	PMOD
36	.	.	.	_	6	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	TFIIH	tfiih	NN	_	2	NMOD
2	Functions	function	NNS	_	0	ROOT
3	and	and	CC	_	2	COORD
4	Mechanisms	mechanism	NNS	_	3	CONJ
5	of	of	IN	_	4	NMOD
6	XPD	xpd	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	Associated	associate	VBN	_	10	NMOD
9	Disease	disease	NN	_	10	NMOD
10	Pleiotropy	pleiotropy	NN	_	5	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Cellular	cellular	JJ	_	5	NMOD
5	survival	survival	NN	_	0	ROOT
6	after	after	IN	_	5	TMP
7	UV	uv	NN	_	8	NMOD
8	irradiation	irradiation	NN	_	6	PMOD
9	.	.	.	_	5	P

1	Rescue	rescue	NN	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	hemizygous	hemizygous	JJ	_	7	NMOD
4	XpdTTD	xpdttd	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	KO	ko	NN	_	7	NMOD
7	survival	survival	NN	_	2	PMOD
8	by	by	IN	_	1	NMOD
9	Xpd†XPCS	xpd†xpcs	NN	_	12	NMOD
10	and	and	CC	_	9	COORD
11	Xpd†XP	xpd†xp	NN	_	10	CONJ
12	alleles	allele	NNS	_	8	PMOD
13	is	be	VBZ	_	0	ROOT
14	illustrated	illustrate	VBN	_	13	VC
15	by	by	IN	_	14	LGS
16	arrows	arrow	NNS	_	15	PMOD
17	marked	mark	VBN	_	16	NMOD
18	A	a	NN	_	17	OPRD
19	and	and	CC	_	18	COORD
20	B	b	NN	_	19	CONJ
21	,	,	,	_	17	P
22	respectively	respectively	RB	_	17	ADV
23	.	.	.	_	13	P

1	UV	uv	NN	_	2	NMOD
2	survival	survival	NN	_	21	SBJ
3	of	of	IN	_	2	NMOD
4	homozygous	homozygous	JJ	_	8	NMOD
5	XpdXPCS	xpdxpcs	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	XPCS	xpcs	NN	_	8	NMOD
8	cells	cell	NNS	_	3	PMOD
9	(	(	-LRB-	_	10	P
10	asterisk	asterisk	NN	_	8	PRN
11	)	)	-RRB-	_	10	P
12	from	from	IN	_	8	NMOD
13	the	the	DT	_	17	NMOD
14	normally	normally	RB	_	15	AMOD
15	expressed	express	VBN	_	17	NMOD
16	viable	viable	JJ	_	17	NMOD
17	allele	allele	NN	_	12	PMOD
18	(	(	-LRB-	_	19	P
19	XpdXPCS	xpdxpcs	NN	_	17	PRN
20	)	)	-RRB-	_	19	P
21	is	be	VBZ	_	0	ROOT
22	depicted	depict	VBN	_	21	VC
23	by	by	IN	_	22	MNR
24	a	a	DT	_	26	NMOD
25	dotted	dot	VBN	_	26	NMOD
26	line	line	NN	_	23	PMOD
27	.	.	.	_	21	P

1	Survival	survival	NN	_	2	NMOD
2	curves	curve	NNS	_	3	SBJ
3	represent	represent	VBP	_	18	DEP
4	an	an	DT	_	5	NMOD
5	average	average	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	four	four	CD	_	9	NMOD
8	independent	independent	JJ	_	9	NMOD
9	experiments	experiment	NNS	_	6	PMOD
10	;	;	:	_	18	P
11	1	0	CD	_	15	NMOD
12	–	–	SYM	_	11	P
13	2	0	CD	_	11	QMOD
14	cell	cell	NN	_	15	NMOD
15	lines	line	NNS	_	18	SBJ
16	per	per	IN	_	15	NMOD
17	genotype	genotype	NN	_	16	PMOD
18	were	be	VBD	_	0	ROOT
19	included	include	VBN	_	18	VC
20	in	in	IN	_	19	ADV
21	each	each	DT	_	22	NMOD
22	experiment	experiment	NN	_	20	PMOD
23	.	.	.	_	18	P

1	Error	error	NN	_	2	NMOD
2	bars	bar	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	SEM	sem	NN	_	3	OBJ
5	between	between	IN	_	4	NMOD
6	experiments	experiment	NNS	_	5	PMOD
7	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	UV	uv	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	UDS	uds	NN	_	0	ROOT
7	,	,	,	_	6	P
8	a	a	DT	_	9	NMOD
9	measure	measure	NN	_	6	APPO
10	of	of	IN	_	9	NMOD
11	global	global	JJ	_	13	NMOD
12	genome	genome	NN	_	13	NMOD
13	repair	repair	NN	_	10	PMOD
14	.	.	.	_	6	P

1	Number	number	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	experiments	experiment	NNS	_	2	PMOD
4	:	:	:	_	1	P
5	n	n	NN	_	7	SBJ
6	=	=	SYM	_	7	P
7	15	0	CD	_	48	DEP
8	(	(	-LRB-	_	11	P
9	XpdTTD	xpdttd	NN	_	11	DEP
10	/	/	SYM	_	9	P
11	TTD	ttd	NN	_	7	PRN
12	)	)	-RRB-	_	11	P
13	,	,	,	_	48	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	6	0	CD	_	48	DEP
17	(	(	-LRB-	_	20	P
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	KO	ko	NN	_	16	PRN
21	)	)	-RRB-	_	20	P
22	,	,	,	_	48	P
23	n	n	NN	_	25	SBJ
24	=	=	SYM	_	25	P
25	4	0	CD	_	48	DEP
26	(	(	-LRB-	_	29	P
27	XpdTTD	xpdttd	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	†XPCS	†xpcs	NN	_	25	PRN
30	)	)	-RRB-	_	29	P
31	,	,	,	_	48	P
32	n	n	NN	_	34	SBJ
33	=	=	SYM	_	34	P
34	2	0	CD	_	48	DEP
35	(	(	-LRB-	_	38	P
36	XpdTTD	xpdttd	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	†XP	†xp	NN	_	34	PRN
39	)	)	-RRB-	_	38	P
40	;	;	:	_	48	P
41	1	0	CD	_	45	NMOD
42	–	–	SYM	_	41	P
43	2	0	CD	_	41	QMOD
44	cell	cell	NN	_	45	NMOD
45	lines	line	NNS	_	48	SBJ
46	per	per	IN	_	45	NMOD
47	genotype	genotype	NN	_	46	PMOD
48	were	be	VBD	_	1	DEP
49	included	include	VBN	_	48	VC
50	in	in	IN	_	49	ADV
51	each	each	DT	_	52	NMOD
52	experiment	experiment	NN	_	50	PMOD
53	.	.	.	_	1	P

1	The	the	DT	_	2	NMOD
2	asterisk	asterisk	NN	_	3	SBJ
3	indicates	indicate	VBZ	_	12	DEP
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	3	OBJ
6	with	with	IN	_	5	NMOD
7	XpdTTD	xpdttd	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	TTD	ttd	NN	_	6	PMOD
10	;	;	:	_	12	P
11	crosses	crosse	NNS	_	12	SBJ
12	indicate	indicate	VBP	_	0	ROOT
13	significant	significant	JJ	_	14	NMOD
14	differences	difference	NNS	_	12	OBJ
15	with	with	IN	_	14	NMOD
16	XpdTTD	xpdttd	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	KO	ko	NN	_	15	PMOD
19	.	.	.	_	12	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	UV	uv	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	RRS	rrs	NN	_	0	ROOT
7	,	,	,	_	6	P
8	a	a	DT	_	9	NMOD
9	measure	measure	NN	_	6	APPO
10	of	of	IN	_	9	NMOD
11	transcription	transcription	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	coupled	couple	VBN	_	14	NMOD
14	repair	repair	NN	_	10	PMOD
15	of	of	IN	_	14	NMOD
16	UV	uv	NN	_	18	AMOD
17	-	-	HYPH	_	16	P
18	induced	induce	VBN	_	19	NMOD
19	lesions	lesion	NNS	_	15	PMOD
20	.	.	.	_	6	P

1	Number	number	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	experiments	experiment	NNS	_	2	PMOD
4	:	:	:	_	1	P
5	n	n	NN	_	7	SBJ
6	=	=	SYM	_	7	P
7	7	0	CD	_	48	DEP
8	(	(	-LRB-	_	11	P
9	XpdTTD	xpdttd	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	TTD	ttd	NN	_	7	PRN
12	)	)	-RRB-	_	11	P
13	,	,	,	_	48	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	2	0	CD	_	48	DEP
17	(	(	-LRB-	_	20	P
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	KO	ko	NN	_	16	PRN
21	)	)	-RRB-	_	20	P
22	,	,	,	_	48	P
23	n	n	NN	_	25	SBJ
24	=	=	SYM	_	25	P
25	4	0	CD	_	48	DEP
26	(	(	-LRB-	_	29	P
27	XpdTTD	xpdttd	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	†XPCS	†xpcs	NN	_	25	PRN
30	)	)	-RRB-	_	29	P
31	,	,	,	_	48	P
32	n	n	NN	_	34	SBJ
33	=	=	SYM	_	34	P
34	2	0	CD	_	48	DEP
35	(	(	-LRB-	_	38	P
36	XpdTTD	xpdttd	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	†XP	†xp	NN	_	34	PRN
39	)	)	-RRB-	_	38	P
40	;	;	:	_	48	P
41	1	0	CD	_	45	NMOD
42	–	–	SYM	_	41	P
43	2	0	CD	_	41	QMOD
44	cell	cell	NN	_	45	NMOD
45	lines	line	NNS	_	48	SBJ
46	per	per	IN	_	45	NMOD
47	genotype	genotype	NN	_	46	PMOD
48	were	be	VBD	_	1	DEP
49	included	include	VBN	_	48	VC
50	in	in	IN	_	49	ADV
51	each	each	DT	_	52	NMOD
52	experiment	experiment	NN	_	50	PMOD
53	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	7	NMOD
3	)	)	-RRB-	_	2	P
4	Incision	incision	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	excision	excision	NN	_	7	NMOD
7	activity	activity	NN	_	0	ROOT
8	of	of	IN	_	7	NMOD
9	combinations	combination	NNS	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	altered	alter	VBN	_	13	NMOD
12	TFIIH	tfiih	NN	_	13	NMOD
13	complexes	complex	NNS	_	10	PMOD
14	in	in	IN	_	13	NMOD
15	a	a	DT	_	18	NMOD
16	reconstituted	reconstitute	VBN	_	18	NMOD
17	NER	ner	NN	_	18	NMOD
18	reaction	reaction	NN	_	14	PMOD
19	.	.	.	_	7	P

1	Equal	equal	JJ	_	2	NMOD
2	amounts	amount	NNS	_	39	SBJ
3	of	of	IN	_	2	NMOD
4	single	single	JJ	_	7	NMOD
5	or	or	CC	_	4	COORD
6	mixed	mixed	JJ	_	5	CONJ
7	populations	population	NNS	_	3	PMOD
8	of	of	IN	_	7	NMOD
9	recombinant	recombinant	JJ	_	10	NMOD
10	TFIIHs	tfiihs	NNS	_	8	PMOD
11	(	(	-LRB-	_	7	P
12	containing	contain	VBG	_	7	NMOD
13	XPD	xpd	NN	_	12	OBJ
14	,	,	,	_	13	P
15	XPB	xpb	NN	_	13	CONJ
16	,	,	,	_	15	P
17	p62	p0	NN	_	15	CONJ
18	,	,	,	_	17	P
19	p52	p0	NN	_	17	CONJ
20	,	,	,	_	19	P
21	His	his	NN	_	23	NMOD
22	-	-	HYPH	_	21	P
23	p44	p0	NN	_	19	CONJ
24	,	,	,	_	23	P
25	Flag	flag	NN	_	27	NMOD
26	-	-	HYPH	_	25	P
27	p34	p0	NN	_	23	CONJ
28	,	,	,	_	27	P
29	cdk7	cdk0	NN	_	27	CONJ
30	,	,	,	_	29	P
31	cyclin	cyclin	NN	_	32	NMOD
32	H	h	NN	_	29	CONJ
33	,	,	,	_	32	P
34	Mat1	mat0	NN	_	32	CONJ
35	,	,	,	_	34	P
36	and	and	CC	_	34	COORD
37	p8	p0	NN	_	36	CONJ
38	)	)	-RRB-	_	39	P
39	were	be	VBD	_	0	ROOT
40	mixed	mix	VBN	_	39	VC
41	with	with	IN	_	40	ADV
42	recombinant	recombinant	JJ	_	53	NMOD
43	XPG	xpg	NN	_	53	NMOD
44	,	,	,	_	53	P
45	XPF	xpf	NN	_	47	NMOD
46	/	/	HYPH	_	45	P
47	ERCC1	ercc0	NN	_	53	NMOD
48	,	,	,	_	53	P
49	XPC	xpc	NN	_	51	NMOD
50	/	/	HYPH	_	49	P
51	hHR23B	hhr0b	NN	_	53	NMOD
52	,	,	,	_	53	P
53	RPA	rpa	NN	_	41	PMOD
54	,	,	,	_	53	P
55	and	and	CC	_	53	COORD
56	a	a	DT	_	60	NMOD
57	radiolabelled	radiolabelled	VBN	_	60	NMOD
58	synthetic	synthetic	JJ	_	60	NMOD
59	NER	ner	NN	_	60	NMOD
60	substrate	substrate	NN	_	55	CONJ
61	.	.	.	_	39	P

1	The	the	DT	_	3	NMOD
2	excision	excision	NN	_	3	NMOD
3	products	product	NNS	_	12	SBJ
4	(	(	-LRB-	_	8	P
5	26	0	CD	_	8	NMOD
6	–	–	SYM	_	5	P
7	34	0	CD	_	5	QMOD
8	nucleotides	nucleotide	NNS	_	3	PRN
9	in	in	IN	_	8	NMOD
10	length	length	NN	_	9	PMOD
11	)	)	-RRB-	_	8	P
12	were	be	VBD	_	0	ROOT
13	visualised	visualise	VBN	_	12	VC
14	at	at	IN	_	13	MNR
15	nucleotide	nucleotide	NN	_	16	NMOD
16	resolution	resolution	NN	_	14	PMOD
17	on	on	IN	_	13	MNR
18	a	a	DT	_	21	NMOD
19	denaturing	denature	VBG	_	21	NMOD
20	polyacrylamide	polyacrylamide	NN	_	21	NMOD
21	gel	gel	NN	_	17	PMOD
22	as	as	IN	_	13	ADV
23	indicated	indicate	VBN	_	22	SUB
24	.	.	.	_	12	P

1	Note	note	VB	_	0	ROOT
2	the	the	DT	_	4	NMOD
3	weak	weak	JJ	_	4	NMOD
4	activity	activity	NN	_	1	OBJ
5	corresponding	correspond	VBG	_	4	NMOD
6	to	to	IN	_	5	ADV
7	each	each	DT	_	12	NMOD
8	single	single	JJ	_	12	NMOD
9	and	and	CC	_	8	COORD
10	combined	combine	VBN	_	9	CONJ
11	TFIIH	tfiih	NN	_	12	NMOD
12	complex	complex	NN	_	6	PMOD
13	(	(	-LRB-	_	15	P
14	lanes	lane	NNS	_	15	NMOD
15	3	0	CD	_	12	PRN
16	–	–	SYM	_	17	P
17	8	0	CD	_	15	NMOD
18	)	)	-RRB-	_	15	P
19	relative	relative	JJ	_	5	ADV
20	to	to	IN	_	19	AMOD
21	the	the	DT	_	22	NMOD
22	wt	wt	NN	_	20	PMOD
23	(	(	-LRB-	_	24	P
24	lane	lane	NN	_	22	PRN
25	1	0	CD	_	24	NMOD
26	)	)	-RRB-	_	24	P
27	and	and	CC	_	22	COORD
28	negative	negative	JJ	_	29	NMOD
29	controls	control	NNS	_	27	CONJ
30	(	(	-LRB-	_	31	P
31	lane	lane	NN	_	29	PRN
32	2	0	CD	_	31	NMOD
33	)	)	-RRB-	_	31	P
34	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	E	e	LS	_	8	NMOD
3	)	)	-RRB-	_	2	P
4	Xpd	xpd	NN	_	8	NMOD
5	dose	dose	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	dependent	dependent	JJ	_	8	NMOD
8	reduction	reduction	NN	_	0	ROOT
9	of	of	IN	_	8	NMOD
10	TFIIH	tfiih	NN	_	9	PMOD
11	in	in	IN	_	8	LOC
12	homozygous	homozygous	JJ	_	15	NMOD
13	XpdTTD	xpdttd	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	TTD	ttd	NN	_	32	NMOD
16	,	,	,	_	15	P
17	hemizygous	hemizygous	JJ	_	20	NMOD
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	KO	ko	NN	_	15	CONJ
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	compound	compound	NN	_	27	NMOD
24	heterozygous	heterozygous	JJ	_	27	NMOD
25	XpdTTD	xpdttd	NN	_	27	NMOD
26	/	/	HYPH	_	25	P
27	†XPCS	†xpcs	NN	_	22	CONJ
28	and	and	CC	_	27	COORD
29	XpdTTD	xpdttd	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	†XP	†xp	NN	_	28	CONJ
32	cells	cell	NNS	_	11	PMOD
33	by	by	IN	_	8	NMOD
34	comparative	comparative	JJ	_	35	NMOD
35	immunofluorescence	immunofluorescence	NN	_	33	PMOD
36	of	of	IN	_	35	NMOD
37	the	the	DT	_	39	NMOD
38	p62	p0	NN	_	39	NMOD
39	subunit	subunit	NN	_	36	PMOD
40	of	of	IN	_	39	NMOD
41	TFIIH	tfiih	NN	_	40	PMOD
42	.	.	.	_	8	P

1	Roman	roman	JJ	_	2	NMOD
2	numerals	numeral	NNS	_	3	SBJ
3	represent	represent	VBP	_	0	ROOT
4	different	different	JJ	_	6	NMOD
5	microscopic	microscopic	JJ	_	6	NMOD
6	slides	slide	NNS	_	3	OBJ
7	and	and	CC	_	3	COORD
8	Arabic	arabic	JJ	_	9	NMOD
9	numerals	numeral	NNS	_	21	DEP
10	different	different	JJ	_	12	NMOD
11	cell	cell	NN	_	12	NMOD
12	lines	line	NNS	_	9	DEP
13	labelled	label	VBN	_	12	NMOD
14	as	as	IN	_	13	ADV
15	follows	follow	VBZ	_	14	SUB
16	:	:	:	_	21	P
17	(	(	-LRB-	_	18	P
18	I	i	LS	_	21	NMOD
19	)	)	-RRB-	_	18	P
20	wt	wt	NN	_	21	NMOD
21	cells	cell	NNS	_	3	DEP
22	(	(	-LRB-	_	23	P
23	1	0	CD	_	21	PRN
24	)	)	-RRB-	_	23	P
25	labelled	label	VBN	_	21	NMOD
26	with	with	IN	_	25	MNR
27	2	0	CD	_	29	NMOD
28	-	-	HYPH	_	27	P
29	μm	μm	NN	_	30	NMOD
30	beads	bead	NNS	_	26	PMOD
31	,	,	,	_	25	P
32	XpdTTD	xpdttd	NN	_	34	NMOD
33	/	/	HYPH	_	32	P
34	TTD	ttd	NN	_	35	NMOD
35	cells	cell	NNS	_	25	GAP
36	(	(	-LRB-	_	37	P
37	2	0	CD	_	35	PRN
38	)	)	-RRB-	_	37	P
39	with	with	IN	_	35	MNR
40	0.79	0	CD	_	42	NMOD
41	-	-	HYPH	_	40	P
42	μm	μm	NN	_	43	NMOD
43	beads	bead	NNS	_	39	PMOD
44	,	,	,	_	35	P
45	and	and	CC	_	35	COORD
46	XpdTTD	xpdttd	NN	_	48	NMOD
47	/	/	HYPH	_	46	P
48	KO	ko	NN	_	49	NMOD
49	cells	cell	NNS	_	45	GAP
50	(	(	-LRB-	_	51	P
51	3	0	CD	_	49	PRN
52	)	)	-RRB-	_	51	P
53	with	with	IN	_	49	MNR
54	no	no	DT	_	55	NMOD
55	beads	bead	NNS	_	53	PMOD
56	;	;	:	_	21	P
57	(	(	-LRB-	_	58	P
58	II	ii	LS	_	61	NMOD
59	)	)	-RRB-	_	58	P
60	wt	wt	NN	_	61	NMOD
61	cells	cell	NNS	_	21	CONJ
62	(	(	-LRB-	_	63	P
63	1	0	CD	_	61	PRN
64	)	)	-RRB-	_	63	P
65	labelled	label	VBN	_	61	NMOD
66	with	with	IN	_	65	MNR
67	0.79	0	CD	_	69	NMOD
68	-	-	HYPH	_	67	P
69	μm	μm	NN	_	70	NMOD
70	beads	bead	NNS	_	66	PMOD
71	and	and	CC	_	65	COORD
72	XpdTTD	xpdttd	NN	_	74	NMOD
73	/	/	HYPH	_	72	P
74	†XPCS	†xpcs	NN	_	75	NMOD
75	cells	cell	NNS	_	71	GAP
76	(	(	-LRB-	_	77	P
77	4	0	CD	_	75	PRN
78	)	)	-RRB-	_	77	P
79	with	with	IN	_	75	MNR
80	no	no	DT	_	81	NMOD
81	beads	bead	NNS	_	79	PMOD
82	;	;	:	_	61	P
83	and	and	CC	_	61	COORD
84	(	(	-LRB-	_	85	P
85	III	iii	LS	_	88	NMOD
86	)	)	-RRB-	_	85	P
87	wt	wt	NN	_	88	NMOD
88	cells	cell	NNS	_	83	CONJ
89	(	(	-LRB-	_	90	P
90	1	0	CD	_	88	PRN
91	)	)	-RRB-	_	90	P
92	labelled	label	VBN	_	88	NMOD
93	with	with	IN	_	92	MNR
94	0.79	0	CD	_	96	NMOD
95	-	-	HYPH	_	94	P
96	μm	μm	NN	_	97	NMOD
97	beads	bead	NNS	_	93	PMOD
98	and	and	CC	_	92	COORD
99	XpdTTD	xpdttd	NN	_	101	NMOD
100	/	/	HYPH	_	99	P
101	†XP	†xp	NN	_	102	NMOD
102	cells	cell	NNS	_	98	GAP
103	(	(	-LRB-	_	104	P
104	5	0	CD	_	102	PRN
105	)	)	-RRB-	_	104	P
106	with	with	IN	_	102	MNR
107	no	no	DT	_	108	NMOD
108	beads	bead	NNS	_	106	PMOD
109	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	F	f	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Quantification	quantification	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	immunofluorescent	immunofluorescent	JJ	_	7	NMOD
7	signal	signal	NN	_	5	PMOD
8	from	from	IN	_	7	NMOD
9	at	at	RB	_	10	QMOD
10	least	least	RBS	_	12	NMOD
11	50	0	CD	_	10	QMOD
12	nuclei	nucleus	NNS	_	8	PMOD
13	per	per	IN	_	12	NMOD
14	cell	cell	NN	_	15	NMOD
15	line	line	NN	_	13	PMOD
16	and	and	CC	_	12	COORD
17	2	0	CD	_	20	NMOD
18	–	–	SYM	_	17	P
19	6	0	CD	_	17	QMOD
20	experiments	experiment	NNS	_	16	CONJ
21	per	per	IN	_	20	NMOD
22	genotype	genotype	NN	_	21	PMOD
23	.	.	.	_	4	P

1	Bars	bar	NNS	_	10	SBJ
2	representing	represent	VBG	_	1	NMOD
3	cells	cell	NNS	_	2	OBJ
4	analysed	analyse	VBN	_	3	NMOD
5	on	on	IN	_	4	MNR
6	the	the	DT	_	9	NMOD
7	same	same	JJ	_	9	NMOD
8	microscopic	microscopic	JJ	_	9	NMOD
9	slide	slide	NN	_	5	PMOD
10	are	be	VBP	_	0	ROOT
11	depicted	depict	VBN	_	10	VC
12	side	side	NN	_	11	ADV
13	by	by	IN	_	12	NMOD
14	side	side	NN	_	13	PMOD
15	,	,	,	_	11	P
16	with	with	IN	_	11	MNR
17	wt	wt	NN	_	16	PMOD
18	set	set	VBN	_	17	NMOD
19	at	at	IN	_	18	ADV
20	100	0	CD	_	21	NMOD
21	%	%	NN	_	19	PMOD
22	.	.	.	_	10	P

1	The	the	DT	_	4	NMOD
2	p	p	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	value	value	NN	_	5	SBJ
5	indicates	indicate	VBZ	_	0	ROOT
6	minimum	minimum	JJ	_	8	NMOD
7	significant	significant	JJ	_	8	NMOD
8	difference	difference	NN	_	5	OBJ
9	between	between	IN	_	8	NMOD
10	wt	wt	NN	_	9	PMOD
11	and	and	CC	_	10	COORD
12	the	the	DT	_	15	NMOD
13	indicated	indicate	VBN	_	15	NMOD
14	cell	cell	NN	_	15	NMOD
15	lines	line	NNS	_	11	CONJ
16	analysed	analyse	VBN	_	15	NMOD
17	on	on	IN	_	16	MNR
18	the	the	DT	_	21	NMOD
19	same	same	JJ	_	21	NMOD
20	microscopic	microscopic	JJ	_	21	NMOD
21	slide	slide	NN	_	17	PMOD
22	within	within	IN	_	8	NMOD
23	one	one	CD	_	24	NMOD
24	experiment	experiment	NN	_	22	PMOD
25	.	.	.	_	5	P

1	Next	next	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	asked	ask	VBD	_	0	ROOT
4	whether	whether	IN	_	3	OBJ
5	the	the	DT	_	9	NMOD
6	Xpd†XPCS	xpd†xpcs	NN	_	9	NMOD
7	and	and	CC	_	6	COORD
8	Xpd†XP	xpd†xp	NN	_	7	CONJ
9	alleles	allele	NNS	_	16	SBJ
10	,	,	,	_	16	P
11	despite	despite	IN	_	16	ADV
12	decreased	decrease	VBN	_	14	NMOD
13	mRNA	mrna	NN	_	14	NMOD
14	levels	level	NNS	_	11	PMOD
15	,	,	,	_	16	P
16	ameliorated	ameliorate	VBN	_	4	SUB
17	TTD	ttd	NN	_	18	NMOD
18	symptoms	symptom	NNS	_	16	OBJ
19	by	by	IN	_	16	MNR
20	increasing	increase	VBG	_	23	NMOD
21	overall	overall	JJ	_	23	NMOD
22	TFIIH	tfiih	NN	_	23	NMOD
23	levels	level	NNS	_	19	PMOD
24	in	in	IN	_	16	LOC
25	compound	compound	NN	_	34	NMOD
26	heterozygous	heterozygous	JJ	_	34	NMOD
27	XpdTTD	xpdttd	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	 †XPCS	 †xpcs	NN	_	34	NMOD
30	and	and	CC	_	29	COORD
31	XpdTTD	xpdttd	NN	_	33	NMOD
32	/	/	HYPH	_	31	P
33	 †XP	 †xp	NN	_	30	CONJ
34	cells	cell	NNS	_	24	PMOD
35	.	.	.	_	3	P

1	Previously	previously	RB	_	10	TMP
2	,	,	,	_	10	P
3	using	use	VBG	_	10	MNR
4	comparative	comparative	JJ	_	5	NMOD
5	immunohistochemistry	immunohistochemistry	NN	_	3	OBJ
6	,	,	,	_	10	P
7	we	we	PRP	_	10	SBJ
8	and	and	CC	_	7	COORD
9	others	others	NNS	_	8	CONJ
10	have	have	VBP	_	0	ROOT
11	shown	show	VBN	_	10	VC
12	an	an	DT	_	17	NMOD
13	up	up	IN	_	15	QMOD
14	to	to	IN	_	15	QMOD
15	70	0	CD	_	16	NMOD
16	%	%	NN	_	17	NMOD
17	reduction	reduction	NN	_	11	OBJ
18	of	of	IN	_	17	NMOD
19	TFIIH	tfiih	NN	_	20	NMOD
20	levels	level	NNS	_	18	PMOD
21	in	in	IN	_	20	NMOD
22	primary	primary	JJ	_	23	NMOD
23	fibroblasts	fibroblast	NNS	_	21	PMOD
24	from	from	IN	_	23	NMOD
25	patients	patient	NNS	_	24	PMOD
26	with	with	IN	_	25	NMOD
27	TTD	ttd	NN	_	26	PMOD
28	compared	compare	VBN	_	17	NMOD
29	with	with	IN	_	28	PMOD
30	wt	wt	NN	_	31	NMOD
31	controls	control	NNS	_	29	PMOD
32	due	due	IN	_	17	NMOD
33	to	to	IN	_	32	PMOD
34	reduced	reduce	VBN	_	35	NMOD
35	stability	stability	NN	_	32	PMOD
36	[	[	-LRB-	_	39	P
37	16	0	CD	_	39	NMOD
38	,	,	,	_	39	P
39	17	0	CD	_	11	PRN
40	]	]	-RRB-	_	39	P
41	.	.	.	_	10	P

1	Despite	despite	IN	_	22	ADV
2	overexpression	overexpression	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	mRNA	mrna	NN	_	3	PMOD
5	from	from	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	XpdTTD	xpdttd	NN	_	8	NMOD
8	allele	allele	NN	_	5	PMOD
9	relative	relative	JJ	_	2	NMOD
10	to	to	IN	_	9	AMOD
11	the	the	DT	_	13	NMOD
12	wt	wt	NN	_	13	NMOD
13	allele	allele	NN	_	10	PMOD
14	(	(	-LRB-	_	16	P
15	Figure	figure	NN	_	16	NMOD
16	1E	0e	NN	_	2	PRN
17	)	)	-RRB-	_	16	P
18	,	,	,	_	22	P
19	TFIIH	tfiih	NN	_	21	NMOD
20	protein	protein	NN	_	21	NMOD
21	levels	level	NNS	_	22	SBJ
22	were	be	VBD	_	0	ROOT
23	reduced	reduce	VBN	_	22	VC
24	by	by	IN	_	23	EXT
25	50	0	CD	_	26	NMOD
26	%	%	NN	_	24	PMOD
27	in	in	IN	_	23	LOC
28	primary	primary	JJ	_	33	NMOD
29	mouse	mouse	NN	_	33	NMOD
30	XpdTTD	xpdttd	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	TTD	ttd	NN	_	33	NMOD
33	fibroblasts	fibroblast	NNS	_	27	PMOD
34	(	(	-LRB-	_	36	P
35	Figure	figure	NN	_	36	NMOD
36	4E	0e	NN	_	23	PRN
37	and	and	CC	_	36	COORD
38	4F	0f	NN	_	37	CONJ
39	)	)	-RRB-	_	36	P
40	,	,	,	_	23	P
41	thereby	thereby	RB	_	42	ADV
42	mimicking	mimic	VBG	_	23	ADV
43	the	the	DT	_	44	NMOD
44	situation	situation	NN	_	42	OBJ
45	in	in	IN	_	42	LOC
46	human	human	JJ	_	47	NMOD
47	patients	patient	NNS	_	45	PMOD
48	with	with	IN	_	47	NMOD
49	TTD	ttd	NN	_	48	PMOD
50	.	.	.	_	22	P

1	In	in	IN	_	20	ADV
2	accordance	accordance	NN	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	gene	gene	NN	_	6	NMOD
6	dosage	dosage	NN	_	3	PMOD
7	,	,	,	_	20	P
8	a	a	DT	_	10	NMOD
9	further	further	JJ	_	10	NMOD
10	reduction	reduction	NN	_	20	SBJ
11	of	of	IN	_	10	NMOD
12	up	up	IN	_	14	QMOD
13	to	to	IN	_	14	QMOD
14	70	0	CD	_	15	NMOD
15	%	%	NN	_	11	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	wt	wt	NN	_	19	NMOD
19	level	level	NN	_	16	PMOD
20	was	be	VBD	_	0	ROOT
21	observed	observe	VBN	_	20	VC
22	in	in	IN	_	21	LOC
23	hemizygous	hemizygous	JJ	_	27	NMOD
24	XpdTTD	xpdttd	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	KO	ko	NN	_	27	NMOD
27	cells	cell	NNS	_	22	PMOD
28	.	.	.	_	20	P

1	Consistent	consistent	JJ	_	15	ADV
2	with	with	IN	_	1	AMOD
3	low	low	JJ	_	6	NMOD
4	mRNA	mrna	NN	_	5	NMOD
5	expression	expression	NN	_	6	NMOD
6	levels	level	NNS	_	2	PMOD
7	,	,	,	_	15	P
8	neither	neither	CC	_	14	COORD
9	the	the	DT	_	10	NMOD
10	Xpd†XPCS	xpd†xpcs	NN	_	14	NMOD
11	nor	nor	CC	_	10	COORD
12	the	the	DT	_	13	NMOD
13	Xpd†XP	xpd†xp	NN	_	11	CONJ
14	allele	allele	NN	_	15	SBJ
15	was	be	VBD	_	0	ROOT
16	able	able	JJ	_	15	PRD
17	to	to	TO	_	16	AMOD
18	restore	restore	VB	_	17	IM
19	TFIIH	tfiih	NN	_	20	NMOD
20	abundance	abundance	NN	_	18	OBJ
21	to	to	IN	_	18	ADV
22	wt	wt	NN	_	23	NMOD
23	levels	level	NNS	_	21	PMOD
24	in	in	IN	_	18	LOC
25	XpdTTD	xpdttd	NN	_	28	NMOD
26	compound	compound	NN	_	28	NMOD
27	heterozygote	heterozygote	NN	_	28	NMOD
28	cells	cell	NNS	_	24	PMOD
29	(	(	-LRB-	_	31	P
30	Figure	figure	NN	_	31	NMOD
31	4E	0e	NN	_	15	PRN
32	and	and	CC	_	31	COORD
33	4F	0f	NN	_	32	CONJ
34	)	)	-RRB-	_	31	P
35	.	.	.	_	15	P

1	Thus	thus	RB	_	28	ADV
2	,	,	,	_	28	P
3	the	the	DT	_	6	NMOD
4	improved	improve	VBN	_	6	NMOD
5	UV	uv	NN	_	6	NMOD
6	survival	survival	NN	_	28	SBJ
7	observed	observe	VBN	_	6	NMOD
8	in	in	IN	_	7	LOC
9	compound	compound	NN	_	11	NMOD
10	heterozygote	heterozygote	NN	_	11	NMOD
11	cells	cell	NNS	_	8	PMOD
12	(	(	-LRB-	_	14	P
13	Figure	figure	NN	_	14	NMOD
14	4A	0a	NN	_	7	PRN
15	)	)	-RRB-	_	14	P
16	and	and	CC	_	7	COORD
17	likely	likely	RB	_	19	NMOD
18	the	the	DT	_	19	NMOD
19	rescue	rescue	NN	_	16	CONJ
20	of	of	IN	_	19	NMOD
21	TTD	ttd	NN	_	23	NMOD
22	progeroid	progeroid	NN	_	23	NMOD
23	symptoms	symptom	NNS	_	20	PMOD
24	(	(	-LRB-	_	25	P
25	Figure	figure	NN	_	19	PRN
26	3	0	CD	_	25	NMOD
27	)	)	-RRB-	_	25	P
28	were	be	VBD	_	0	ROOT
29	not	not	RB	_	28	ADV
30	due	due	IN	_	28	PRP
31	to	to	IN	_	30	PMOD
32	normalisation	normalisation	NN	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	TFIIH	tfiih	NN	_	35	NMOD
35	levels	level	NNS	_	33	PMOD
36	,	,	,	_	28	P
37	suggesting	suggest	VBG	_	28	ADV
38	a	a	DT	_	39	AMOD
39	qualitative	qualitative	JJ	_	44	NMOD
40	rather	rather	RB	_	41	ADV
41	than	than	IN	_	39	COORD
42	a	a	DT	_	43	AMOD
43	quantitative	quantitative	JJ	_	41	CONJ
44	effect	effect	NN	_	37	OBJ
45	on	on	IN	_	44	NMOD
46	these	these	DT	_	47	NMOD
47	phenotypes	phenotype	NNS	_	45	PMOD
48	in	in	FW	_	49	AMOD
49	vivo	vivo	FW	_	44	NMOD
50	.	.	.	_	28	P

1	In	in	IN	_	10	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	10	P
4	the	the	DT	_	5	NMOD
5	level	level	NN	_	10	SBJ
6	of	of	IN	_	5	NMOD
7	XPCS	xpcs	NN	_	9	NMOD
8	mRNA	mrna	NN	_	9	NMOD
9	expression	expression	NN	_	6	PMOD
10	did	do	VBD	_	0	ROOT
11	affect	affect	VB	_	10	VC
12	the	the	DT	_	13	NMOD
13	ability	ability	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	17	NMOD
16	encoded	encode	VBN	_	17	NMOD
17	protein	protein	NN	_	19	NMOD
18	(	(	-LRB-	_	19	P
19	XPDG602D	xpdg0d	NN	_	14	PMOD
20	)	)	-RRB-	_	13	P
21	to	to	TO	_	13	NMOD
22	restore	restore	VB	_	21	IM
23	the	the	DT	_	26	NMOD
24	TTD	ttd	NN	_	26	NMOD
25	hair	hair	NN	_	26	NMOD
26	phenotype	phenotype	NN	_	22	OBJ
27	to	to	IN	_	22	ADV
28	normal	normal	JJ	_	27	PMOD
29	.	.	.	_	10	P

1	Notably	notably	RB	_	7	ADV
2	,	,	,	_	7	P
3	XpdTTD	xpdttd	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	 †XPCS	 †xpcs	NN	_	6	NMOD
6	animals	animal	NNS	_	7	SBJ
7	had	have	VBD	_	0	ROOT
8	a	a	DT	_	12	NMOD
9	partial	partial	JJ	_	12	NMOD
10	TTD	ttd	NN	_	12	NMOD
11	hair	hair	NN	_	12	NMOD
12	phenotype	phenotype	NN	_	7	OBJ
13	,	,	,	_	12	P
14	correlating	correlate	VBG	_	12	NMOD
15	with	with	IN	_	14	ADV
16	low	low	JJ	_	17	NMOD
17	levels	level	NNS	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	Xpd†XPCS	xpd†xpcs	NN	_	20	NMOD
20	expression	expression	NN	_	18	PMOD
21	,	,	,	_	7	P
22	whereas	whereas	IN	_	7	ADV
23	XpdTTD	xpdttd	NN	_	25	NMOD
24	/	/	HYPH	_	23	P
25	XPCS	xpcs	NN	_	26	NMOD
26	animals	animal	NNS	_	27	SBJ
27	had	have	VBD	_	22	SUB
28	wt	wt	NN	_	29	NMOD
29	hair	hair	NN	_	27	OBJ
30	,	,	,	_	29	P
31	correlating	correlate	VBG	_	29	NMOD
32	with	with	IN	_	31	ADV
33	normal	normal	JJ	_	35	NMOD
34	expression	expression	NN	_	35	NMOD
35	levels	level	NNS	_	32	PMOD
36	from	from	IN	_	35	NMOD
37	the	the	DT	_	40	NMOD
38	viable	viable	JJ	_	40	NMOD
39	XpdXPCS	xpdxpcs	NN	_	40	NMOD
40	allele	allele	NN	_	36	PMOD
41	(	(	-LRB-	_	42	P
42	Table	table	NN	_	7	PRN
43	2	0	CD	_	42	NMOD
44	and	and	CC	_	42	COORD
45	unpublished	unpublished	JJ	_	46	NMOD
46	data	datum	NNS	_	44	CONJ
47	)	)	-RRB-	_	42	P
48	.	.	.	_	7	P

1	Thus	thus	RB	_	13	ADV
2	,	,	,	_	13	P
3	the	the	DT	_	4	NMOD
4	range	range	NN	_	13	SBJ
5	of	of	IN	_	4	NMOD
6	expression	expression	NN	_	7	NMOD
7	levels	level	NNS	_	5	PMOD
8	from	from	IN	_	4	NMOD
9	these	these	DT	_	12	NMOD
10	two	two	CD	_	12	NMOD
11	mutant	mutant	JJ	_	12	NMOD
12	alleles	allele	NNS	_	8	PMOD
13	affected	affect	VBD	_	0	ROOT
14	their	their	PRP$	_	15	NMOD
15	ability	ability	NN	_	13	OBJ
16	to	to	TO	_	15	NMOD
17	complement	complement	VB	_	16	IM
18	some	some	DT	_	19	NMOD
19	phenotypes	phenotype	NNS	_	17	OBJ
20	(	(	-LRB-	_	21	P
21	hair	hair	NN	_	19	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	13	P

1	An	an	DT	_	2	NMOD
2	overview	overview	NN	_	23	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	functional	functional	JJ	_	6	NMOD
6	relationships	relationship	NNS	_	3	PMOD
7	between	between	IN	_	6	NMOD
8	Xpd	xpd	NN	_	9	NMOD
9	alleles	allele	NNS	_	7	PMOD
10	,	,	,	_	9	P
11	phenotypes	phenotype	NNS	_	9	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	the	the	DT	_	18	NMOD
15	presumed	presume	VBN	_	18	NMOD
16	underlying	underlie	VBG	_	18	NMOD
17	TFIIH	tfiih	NN	_	18	NMOD
18	function	function	NN	_	13	CONJ
19	in	in	IN	_	6	LOC
20	mice	mouse	NNS	_	19	PMOD
21	and	and	CC	_	20	COORD
22	cells	cell	NNS	_	21	CONJ
23	is	be	VBZ	_	0	ROOT
24	presented	present	VBN	_	23	VC
25	in	in	IN	_	24	ADV
26	Table	table	NN	_	25	PMOD
27	2	0	CD	_	26	NMOD
28	.	.	.	_	23	P

1	Discussion	discussion	NN	_	0	ROOT

1	Dissection	dissection	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Biallelic	biallelic	JJ	_	4	NMOD
4	Effects	effect	NNS	_	2	PMOD
5	from	from	IN	_	1	NMOD
6	other	other	JJ	_	7	NMOD
7	Determinants	determinant	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	Phenotype	phenotype	NN	_	8	PMOD

1	Although	although	IN	_	28	ADV
2	phenotypic	phenotypic	JJ	_	3	NMOD
3	consequences	consequence	NNS	_	22	SBJ
4	,	,	,	_	3	P
5	referred	refer	VBN	_	3	NMOD
6	to	to	IN	_	5	ADV
7	here	here	RB	_	5	ADV
8	as	as	IN	_	5	MNR
9	biallelic	biallelic	JJ	_	10	NMOD
10	effects	effect	NNS	_	8	PMOD
11	,	,	,	_	3	P
12	resulting	result	VBG	_	3	NMOD
13	from	from	IN	_	12	ADV
14	two	two	CD	_	17	NMOD
15	different	different	JJ	_	17	NMOD
16	mutant	mutant	JJ	_	17	NMOD
17	alleles	allele	NNS	_	13	PMOD
18	in	in	IN	_	17	LOC
19	compound	compound	NN	_	21	NMOD
20	heterozygote	heterozygote	NN	_	21	NMOD
21	patients	patient	NNS	_	18	PMOD
22	have	have	VBP	_	1	SUB
23	been	be	VBN	_	22	VC
24	postulated	postulate	VBN	_	23	VC
25	,	,	,	_	28	P
26	such	such	JJ	_	27	NMOD
27	effects	effect	NNS	_	28	SBJ
28	have	have	VBP	_	0	ROOT
29	historically	historically	RB	_	28	ADV
30	been	be	VBN	_	28	VC
31	difficult	difficult	JJ	_	30	PRD
32	to	to	TO	_	31	AMOD
33	distinguish	distinguish	VB	_	32	IM
34	from	from	IN	_	33	ADV
35	the	the	DT	_	36	NMOD
36	influence	influence	NN	_	34	PMOD
37	of	of	IN	_	36	NMOD
38	environment	environment	NN	_	37	PMOD
39	and	and	CC	_	38	COORD
40	genetic	genetic	JJ	_	41	NMOD
41	background	background	NN	_	39	CONJ
42	.	.	.	_	28	P

1	We	we	PRP	_	2	SBJ
2	used	use	VBD	_	0	ROOT
3	a	a	DT	_	8	NMOD
4	genetically	genetically	RB	_	5	AMOD
5	defined	define	VBN	_	8	NMOD
6	mammalian	mammalian	JJ	_	8	NMOD
7	model	model	NN	_	8	NMOD
8	system	system	NN	_	2	OBJ
9	under	under	IN	_	2	MNR
10	controlled	controlled	JJ	_	12	NMOD
11	environmental	environmental	JJ	_	12	NMOD
12	conditions	condition	NNS	_	9	PMOD
13	to	to	TO	_	2	PRP
14	reveal	reveal	VB	_	13	IM
15	phenotypic	phenotypic	JJ	_	16	NMOD
16	effects	effect	NNS	_	14	OBJ
17	attributable	attributable	JJ	_	16	NMOD
18	specifically	specifically	RB	_	19	PMOD
19	to	to	IN	_	17	AMOD
20	combinations	combination	NNS	_	19	PMOD
21	of	of	IN	_	20	NMOD
22	differentially	differentially	RB	_	23	AMOD
23	mutated	mutate	VBN	_	25	NMOD
24	Xpd	xpd	NN	_	25	NMOD
25	alleles	allele	NNS	_	21	PMOD
26	.	.	.	_	2	P

1	The	the	DT	_	4	NMOD
2	observed	observe	VBN	_	4	NMOD
3	biallelic	biallelic	JJ	_	4	NMOD
4	effects	effect	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	of	of	IN	_	5	PRD
7	three	three	CD	_	9	NMOD
8	general	general	JJ	_	9	NMOD
9	types	type	NNS	_	6	PMOD
10	.	.	.	_	5	P

1	In	in	IN	_	19	ADV
2	the	the	DT	_	3	NMOD
3	first	$#ORD#$	JJ	_	1	PMOD
4	,	,	,	_	19	P
5	the	the	DT	_	6	NMOD
6	allele	allele	NN	_	19	SBJ
7	associated	associate	VBN	_	6	NMOD
8	in	in	IN	_	7	ADV
9	a	a	DT	_	11	NMOD
10	homozygous	homozygous	JJ	_	11	NMOD
11	state	state	NN	_	8	PMOD
12	with	with	IN	_	7	ADV
13	a	a	DT	_	14	NMOD
14	phenotype	phenotype	NN	_	12	PMOD
15	closer	closer	RBR	_	16	AMOD
16	to	to	IN	_	14	NMOD
17	wt	wt	NN	_	16	PMOD
18	singularly	singularly	RB	_	19	ADV
19	determined	determine	VBN	_	0	ROOT
20	the	the	DT	_	22	NMOD
21	phenotypic	phenotypic	JJ	_	22	NMOD
22	outcome	outcome	NN	_	19	OBJ
23	,	,	,	_	19	P
24	a	a	DT	_	25	NMOD
25	phenomenon	phenomenon	NN	_	19	ADV
26	widely	widely	RB	_	27	ADV
27	known	know	VBN	_	25	NMOD
28	in	in	IN	_	27	ADV
29	human	human	JJ	_	31	NMOD
30	recessive	recessive	JJ	_	31	NMOD
31	disease	disease	NN	_	28	PMOD
32	.	.	.	_	19	P

1	Because	because	IN	_	19	PRP
2	these	these	DT	_	4	NMOD
3	Xpd	xpd	NN	_	4	NMOD
4	alleles	allele	NNS	_	5	SBJ
5	functioned	function	VBD	_	1	SUB
6	at	at	IN	_	5	ADV
7	or	or	CC	_	6	COORD
8	near	near	IN	_	7	CONJ
9	wt	wt	NN	_	10	NMOD
10	levels	level	NNS	_	6	PMOD
11	with	with	IN	_	5	ADV
12	respect	respect	NN	_	11	PMOD
13	to	to	IN	_	12	NMOD
14	a	a	DT	_	16	NMOD
15	particular	particular	JJ	_	16	NMOD
16	function	function	NN	_	13	PMOD
17	,	,	,	_	19	P
18	we	we	PRP	_	19	SBJ
19	call	call	VBP	_	0	ROOT
20	these	these	DT	_	21	NMOD
21	effects	effect	NNS	_	19	OBJ
22	“	“	``	_	19	P
23	dominant	dominant	JJ	_	19	OPRD
24	”	”	''	_	19	P
25	.	.	.	_	19	P

1	Such	such	JJ	_	2	NMOD
2	alleles	allele	NNS	_	3	SBJ
3	can	can	MD	_	0	ROOT
4	also	also	RB	_	3	ADV
5	be	be	VB	_	3	VC
6	referred	refer	VBN	_	5	VC
7	to	to	IN	_	6	ADV
8	as	as	IN	_	6	MNR
9	“	“	``	_	14	P
10	separation	separation	NN	_	14	NMOD
11	of	of	IN	_	10	NMOD
12	function	function	NN	_	11	PMOD
13	”	”	''	_	14	P
14	alleles	allele	NNS	_	8	PMOD
15	,	,	,	_	6	P
16	because	because	IN	_	6	PRP
17	they	they	PRP	_	18	SBJ
18	allow	allow	VBP	_	16	SUB
19	dissection	dissection	NN	_	18	OBJ
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	22	NMOD
22	roles	role	NNS	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	multifunctional	multifunctional	JJ	_	25	NMOD
25	proteins	protein	NNS	_	23	PMOD
26	in	in	IN	_	18	LOC
27	specific	specific	JJ	_	28	NMOD
28	phenotypes	phenotype	NNS	_	26	PMOD
29	.	.	.	_	3	P

1	Secondly	secondly	RB	_	16	ADV
2	,	,	,	_	16	P
3	highlighting	highlight	VBG	_	16	DEP
4	the	the	DT	_	6	NMOD
5	potential	potential	JJ	_	6	NMOD
6	relevance	relevance	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	current	current	JJ	_	9	NMOD
9	findings	finding	NNS	_	7	PMOD
10	to	to	IN	_	6	NMOD
11	all	all	DT	_	13	NMOD
12	diploid	diploid	JJ	_	13	NMOD
13	organisms	organism	NNS	_	10	PMOD
14	including	include	VBG	_	13	NMOD
15	humans	human	NNS	_	14	PMOD
16	was	be	VBD	_	0	ROOT
17	the	the	DT	_	18	NMOD
18	observation	observation	NN	_	16	SBJ
19	that	that	IN	_	18	NMOD
20	in	in	IN	_	30	LOC
21	one	one	CD	_	24	NMOD
22	compound	compound	NN	_	24	NMOD
23	heterozygous	heterozygous	JJ	_	24	NMOD
24	animal	animal	NN	_	20	PMOD
25	,	,	,	_	30	P
26	the	the	DT	_	29	NMOD
27	Xpd	xpd	NN	_	29	NMOD
28	allelic	allelic	JJ	_	29	NMOD
29	relationship	relationship	NN	_	30	SBJ
30	could	could	MD	_	19	SUB
31	shift	shift	VB	_	30	VC
32	from	from	IN	_	31	ADV
33	Adominant	adominant	JJ	_	35	NMOD
34	|	|	HYPH	_	33	P
35	arecessive	arecessive	JJ	_	32	PMOD
36	to	to	IN	_	32	PMOD
37	Arecessive	arecessive	JJ	_	39	NMOD
38	|	|	HYPH	_	37	P
39	adominant	adominant	JJ	_	36	PMOD
40	with	with	IN	_	31	ADV
41	respect	respect	NN	_	40	PMOD
42	to	to	IN	_	41	NMOD
43	different	different	JJ	_	44	NMOD
44	phenotypes	phenotype	NNS	_	42	PMOD
45	in	in	IN	_	31	MNR
46	a	a	DT	_	54	NMOD
47	time	time	NN	_	49	AMOD
48	-	-	HYPH	_	47	P
49	dependent	dependent	JJ	_	54	NMOD
50	and	and	CC	_	49	COORD
51	tissue	tissue	NN	_	53	AMOD
52	-	-	HYPH	_	51	P
53	specific	specific	JJ	_	50	CONJ
54	manner	manner	NN	_	45	PMOD
55	(	(	-LRB-	_	56	P
56	see	see	VB	_	31	PRN
57	below	below	RB	_	56	ADV
58	and	and	CC	_	57	COORD
59	Table	table	NN	_	58	CONJ
60	2	0	CD	_	59	NMOD
61	)	)	-RRB-	_	56	P
62	.	.	.	_	16	P

1	In	in	IN	_	17	LOC
2	the	the	DT	_	4	NMOD
3	third	$#ORD#$	JJ	_	4	NMOD
4	type	type	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	biallelic	biallelic	JJ	_	7	NMOD
7	effect	effect	NN	_	5	PMOD
8	,	,	,	_	4	P
9	known	know	VBN	_	4	NMOD
10	as	as	IN	_	9	MNR
11	interallelic	interallelic	JJ	_	12	NMOD
12	complementation	complementation	NN	_	10	PMOD
13	,	,	,	_	17	P
14	two	two	CD	_	16	NMOD
15	mutant	mutant	JJ	_	16	NMOD
16	alleles	allele	NNS	_	17	SBJ
17	produced	produce	VBD	_	0	ROOT
18	a	a	DT	_	19	NMOD
19	phenotype	phenotype	NN	_	17	OBJ
20	closer	closer	RBR	_	21	AMOD
21	to	to	IN	_	19	NMOD
22	wt	wt	NN	_	21	PMOD
23	than	than	IN	_	21	AMOD
24	either	either	DT	_	25	SBJ
25	could	could	MD	_	23	SUB
26	alone	alone	RB	_	25	ADV
27	in	in	IN	_	26	ADV
28	a	a	DT	_	33	NMOD
29	homo	homo	AFX	_	33	NMOD
30	-	-	HYPH	_	29	P
31	or	or	CC	_	29	COORD
32	hemizygous	hemizygous	JJ	_	31	CONJ
33	state	state	NN	_	27	PMOD
34	.	.	.	_	17	P

1	As	as	IN	_	14	ADV
2	summarised	summarise	VBN	_	1	SUB
3	in	in	IN	_	2	ADV
4	Table	table	NN	_	3	PMOD
5	2	0	CD	_	4	NMOD
6	,	,	,	_	14	P
7	examples	example	NNS	_	14	SBJ
8	of	of	IN	_	7	NMOD
9	all	all	DT	_	10	NMOD
10	types	type	NNS	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	biallelic	biallelic	JJ	_	13	NMOD
13	effects	effect	NNS	_	11	PMOD
14	were	be	VBD	_	0	ROOT
15	observed	observe	VBN	_	14	VC
16	in	in	IN	_	15	LOC
17	a	a	DT	_	18	NMOD
18	variety	variety	NN	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	Xpd	xpd	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	associated	associate	VBN	_	23	NMOD
23	phenotypes	phenotype	NNS	_	19	PMOD
24	,	,	,	_	18	P
25	ranging	range	VBG	_	18	NMOD
26	from	from	IN	_	25	ADV
27	brittle	brittle	JJ	_	28	NMOD
28	hair	hair	NN	_	26	PMOD
29	to	to	IN	_	26	PMOD
30	segmental	segmental	JJ	_	31	NMOD
31	progeria	progeria	NN	_	29	PMOD
32	.	.	.	_	14	P

1	TFIIH	tfiih	NN	_	7	NMOD
2	in	in	IN	_	1	NMOD
3	Transcription	transcription	NN	_	2	PMOD
4	and	and	CC	_	3	COORD
5	Repair	repair	NN	_	4	CONJ
6	:	:	:	_	7	P
7	Mechanisms	mechanism	NNS	_	0	ROOT
8	of	of	IN	_	7	NMOD
9	XPD	xpd	NN	_	11	NMOD
10	Disease	disease	NN	_	11	NMOD
11	Pleiotropy	pleiotropy	NN	_	8	PMOD

1	We	we	PRP	_	2	SBJ
2	observed	observe	VBD	_	0	ROOT
3	differences	difference	NNS	_	35	NMOD
4	in	in	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	ability	ability	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	XpdTTD	xpdttd	NN	_	7	PMOD
9	versus	versus	CC	_	8	COORD
10	homozygous	homozygous	JJ	_	15	NMOD
11	lethal	lethal	JJ	_	15	NMOD
12	Xpd†XPCS	xpd†xpcs	NN	_	15	NMOD
13	and	and	CC	_	12	COORD
14	Xpd†XP	xpd†xp	NN	_	13	CONJ
15	alleles	allele	NNS	_	9	CONJ
16	to	to	TO	_	6	NMOD
17	function	function	VB	_	16	IM
18	in	in	IN	_	17	ADV
19	two	two	CD	_	23	NMOD
20	transcription	transcription	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	related	relate	VBN	_	23	NMOD
23	phenotypes	phenotype	NNS	_	18	PMOD
24	separated	separate	VBN	_	23	NMOD
25	in	in	IN	_	24	LOC
26	the	the	DT	_	27	NMOD
27	organism	organism	NN	_	25	PMOD
28	by	by	IN	_	24	MNR
29	both	both	CC	_	30	COORD
30	time	time	NN	_	28	PMOD
31	and	and	CC	_	30	COORD
32	space	space	NN	_	31	CONJ
33	:	:	:	_	35	P
34	embryonic	embryonic	JJ	_	35	NMOD
35	lethality	lethality	NN	_	2	OBJ
36	and	and	CC	_	35	COORD
37	terminal	terminal	JJ	_	38	NMOD
38	differentiation	differentiation	NN	_	36	CONJ
39	of	of	IN	_	38	NMOD
40	enucleating	enucleate	VBG	_	41	NMOD
41	skin	skin	NN	_	39	PMOD
42	and	and	CC	_	41	COORD
43	blood	blood	NN	_	44	NMOD
44	cells	cell	NNS	_	42	CONJ
45	.	.	.	_	2	P

1	The	the	DT	_	6	NMOD
2	preblastocyst	preblastocyst	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	stage	stage	NN	_	6	NMOD
5	homozygous	homozygous	JJ	_	6	NMOD
6	lethality	lethality	NN	_	19	SBJ
7	shared	share	VBN	_	6	NMOD
8	by	by	IN	_	7	LGS
9	the	the	DT	_	16	NMOD
10	XpdKO	xpdko	NN	_	16	NMOD
11	,	,	,	_	10	P
12	Xpd†XPCS	xpd†xpcs	NN	_	10	CONJ
13	,	,	,	_	12	P
14	and	and	CC	_	12	COORD
15	Xpd†XP	xpd†xp	NN	_	14	CONJ
16	alleles	allele	NNS	_	8	PMOD
17	most	most	RBS	_	18	AMOD
18	likely	likely	RB	_	19	ADV
19	reflects	reflect	VBZ	_	0	ROOT
20	a	a	DT	_	21	NMOD
21	defect	defect	NN	_	19	OBJ
22	in	in	IN	_	21	NMOD
23	basal	basal	JJ	_	24	NMOD
24	transcription	transcription	NN	_	22	PMOD
25	that	that	WDT	_	26	SBJ
26	is	be	VBZ	_	21	NMOD
27	incompatible	incompatible	JJ	_	26	PRD
28	with	with	IN	_	27	AMOD
29	life	life	NN	_	28	PMOD
30	.	.	.	_	19	P

1	In	in	IN	_	15	LOC
2	XpdTTD	xpdttd	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	 †XPCS	 †xpcs	NN	_	11	NMOD
5	and	and	CC	_	4	COORD
6	XpdTTD	xpdttd	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	 †XP	 †xp	NN	_	5	CONJ
9	compound	compound	NN	_	11	NMOD
10	heterozygous	heterozygous	JJ	_	11	NMOD
11	mice	mouse	NNS	_	1	PMOD
12	,	,	,	_	15	P
13	embryonic	embryonic	JJ	_	14	NMOD
14	lethality	lethality	NN	_	15	SBJ
15	was	be	VBD	_	0	ROOT
16	fully	fully	RB	_	15	ADV
17	rescued	rescue	VBN	_	15	VC
18	by	by	IN	_	17	LGS
19	the	the	DT	_	21	NMOD
20	XpdTTD	xpdttd	NN	_	21	NMOD
21	allele	allele	NN	_	18	PMOD
22	.	.	.	_	15	P

1	Because	because	IN	_	18	PRP
2	embryonic	embryonic	JJ	_	3	NMOD
3	lethality	lethality	NN	_	4	SBJ
4	was	be	VBD	_	1	SUB
5	also	also	RB	_	4	ADV
6	fully	fully	RB	_	4	ADV
7	rescued	rescue	VBN	_	4	VC
8	in	in	IN	_	7	LOC
9	XpdTTD	xpdttd	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	KO	ko	NN	_	13	NMOD
12	hemizygous	hemizygous	JJ	_	13	NMOD
13	mice	mouse	NNS	_	8	PMOD
14	,	,	,	_	18	P
15	the	the	DT	_	17	NMOD
16	XpdTTD	xpdttd	NN	_	17	NMOD
17	allele	allele	NN	_	18	SBJ
18	can	can	MD	_	0	ROOT
19	be	be	VB	_	18	VC
20	considered	consider	VBN	_	19	VC
21	as	as	IN	_	20	ADV
22	wt	wt	NN	_	21	PMOD
23	and	and	CC	_	22	COORD
24	thus	thus	RB	_	25	AMOD
25	dominant	dominant	JJ	_	23	CONJ
26	to	to	IN	_	25	AMOD
27	each	each	DT	_	26	PMOD
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	32	NMOD
30	homozygous	homozygous	JJ	_	32	NMOD
31	lethal	lethal	JJ	_	32	NMOD
32	alleles	allele	NNS	_	28	PMOD
33	(	(	-LRB-	_	34	P
34	XpdKO	xpdko	NN	_	32	PRN
35	,	,	,	_	34	P
36	Xpd†XPCS	xpd†xpcs	NN	_	34	CONJ
37	,	,	,	_	36	P
38	and	and	CC	_	36	COORD
39	Xpd†XP	xpd†xp	NN	_	38	CONJ
40	)	)	-RRB-	_	34	P
41	with	with	IN	_	25	AMOD
42	respect	respect	NN	_	41	PMOD
43	to	to	IN	_	42	NMOD
44	this	this	DT	_	46	NMOD
45	particular	particular	JJ	_	46	NMOD
46	phenotype	phenotype	NN	_	43	PMOD
47	(	(	-LRB-	_	48	P
48	Table	table	NN	_	20	PRN
49	2	0	CD	_	48	NMOD
50	)	)	-RRB-	_	48	P
51	.	.	.	_	18	P

1	TTD	ttd	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	specific	specific	JJ	_	7	NMOD
4	cutaneous	cutaneous	JJ	_	7	NMOD
5	and	and	CC	_	4	COORD
6	anaemic	anaemic	JJ	_	5	CONJ
7	features	feature	NNS	_	14	SBJ
8	,	,	,	_	14	P
9	on	on	IN	_	14	ADV
10	the	the	DT	_	12	NMOD
11	other	other	JJ	_	12	NMOD
12	hand	hand	NN	_	9	PMOD
13	,	,	,	_	14	P
14	are	be	VBP	_	0	ROOT
15	thought	think	VBN	_	14	VC
16	to	to	TO	_	15	OPRD
17	result	result	VB	_	16	IM
18	from	from	IN	_	17	ADV
19	a	a	DT	_	21	NMOD
20	specific	specific	JJ	_	21	NMOD
21	kind	kind	NN	_	18	PMOD
22	of	of	IN	_	21	NMOD
23	transcriptional	transcriptional	JJ	_	24	NMOD
24	insufficiency	insufficiency	NN	_	22	PMOD
25	caused	cause	VBN	_	21	NMOD
26	by	by	IN	_	25	LGS
27	depletion	depletion	NN	_	26	PMOD
28	of	of	IN	_	27	NMOD
29	unstable	unstable	JJ	_	30	NMOD
30	TFIIH	tfiih	NN	_	28	PMOD
31	during	during	IN	_	27	TMP
32	the	the	DT	_	34	NMOD
33	terminal	terminal	JJ	_	34	NMOD
34	differentiation	differentiation	NN	_	31	PMOD
35	of	of	IN	_	34	NMOD
36	skin	skin	NN	_	44	NMOD
37	,	,	,	_	36	P
38	hair	hair	NN	_	40	NMOD
39	-	-	HYPH	_	38	P
40	shaft	shaft	NN	_	36	CONJ
41	,	,	,	_	40	P
42	and	and	CC	_	40	COORD
43	blood	blood	NN	_	42	CONJ
44	cells	cell	NNS	_	35	PMOD
45	[	[	-LRB-	_	48	P
46	16	0	CD	_	48	NMOD
47	,	,	,	_	48	P
48	24	0	CD	_	15	PRN
49	]	]	-RRB-	_	48	P
50	.	.	.	_	14	P

1	In	in	IN	_	13	LOC
2	compound	compound	NN	_	4	NMOD
3	heterozygous	heterozygous	JJ	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	,	,	,	_	13	P
6	both	both	DT	_	12	NMOD
7	homozygous	homozygous	JJ	_	12	NMOD
8	lethal	lethal	JJ	_	12	NMOD
9	Xpd†XPCS	xpd†xpcs	NN	_	12	NMOD
10	and	and	CC	_	9	COORD
11	Xpd†XP	xpd†xp	NN	_	10	CONJ
12	alleles	allele	NNS	_	13	SBJ
13	were	be	VBD	_	0	ROOT
14	able	able	JJ	_	13	PRD
15	to	to	TO	_	14	AMOD
16	alleviate	alleviate	VB	_	15	IM
17	XpdTTD	xpdttd	NN	_	19	AMOD
18	-	-	HYPH	_	17	P
19	specific	specific	JJ	_	23	NMOD
20	cutaneous	cutaneous	JJ	_	23	NMOD
21	and	and	CC	_	20	COORD
22	anaemic	anaemic	JJ	_	21	CONJ
23	features	feature	NNS	_	16	OBJ
24	and	and	CC	_	13	COORD
25	can	can	MD	_	24	CONJ
26	thus	thus	RB	_	25	ADV
27	be	be	VB	_	25	VC
28	defined	define	VBN	_	27	VC
29	as	as	IN	_	28	MNR
30	dominant	dominant	JJ	_	29	PMOD
31	over	over	IN	_	28	ADV
32	the	the	DT	_	34	NMOD
33	XpdTTD	xpdttd	NN	_	34	NMOD
34	allele	allele	NN	_	31	PMOD
35	with	with	IN	_	28	ADV
36	respect	respect	NN	_	35	PMOD
37	to	to	IN	_	36	NMOD
38	these	these	DT	_	39	NMOD
39	phenotypes	phenotype	NNS	_	37	PMOD
40	.	.	.	_	13	P

1	We	we	PRP	_	2	SBJ
2	conclude	conclude	VBP	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	the	the	DT	_	5	NMOD
5	defects	defect	NNS	_	22	SBJ
6	leading	lead	VBG	_	5	NMOD
7	to	to	IN	_	6	ADV
8	embryonic	embryonic	JJ	_	9	NMOD
9	lethality	lethality	NN	_	7	PMOD
10	and	and	CC	_	9	COORD
11	aberrant	aberrant	JJ	_	13	NMOD
12	terminal	terminal	JJ	_	13	NMOD
13	differentiation	differentiation	NN	_	10	CONJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	skin	skin	NN	_	14	PMOD
17	,	,	,	_	16	P
18	hair	hair	NN	_	16	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	blood	blood	NN	_	20	CONJ
22	represent	represent	VBP	_	3	SUB
23	two	two	CD	_	31	NMOD
24	qualitatively	qualitatively	RB	_	29	AMOD
25	and	and	CC	_	24	COORD
26	/	/	HYPH	_	25	P
27	or	or	CC	_	25	COORD
28	quantitatively	quantitatively	RB	_	25	CONJ
29	different	different	JJ	_	31	NMOD
30	transcriptional	transcriptional	JJ	_	31	NMOD
31	deficiencies	deficiency	NNS	_	22	OBJ
32	.	.	.	_	2	P

1	During	during	IN	_	7	TMP
2	early	early	JJ	_	4	NMOD
3	embryonic	embryonic	JJ	_	4	NMOD
4	development	development	NN	_	1	PMOD
5	,	,	,	_	7	P
6	XpdTTD	xpdttd	NN	_	7	SBJ
7	is	be	VBZ	_	0	ROOT
8	dominant	dominant	JJ	_	7	PRD
9	over	over	IN	_	8	AMOD
10	the	the	DT	_	14	NMOD
11	Xpd†XPCS	xpd†xpcs	NN	_	14	NMOD
12	and	and	CC	_	11	COORD
13	Xpd†XP	xpd†xp	NN	_	12	CONJ
14	alleles	allele	NNS	_	9	PMOD
15	,	,	,	_	7	P
16	whereas	whereas	IN	_	7	ADV
17	later	later	RB	_	34	TMP
18	in	in	IN	_	17	AMOD
19	the	the	DT	_	20	NMOD
20	ontogenesis	ontogenesis	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	skin	skin	NN	_	21	PMOD
23	,	,	,	_	22	P
24	hair	hair	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	shaft	shaft	NN	_	22	CONJ
27	,	,	,	_	26	P
28	and	and	CC	_	26	COORD
29	blood	blood	NN	_	30	NMOD
30	cells	cell	NNS	_	28	CONJ
31	,	,	,	_	34	P
32	the	the	DT	_	33	NMOD
33	situation	situation	NN	_	34	SBJ
34	is	be	VBZ	_	16	SUB
35	reversed	reverse	VBN	_	34	VC
36	.	.	.	_	7	P

1	In	in	IN	_	14	ADV
2	its	its	PRP$	_	3	NMOD
3	role	role	NN	_	1	PMOD
4	in	in	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	repair	repair	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	UV	uv	NN	_	9	NMOD
9	photolesions	photolesions	NNS	_	7	PMOD
10	,	,	,	_	14	P
11	the	the	DT	_	13	NMOD
12	Xpd†XPCS	xpd†xpcs	NN	_	13	NMOD
13	allele	allele	NN	_	14	SBJ
14	imparted	impart	VBD	_	0	ROOT
15	a	a	DT	_	19	NMOD
16	clear	clear	JJ	_	19	NMOD
17	UV	uv	NN	_	19	NMOD
18	survival	survival	NN	_	19	NMOD
19	benefit	benefit	NN	_	14	OBJ
20	over	over	IN	_	19	NMOD
21	a	a	DT	_	24	NMOD
22	single	single	JJ	_	24	NMOD
23	XpdTTD	xpdttd	NN	_	24	NMOD
24	allele	allele	NN	_	20	PMOD
25	or	or	CC	_	24	COORD
26	two	two	CD	_	28	NMOD
27	XpdXPCS	xpdxpcs	NN	_	28	NMOD
28	alleles	allele	NNS	_	25	CONJ
29	independent	independent	JJ	_	19	NMOD
30	of	of	IN	_	29	AMOD
31	expression	expression	NN	_	32	NMOD
32	levels	level	NNS	_	30	PMOD
33	,	,	,	_	14	P
34	which	which	WDT	_	35	SBJ
35	is	be	VBZ	_	14	ADV
36	consistent	consistent	JJ	_	35	PRD
37	with	with	IN	_	36	AMOD
38	interallelic	interallelic	JJ	_	39	NMOD
39	complementation	complementation	NN	_	37	PMOD
40	.	.	.	_	14	P

1	However	however	RB	_	21	ADV
2	,	,	,	_	21	P
3	the	the	DT	_	4	NMOD
4	observation	observation	NN	_	21	SBJ
5	that	that	IN	_	4	NMOD
6	no	no	DT	_	14	NMOD
7	other	other	JJ	_	14	NMOD
8	cellular	cellular	JJ	_	14	NMOD
9	or	or	CC	_	8	COORD
10	biochemical	biochemical	JJ	_	9	CONJ
11	UV	uv	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	related	relate	VBN	_	14	NMOD
14	parameters	parameter	NNS	_	15	SBJ
15	were	be	VBD	_	5	SUB
16	improved	improve	VBN	_	15	VC
17	in	in	IN	_	16	LOC
18	XpdTTD	xpdttd	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	 †XPCS	 †xpcs	NN	_	17	PMOD
21	argues	argue	VBZ	_	0	ROOT
22	against	against	IN	_	21	ADV
23	complementation	complementation	NN	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	this	this	DT	_	27	NMOD
26	repair	repair	NN	_	27	NMOD
27	activity	activity	NN	_	24	PMOD
28	in	in	IN	_	23	NMOD
29	the	the	DT	_	30	NMOD
30	rescue	rescue	NN	_	28	PMOD
31	of	of	IN	_	30	NMOD
32	TTD	ttd	NN	_	34	NMOD
33	progeroid	progeroid	JJ	_	34	NMOD
34	symptoms	symptom	NNS	_	31	PMOD
35	in	in	FW	_	36	AMOD
36	vivo	vivo	FW	_	30	NMOD
37	.	.	.	_	21	P

1	Interallelic	interallelic	JJ	_	2	NMOD
2	Complementation	complementation	NN	_	0	ROOT
3	and	and	CC	_	2	COORD
4	XPD	xpd	NN	_	5	NMOD
5	Function	function	NN	_	3	CONJ

1	What	what	WP	_	5	OBJ
2	does	do	VBZ	_	0	ROOT
3	interallelic	interallelic	JJ	_	4	NMOD
4	complementation	complementation	NN	_	2	SBJ
5	tell	tell	VB	_	2	VC
6	us	us	PRP	_	5	OBJ
7	about	about	IN	_	5	ADV
8	the	the	DT	_	9	NMOD
9	mechanism	mechanism	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	XPD	xpd	NN	_	12	NMOD
12	function	function	NN	_	10	PMOD
13	?	?	.	_	2	P

1	Interallelic	interallelic	JJ	_	2	NMOD
2	complementation	complementation	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	most	most	RBS	_	5	AMOD
5	often	often	RB	_	3	TMP
6	observed	observe	VBN	_	3	VC
7	in	in	IN	_	6	LOC
8	multimeric	multimeric	JJ	_	9	NMOD
9	proteins	protein	NNS	_	7	PMOD
10	with	with	IN	_	9	NMOD
11	multiple	multiple	JJ	_	13	NMOD
12	functional	functional	JJ	_	13	NMOD
13	domains	domain	NNS	_	10	PMOD
14	.	.	.	_	3	P

1	Unfortunately	unfortunately	RB	_	31	ADV
2	,	,	,	_	31	P
3	the	the	DT	_	7	NMOD
4	structure	structure	NN	_	6	NMOD
5	–	–	HYPH	_	4	P
6	function	function	NN	_	7	NMOD
7	relationship	relationship	NN	_	31	SBJ
8	between	between	IN	_	7	NMOD
9	disease	disease	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	causing	cause	VBG	_	12	NMOD
12	mutations	mutation	NNS	_	8	PMOD
13	and	and	CC	_	12	COORD
14	XPD	xpd	NN	_	16	NMOD
15	functional	functional	JJ	_	16	NMOD
16	domains	domain	NNS	_	13	CONJ
17	,	,	,	_	7	P
18	including	include	VBG	_	7	NMOD
19	detailed	detailed	JJ	_	21	NMOD
20	structural	structural	JJ	_	21	NMOD
21	information	information	NN	_	18	PMOD
22	on	on	IN	_	21	NMOD
23	XPD	xpd	NN	_	22	PMOD
24	or	or	CC	_	23	COORD
25	even	even	RB	_	27	NMOD
26	its	its	PRP$	_	27	NMOD
27	stoichiometry	stoichiometry	NN	_	24	CONJ
28	within	within	IN	_	21	LOC
29	TFIIH	tfiih	NN	_	28	PMOD
30	,	,	,	_	31	P
31	remains	remain	VBZ	_	0	ROOT
32	unknown	unknown	JJ	_	31	PRD
33	.	.	.	_	31	P

1	However	however	RB	_	34	ADV
2	,	,	,	_	34	P
3	based	base	VBN	_	34	ADV
4	on	on	IN	_	3	PMOD
5	the	the	DT	_	6	NMOD
6	ability	ability	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	cell	cell	NN	_	9	NMOD
9	extracts	extract	NNS	_	7	PMOD
10	that	that	WDT	_	11	SBJ
11	are	be	VBP	_	9	NMOD
12	defective	defective	JJ	_	11	PRD
13	in	in	IN	_	12	LOC
14	two	two	CD	_	17	NMOD
15	different	different	JJ	_	17	NMOD
16	TFIIH	tfiih	NN	_	17	NMOD
17	components	component	NNS	_	19	NMOD
18	(	(	-LRB-	_	19	P
19	XPD	xpd	NN	_	13	PMOD
20	and	and	CC	_	19	COORD
21	XPB	xpb	NN	_	20	CONJ
22	)	)	-RRB-	_	6	P
23	to	to	TO	_	6	NMOD
24	complement	complement	VB	_	23	IM
25	NER	ner	NN	_	26	NMOD
26	activity	activity	NN	_	24	OBJ
27	in	in	FW	_	28	AMOD
28	vitro	vitro	FW	_	24	ADV
29	[	[	-LRB-	_	30	P
30	26	0	CD	_	6	PRN
31	]	]	-RRB-	_	30	P
32	,	,	,	_	34	P
33	it	it	PRP	_	34	SBJ
34	is	be	VBZ	_	0	ROOT
35	likely	likely	JJ	_	34	PRD
36	that	that	IN	_	34	OBJ
37	TFIIH	tfiih	NN	_	43	SBJ
38	(	(	-LRB-	_	37	P
39	or	or	CC	_	37	COORD
40	its	its	PRP$	_	41	NMOD
41	components	component	NNS	_	39	CONJ
42	)	)	-RRB-	_	43	P
43	can	can	MD	_	36	SUB
44	either	either	CC	_	45	COORD
45	multimerise	multimerise	VB	_	43	VC
46	or	or	CC	_	45	COORD
47	exchange	exchange	VB	_	46	CONJ
48	at	at	RB	_	50	PMOD
49	least	least	RBS	_	48	AMOD
50	during	during	IN	_	45	TMP
51	the	the	DT	_	53	NMOD
52	NER	ner	NN	_	53	NMOD
53	reaction	reaction	NN	_	50	PMOD
54	.	.	.	_	34	P

1	Furthermore	furthermore	RB	_	4	ADV
2	,	,	,	_	4	P
3	XPD	xpd	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	known	know	VBN	_	4	VC
6	to	to	TO	_	5	OPRD
7	be	be	VB	_	6	IM
8	a	a	DT	_	13	NMOD
9	“	“	RB	_	13	NMOD
10	loosely	loosely	RB	_	11	AMOD
11	bound	bind	VBN	_	13	NMOD
12	”	”	''	_	13	P
13	subunit	subunit	NN	_	7	PRD
14	of	of	IN	_	13	NMOD
15	TFIIH	tfiih	NN	_	14	PMOD
16	[	[	-LRB-	_	17	P
17	27	0	CD	_	5	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	4	P

1	We	we	PRP	_	3	SBJ
2	thus	thus	RB	_	3	ADV
3	envisage	envisage	VBP	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	molecular	molecular	JJ	_	6	NMOD
6	mechanism	mechanism	NN	_	10	SBJ
7	of	of	IN	_	6	NMOD
8	interallelic	interallelic	JJ	_	9	NMOD
9	complementation	complementation	NN	_	7	PMOD
10	to	to	TO	_	3	OPRD
11	involve	involve	VB	_	10	IM
12	the	the	DT	_	13	NMOD
13	exchange	exchange	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	XPD	xpd	NN	_	16	NMOD
16	molecules	molecule	NNS	_	14	PMOD
17	within	within	IN	_	13	LOC
18	the	the	DT	_	20	NMOD
19	TFIIH	tfiih	NN	_	20	NMOD
20	complex	complex	NN	_	17	PMOD
21	or	or	CC	_	13	COORD
22	turnover	turnover	NN	_	21	CONJ
23	of	of	IN	_	22	NMOD
24	TFIIH	tfiih	NN	_	25	NMOD
25	complexes	complex	NNS	_	23	PMOD
26	containing	contain	VBG	_	25	NMOD
27	different	different	JJ	_	29	NMOD
28	XPD	xpd	NN	_	29	NMOD
29	molecules	molecule	NNS	_	26	OBJ
30	at	at	IN	_	22	LOC
31	the	the	DT	_	32	NMOD
32	site	site	NN	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	DNA	dna	NN	_	35	NMOD
35	damage	damage	NN	_	33	PMOD
36	during	during	IN	_	22	TMP
37	the	the	DT	_	38	NMOD
38	course	course	NN	_	36	PMOD
39	of	of	IN	_	38	NMOD
40	the	the	DT	_	42	NMOD
41	global	global	JJ	_	42	NMOD
42	genome	genome	NN	_	39	PMOD
43	as	as	RB	_	45	ADV
44	well	well	RB	_	45	ADV
45	as	as	IN	_	13	COORD
46	transcription	transcription	NN	_	48	AMOD
47	-	-	HYPH	_	46	P
48	coupled	couple	VBN	_	49	NMOD
49	repair	repair	NN	_	45	CONJ
50	of	of	IN	_	49	NMOD
51	either	either	CC	_	58	COORD
52	UV	uv	NN	_	54	AMOD
53	-	-	HYPH	_	52	P
54	induced	induce	VBN	_	58	NMOD
55	or	or	CC	_	54	COORD
56	endogenous	endogenous	JJ	_	55	CONJ
57	DNA	dna	NN	_	58	NMOD
58	damage	damage	NN	_	50	PMOD
59	.	.	.	_	3	P

1	A	a	DT	_	3	NMOD
2	Biallelic	biallelic	JJ	_	3	NMOD
3	Paradigm	paradigm	NN	_	0	ROOT
4	for	for	IN	_	3	NMOD
5	XPD	xpd	NN	_	6	NMOD
6	Disorders	disorder	NNS	_	4	PMOD

1	Recently	recently	RB	_	9	ADV
2	,	,	,	_	9	P
3	proteins	protein	NNS	_	9	SBJ
4	originating	originate	VBG	_	3	NMOD
5	from	from	IN	_	4	ADV
6	presumed	presume	VBN	_	8	NMOD
7	null	null	JJ	_	8	NMOD
8	alleles	allele	NNS	_	5	PMOD
9	were	be	VBD	_	0	ROOT
10	biochemically	biochemically	RB	_	9	ADV
11	characterised	characterise	VBN	_	9	VC
12	as	as	IN	_	11	MNR
13	inactive	inactive	JJ	_	12	PMOD
14	in	in	IN	_	11	ADV
15	basal	basal	JJ	_	16	NMOD
16	transcription	transcription	NN	_	14	PMOD
17	[	[	-LRB-	_	18	P
18	27	0	CD	_	11	PRN
19	]	]	-RRB-	_	18	P
20	,	,	,	_	11	P
21	providing	provide	VBG	_	11	ADV
22	an	an	DT	_	23	NMOD
23	explanation	explanation	NN	_	21	OBJ
24	as	as	IN	_	23	NMOD
25	to	to	IN	_	24	PMOD
26	why	why	WRB	_	29	PRP
27	these	these	DT	_	28	NMOD
28	alleles	allele	NNS	_	29	SBJ
29	failed	fail	VBD	_	25	PMOD
30	to	to	TO	_	29	OPRD
31	rescue	rescue	VB	_	30	IM
32	lethality	lethality	NN	_	31	OBJ
33	in	in	IN	_	31	LOC
34	haploid	haploid	JJ	_	36	NMOD
35	S.	s.	FW	_	36	NMOD
36	pombe	pombe	FW	_	33	PMOD
37	with	with	IN	_	36	NMOD
38	a	a	DT	_	40	NMOD
39	null	null	JJ	_	40	NMOD
40	mutation	mutation	NN	_	37	PMOD
41	in	in	IN	_	40	LOC
42	the	the	DT	_	44	NMOD
43	XPD	xpd	NN	_	44	NMOD
44	homologue	homologue	NN	_	45	NMOD
45	rad15	rad0	NN	_	41	PMOD
46	[	[	-LRB-	_	47	P
47	19	0	CD	_	29	PRN
48	]	]	-RRB-	_	47	P
49	.	.	.	_	9	P

1	Our	our	PRP$	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	certain	certain	JJ	_	8	NMOD
6	presumed	presume	VBN	_	7	AMOD
7	null	null	JJ	_	8	NMOD
8	alleles	allele	NNS	_	20	SBJ
9	,	,	,	_	20	P
10	although	although	IN	_	20	ADV
11	unable	unable	JJ	_	10	SUB
12	on	on	IN	_	15	ADV
13	their	their	PRP$	_	14	NMOD
14	own	own	NN	_	12	PMOD
15	to	to	TO	_	11	AMOD
16	support	support	VB	_	15	IM
17	basal	basal	JJ	_	18	NMOD
18	transcription	transcription	NN	_	16	OBJ
19	,	,	,	_	20	P
20	may	may	MD	_	4	SUB
21	in	in	IN	_	20	ADV
22	fact	fact	NN	_	21	PMOD
23	have	have	VB	_	20	VC
24	a	a	DT	_	26	NMOD
25	substantial	substantial	JJ	_	26	NMOD
26	impact	impact	NN	_	23	OBJ
27	on	on	IN	_	26	NMOD
28	disease	disease	NN	_	29	NMOD
29	outcome	outcome	NN	_	27	PMOD
30	in	in	IN	_	26	LOC
31	compound	compound	NN	_	33	NMOD
32	heterozygous	heterozygous	JJ	_	33	NMOD
33	humans	human	NNS	_	30	PMOD
34	,	,	,	_	23	P
35	as	as	IN	_	23	ADV
36	they	they	PRP	_	37	SBJ
37	do	do	VBP	_	35	SUB
38	in	in	IN	_	37	DEP
39	mouse	mouse	NN	_	40	NMOD
40	models	model	NNS	_	38	PMOD
41	.	.	.	_	3	P

1	Clinical	clinical	JJ	_	2	NMOD
2	evidence	evidence	NN	_	8	SBJ
3	in	in	IN	_	2	NMOD
4	support	support	NN	_	3	PMOD
5	of	of	IN	_	4	NMOD
6	this	this	DT	_	7	NMOD
7	hypothesis	hypothesis	NN	_	5	PMOD
8	comes	come	VBZ	_	0	ROOT
9	from	from	IN	_	8	ADV
10	a	a	DT	_	11	NMOD
11	number	number	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	XP	xp	NN	_	17	NMOD
14	complementation	complementation	NN	_	17	NMOD
15	group	group	NN	_	16	NMOD
16	D	d	NN	_	17	NMOD
17	patients	patient	NNS	_	12	PMOD
18	that	that	WDT	_	19	SBJ
19	do	do	VBP	_	17	NMOD
20	not	not	RB	_	19	ADV
21	fit	fit	VB	_	19	VC
22	within	within	IN	_	21	ADV
23	the	the	DT	_	24	NMOD
24	framework	framework	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	29	NMOD
27	current	current	JJ	_	29	NMOD
28	monoallelic	monoallelic	JJ	_	29	NMOD
29	paradigm	paradigm	NN	_	25	PMOD
30	of	of	IN	_	29	NMOD
31	XPD	xpd	NN	_	32	NMOD
32	disorders	disorder	NNS	_	30	PMOD
33	(	(	-LRB-	_	34	P
34	Figure	figure	NN	_	8	PRN
35	5	0	CD	_	34	NMOD
36	)	)	-RRB-	_	34	P
37	.	.	.	_	8	P

1	In	in	IN	_	55	ADV
2	contrast	contrast	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	two	two	CD	_	7	NMOD
5	hemizygous	hemizygous	JJ	_	7	NMOD
6	XPDXPCS	xpdxpcs	NN	_	7	NMOD
7	patients	patient	NNS	_	3	PMOD
8	carrying	carry	VBG	_	7	NMOD
9	the	the	DT	_	16	NMOD
10	XPDG47R	xpdg0r	NN	_	15	AMOD
11	-	-	HYPH	_	10	P
12	or	or	CC	_	10	COORD
13	XPDR666W	xpdr0w	NN	_	12	CONJ
14	-	-	HYPH	_	10	P
15	encoding	encode	VBG	_	16	NMOD
16	alleles	allele	NNS	_	8	OBJ
17	who	who	WP	_	18	SBJ
18	died	die	VBD	_	16	NMOD
19	of	of	IN	_	18	MNR
20	the	the	DT	_	21	NMOD
21	disease	disease	NN	_	19	PMOD
22	before	before	IN	_	18	TMP
23	2	0	CD	_	24	NMOD
24	y	y	NNS	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	age	age	NN	_	25	PMOD
27	,	,	,	_	55	P
28	two	two	CD	_	32	NMOD
29	compound	compound	JJ	_	32	NMOD
30	heterozygous	heterozygous	JJ	_	32	NMOD
31	XPDXPCS	xpdxpcs	NN	_	32	NMOD
32	patients	patient	NNS	_	54	NMOD
33	carrying	carry	VBG	_	32	NMOD
34	the	the	DT	_	42	NMOD
35	same	same	JJ	_	42	NMOD
36	XPDG47R	xpdg0r	NN	_	41	AMOD
37	-	-	HYPH	_	36	P
38	or	or	CC	_	36	COORD
39	XPDR666W	xpdr0w	NN	_	38	CONJ
40	-	-	HYPH	_	36	P
41	encoding	encode	VBG	_	42	NMOD
42	alleles	allele	NNS	_	33	OBJ
43	in	in	IN	_	42	NMOD
44	addition	addition	NN	_	43	PMOD
45	to	to	IN	_	44	NMOD
46	the	the	DT	_	53	NMOD
47	presumed	presume	VBN	_	48	AMOD
48	null	null	JJ	_	53	NMOD
49	XPDL461V	xpdl0v	NN	_	53	NMOD
50	+	+	SYM	_	53	P
51	del716	del0	NN	_	53	NMOD
52	−	−	HYPH	_	51	P
53	730	0	NN	_	45	PMOD
54	both	both	DT	_	55	SBJ
55	had	have	VBD	_	0	ROOT
56	considerably	considerably	RB	_	57	AMOD
57	milder	mild	JJR	_	59	NMOD
58	disease	disease	NN	_	59	NMOD
59	symptoms	symptom	NNS	_	55	OBJ
60	and	and	CC	_	55	COORD
61	survived	survive	VBD	_	60	CONJ
62	more	more	JJR	_	65	NMOD
63	than	than	IN	_	62	QMOD
64	ten	ten	CD	_	62	QMOD
65	times	time	NNS	_	66	AMOD
66	longer	longer	RBR	_	61	TMP
67	(	(	-LRB-	_	68	P
68	A.	a.	NNP	_	55	CIT
69	Lehmann	lehmann	NNP	_	68	DEP
70	,	,	,	_	68	P
71	personal	personal	JJ	_	68	DEP
72	communication	communication	NN	_	68	DEP
73	)	)	-RRB-	_	68	P
74	(	(	-LRB-	_	75	P
75	Figure	figure	NN	_	55	PRN
76	5	0	CD	_	75	NMOD
77	)	)	-RRB-	_	75	P
78	.	.	.	_	55	P

1	Compound	compound	NN	_	2	NMOD
2	heterozygosity	heterozygosity	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	also	also	RB	_	3	ADV
5	associated	associate	VBN	_	3	VC
6	with	with	IN	_	5	ADV
7	the	the	DT	_	17	NMOD
8	recently	recently	RB	_	9	AMOD
9	reported	report	VBN	_	17	NMOD
10	combination	combination	NN	_	17	NMOD
11	XP	xp	NN	_	17	NMOD
12	and	and	CC	_	11	COORD
13	TTD	ttd	NN	_	12	CONJ
14	(	(	-LRB-	_	15	P
15	XPTTD	xpttd	NN	_	11	PRN
16	)	)	-RRB-	_	15	P
17	syndrome	syndrome	NN	_	6	PMOD
18	[	[	-LRB-	_	19	P
19	8	0	CD	_	5	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	3	P

1	Similar	similar	JJ	_	22	ADV
2	to	to	IN	_	1	AMOD
3	the	the	DT	_	11	NMOD
4	XpdTTD	xpdttd	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	†XPCS	†xpcs	NN	_	11	NMOD
7	and	and	CC	_	6	COORD
8	XpdTTD	xpdttd	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	†XP	†xp	NN	_	7	CONJ
11	mice	mouse	NNS	_	2	PMOD
12	described	describe	VBN	_	11	NMOD
13	here	here	RB	_	12	ADV
14	,	,	,	_	22	P
15	both	both	DT	_	16	NMOD
16	patients	patient	NNS	_	22	SBJ
17	with	with	IN	_	16	NMOD
18	XPTTD	xpttd	NN	_	17	PMOD
19	described	describe	VBN	_	16	NMOD
20	so	so	RB	_	21	AMOD
21	far	far	RB	_	19	TMP
22	had	have	VBD	_	0	ROOT
23	intermediate	intermediate	JJ	_	26	NMOD
24	hair	hair	NN	_	25	NMOD
25	cysteine	cysteine	NN	_	26	NMOD
26	values	value	NNS	_	22	OBJ
27	.	.	.	_	22	P

1	Furthermore	furthermore	RB	_	6	ADV
2	,	,	,	_	6	P
3	XPTTD	xpttd	NN	_	5	NMOD
4	patient	patient	NN	_	5	NMOD
5	XP38BR	xp0br	NN	_	6	SBJ
6	carried	carry	VBD	_	0	ROOT
7	a	a	DT	_	12	NMOD
8	“	“	``	_	12	P
9	causative	causative	JJ	_	12	NMOD
10	”	”	''	_	12	P
11	TTD	ttd	NN	_	12	NMOD
12	mutation	mutation	NN	_	6	OBJ
13	in	in	IN	_	6	LOC
14	one	one	CD	_	15	NMOD
15	allele	allele	NN	_	13	PMOD
16	and	and	CC	_	6	COORD
17	a	a	DT	_	20	NMOD
18	novel	novel	JJ	_	20	NMOD
19	point	point	NN	_	20	NMOD
20	mutation	mutation	NN	_	16	GAP
21	encoding	encode	VBG	_	20	NMOD
22	XPDL485P	xpdl0p	NN	_	21	OBJ
23	in	in	IN	_	20	LOC
24	the	the	DT	_	25	NMOD
25	other	other	JJ	_	23	PMOD
26	.	.	.	_	6	P

1	Although	although	IN	_	33	ADV
2	the	the	DT	_	6	NMOD
3	XPDL485P	xpdl0p	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	encoding	encode	VBG	_	6	NMOD
6	allele	allele	NN	_	7	SBJ
7	fails	fail	VBZ	_	1	SUB
8	to	to	TO	_	7	OPRD
9	complement	complement	VB	_	8	IM
10	viability	viability	NN	_	9	OBJ
11	in	in	IN	_	9	LOC
12	the	the	DT	_	18	NMOD
13	haploid	haploid	JJ	_	18	NMOD
14	S.	s.	FW	_	18	NMOD
15	pombe	pombe	FW	_	18	NMOD
16	rad15	rad0	NN	_	18	NMOD
17	deletion	deletion	NN	_	18	NMOD
18	strain	strain	NN	_	11	PMOD
19	and	and	CC	_	7	COORD
20	is	be	VBZ	_	19	CONJ
21	thus	thus	RB	_	20	ADV
22	interpretable	interpretable	JJ	_	20	PRD
23	as	as	IN	_	22	AMOD
24	a	a	DT	_	26	NMOD
25	null	null	JJ	_	26	NMOD
26	allele	allele	NN	_	23	PMOD
27	[	[	-LRB-	_	28	P
28	8	0	CD	_	7	PRN
29	]	]	-RRB-	_	28	P
30	,	,	,	_	33	P
31	we	we	PRP	_	33	SBJ
32	nonetheless	nonetheless	RB	_	33	ADV
33	suggest	suggest	VBP	_	0	ROOT
34	that	that	IN	_	33	OBJ
35	the	the	DT	_	38	NMOD
36	combined	combined	JJ	_	38	NMOD
37	XPTTD	xpttd	NN	_	38	NMOD
38	phenotype	phenotype	NN	_	42	SBJ
39	in	in	IN	_	38	LOC
40	this	this	DT	_	41	NMOD
41	patient	patient	NN	_	39	PMOD
42	involves	involve	VBZ	_	34	SUB
43	phenotypic	phenotypic	JJ	_	44	NMOD
44	contributions	contribution	NNS	_	42	OBJ
45	from	from	IN	_	44	NMOD
46	both	both	DT	_	47	NMOD
47	alleles	allele	NNS	_	45	PMOD
48	.	.	.	_	33	P

1	Taken	take	VBN	_	6	ADV
2	together	together	RB	_	1	ADV
3	,	,	,	_	6	P
4	these	these	DT	_	5	NMOD
5	data	datum	NNS	_	6	SBJ
6	suggest	suggest	VBP	_	0	ROOT
7	a	a	DT	_	8	NMOD
8	shift	shift	NN	_	6	OBJ
9	to	to	IN	_	8	NMOD
10	a	a	DT	_	12	NMOD
11	biallelic	biallelic	JJ	_	12	NMOD
12	paradigm	paradigm	NN	_	9	PMOD
13	for	for	IN	_	12	NMOD
14	compound	compound	NN	_	16	NMOD
15	heterozygous	heterozygous	JJ	_	16	NMOD
16	patients	patient	NNS	_	13	PMOD
17	in	in	IN	_	16	NMOD
18	XP	xp	NN	_	21	NMOD
19	complementation	complementation	NN	_	21	NMOD
20	group	group	NN	_	21	NMOD
21	D	d	NN	_	17	PMOD
22	.	.	.	_	6	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	Genotype	genotype	NN	_	3	NMOD
2	–	–	HYPH	_	1	P
3	Phenotype	phenotype	NN	_	4	NMOD
4	Relationships	relationship	NNS	_	0	ROOT
5	in	in	IN	_	4	NMOD
6	XPD	xpd	NN	_	7	NMOD
7	Disorders	disorder	NNS	_	5	PMOD

1	According	accord	VBG	_	9	ADV
2	to	to	IN	_	1	PMOD
3	the	the	DT	_	6	NMOD
4	current	current	JJ	_	6	NMOD
5	monoallelic	monoallelic	JJ	_	6	NMOD
6	hypothesis	hypothesis	NN	_	2	PMOD
7	,	,	,	_	9	P
8	phenotype	phenotype	NN	_	9	SBJ
9	is	be	VBZ	_	0	ROOT
10	determined	determine	VBN	_	9	VC
11	solely	solely	RB	_	12	PMOD
12	by	by	IN	_	10	LGS
13	the	the	DT	_	16	NMOD
14	causative	causative	JJ	_	16	NMOD
15	allele	allele	NN	_	16	NMOD
16	product	product	NN	_	12	PMOD
17	.	.	.	_	9	P

1	If	if	IN	_	11	ADV
2	a	a	DT	_	6	NMOD
3	second	$#ORD#$	JJ	_	6	NMOD
4	,	,	,	_	6	P
5	different	different	JJ	_	6	NMOD
6	allele	allele	NN	_	7	SBJ
7	is	be	VBZ	_	1	SUB
8	present	present	JJ	_	7	PRD
9	,	,	,	_	11	P
10	it	it	PRP	_	11	SBJ
11	is	be	VBZ	_	0	ROOT
12	considered	consider	VBN	_	11	VC
13	a	a	DT	_	15	NMOD
14	functional	functional	JJ	_	15	NMOD
15	null	null	NN	_	12	OPRD
16	.	.	.	_	11	P

1	There	there	EX	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	lack	lack	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	any	any	DT	_	7	NMOD
7	correlation	correlation	NN	_	5	PMOD
8	between	between	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	site	site	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	XPD	xpd	NN	_	14	NMOD
14	mutation	mutation	NN	_	11	PMOD
15	and	and	CC	_	10	COORD
16	the	the	DT	_	18	NMOD
17	resulting	result	VBG	_	18	NMOD
18	disorder	disorder	NN	_	15	CONJ
19	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	propose	propose	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	biallelic	biallelic	JJ	_	5	NMOD
5	hypothesis	hypothesis	NN	_	2	OBJ
6	for	for	IN	_	5	NMOD
7	compound	compound	NN	_	8	NMOD
8	heterozygotes	heterozygote	NNS	_	6	PMOD
9	in	in	IN	_	14	ADV
10	which	which	WDT	_	9	PMOD
11	both	both	DT	_	12	NMOD
12	alleles	allele	NNS	_	13	SBJ
13	can	can	MD	_	5	NMOD
14	contribute	contribute	VB	_	13	VC
15	to	to	IN	_	14	ADV
16	the	the	DT	_	17	NMOD
17	phenotype	phenotype	NN	_	15	PMOD
18	.	.	.	_	2	P

1	Examples	example	NNS	_	21	SBJ
2	of	of	IN	_	1	NMOD
3	compound	compound	NN	_	5	NMOD
4	heterozygous	heterozygous	JJ	_	5	NMOD
5	patients	patient	NNS	_	2	PMOD
6	in	in	IN	_	14	LOC
7	which	which	WDT	_	6	PMOD
8	a	a	DT	_	13	NMOD
9	second	$#ORD#$	JJ	_	13	NMOD
10	,	,	,	_	13	P
11	presumed	presumed	JJ	_	12	AMOD
12	null	null	JJ	_	13	NMOD
13	allele	allele	NN	_	14	SBJ
14	is	be	VBZ	_	5	NMOD
15	likely	likely	JJ	_	14	PRD
16	to	to	TO	_	15	AMOD
17	contribute	contribute	VB	_	16	IM
18	to	to	IN	_	17	ADV
19	disease	disease	NN	_	20	NMOD
20	outcome	outcome	NN	_	18	PMOD
21	are	be	VBP	_	0	ROOT
22	provided	provide	VBN	_	21	VC
23	above	above	RB	_	22	ADV
24	in	in	IN	_	22	ADV
25	comparison	comparison	NN	_	24	PMOD
26	to	to	IN	_	25	NMOD
27	corresponding	correspond	VBG	_	32	NMOD
28	homo	homo	AFX	_	32	NMOD
29	-	-	HYPH	_	28	P
30	or	or	CC	_	28	COORD
31	hemizygous	hemizygous	JJ	_	30	CONJ
32	patients	patient	NNS	_	26	PMOD
33	with	with	IN	_	32	NMOD
34	the	the	DT	_	37	NMOD
35	same	same	JJ	_	37	NMOD
36	causative	causative	JJ	_	37	NMOD
37	allele	allele	NN	_	33	PMOD
38	.	.	.	_	21	P

1	Numbers	number	NNS	_	8	SBJ
2	in	in	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	schematic	schematic	NN	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	protein	protein	NN	_	5	PMOD
8	indicate	indicate	VBP	_	0	ROOT
9	the	the	DT	_	11	NMOD
10	helicase	helicase	NN	_	11	NMOD
11	domains	domain	NNS	_	8	OBJ
12	.	.	.	_	8	P

1	Potential	potential	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Combined	combine	VBN	_	5	NMOD
4	Recessive	recessive	JJ	_	5	NMOD
5	Alleles	allele	NNS	_	2	PMOD
6	to	to	TO	_	1	NMOD
7	Affect	affect	VB	_	6	IM
8	Phenotypic	phenotypic	JJ	_	9	NMOD
9	Diversity	diversity	NN	_	7	OBJ
10	in	in	IN	_	7	LOC
11	Mammals	mammal	NNS	_	10	PMOD

1	In	in	IN	_	14	LOC
2	humans	human	NNS	_	1	PMOD
3	,	,	,	_	14	P
4	the	the	DT	_	6	NMOD
5	clinical	clinical	JJ	_	6	NMOD
6	relevance	relevance	NN	_	14	SBJ
7	of	of	IN	_	6	NMOD
8	biallelic	biallelic	JJ	_	9	NMOD
9	effects	effect	NNS	_	7	PMOD
10	such	such	JJ	_	11	PMOD
11	as	as	IN	_	9	NMOD
12	interallelic	interallelic	JJ	_	13	NMOD
13	complementation	complementation	NN	_	11	PMOD
14	remains	remain	VBZ	_	0	ROOT
15	unknown	unknown	JJ	_	14	PRD
16	.	.	.	_	14	P

1	Although	although	IN	_	29	ADV
2	interallelic	interallelic	JJ	_	3	NMOD
3	complementation	complementation	NN	_	9	SBJ
4	between	between	IN	_	3	NMOD
5	two	two	CD	_	8	NMOD
6	endogenous	endogenous	JJ	_	8	NMOD
7	mutant	mutant	JJ	_	8	NMOD
8	alleles	allele	NNS	_	4	PMOD
9	has	have	VBZ	_	1	SUB
10	been	be	VBN	_	9	VC
11	described	describe	VBN	_	10	VC
12	in	in	IN	_	3	LOC
13	cells	cell	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	a	a	DT	_	18	NMOD
16	compound	compound	NN	_	18	NMOD
17	heterozygous	heterozygous	JJ	_	18	NMOD
18	patient	patient	NN	_	14	PMOD
19	with	with	IN	_	18	NMOD
20	methylmalonic	methylmalonic	JJ	_	21	NMOD
21	acidaemia	acidaemia	NN	_	19	PMOD
22	,	,	,	_	29	P
23	no	no	DT	_	25	NMOD
24	observable	observable	JJ	_	25	NMOD
25	effects	effect	NNS	_	29	SBJ
26	on	on	IN	_	25	NMOD
27	disease	disease	NN	_	28	NMOD
28	outcome	outcome	NN	_	26	PMOD
29	were	be	VBD	_	0	ROOT
30	noted	note	VBN	_	29	VC
31	in	in	IN	_	30	LOC
32	the	the	DT	_	33	NMOD
33	patient	patient	NN	_	31	PMOD
34	[	[	-LRB-	_	35	P
35	28	0	CD	_	30	PRN
36	]	]	-RRB-	_	35	P
37	.	.	.	_	29	P

1	Thus	thus	RB	_	17	ADV
2	,	,	,	_	17	P
3	to	to	IN	_	17	ADV
4	the	the	DT	_	5	NMOD
5	best	good	JJS	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	our	our	PRP$	_	8	NMOD
8	knowledge	knowledge	NN	_	6	PMOD
9	,	,	,	_	17	P
10	the	the	DT	_	11	NMOD
11	amelioration	amelioration	NN	_	17	SBJ
12	of	of	IN	_	11	NMOD
13	progeroid	progeroid	JJ	_	14	NMOD
14	features	feature	NNS	_	12	PMOD
15	observed	observe	VBN	_	11	NMOD
16	here	here	RB	_	15	ADV
17	is	be	VBZ	_	0	ROOT
18	the	the	DT	_	22	NMOD
19	first	$#ORD#$	JJ	_	22	NMOD
20	in	in	FW	_	21	AMOD
21	vivo	vivo	FW	_	22	NMOD
22	demonstration	demonstration	NN	_	17	PRD
23	in	in	IN	_	22	LOC
24	compound	compound	NN	_	26	NMOD
25	heterozygous	heterozygous	JJ	_	26	NMOD
26	animals	animal	NNS	_	23	PMOD
27	of	of	IN	_	26	NMOD
28	interallelic	interallelic	JJ	_	29	NMOD
29	complementation	complementation	NN	_	27	PMOD
30	relevant	relevant	JJ	_	22	NMOD
31	to	to	IN	_	30	AMOD
32	a	a	DT	_	34	NMOD
33	human	human	JJ	_	34	NMOD
34	disease	disease	NN	_	31	PMOD
35	.	.	.	_	17	P

1	Keeping	keep	VBG	_	56	ADV
2	in	in	IN	_	1	ADV
3	mind	mind	NN	_	2	PMOD
4	that	that	IN	_	1	OBJ
5	the	the	DT	_	8	NMOD
6	~	~	SYM	_	7	P
7	1,200	0	CD	_	8	NMOD
8	alleles	allele	NNS	_	29	SBJ
9	known	know	VBN	_	8	NMOD
10	to	to	TO	_	9	OPRD
11	exist	exist	VB	_	10	IM
12	for	for	IN	_	11	ADV
13	the	the	DT	_	15	NMOD
14	CTRF	ctrf	NN	_	15	NMOD
15	gene	gene	NN	_	12	PMOD
16	implicated	implicate	VBN	_	15	NMOD
17	in	in	IN	_	16	ADV
18	the	the	DT	_	22	NMOD
19	common	common	JJ	_	22	NMOD
20	autosomal	autosomal	JJ	_	22	NMOD
21	recessive	recessive	JJ	_	22	NMOD
22	disorder	disorder	NN	_	24	NMOD
23	cystic	cystic	JJ	_	24	NMOD
24	fibrosis	fibrosis	NN	_	17	PMOD
25	alone	alone	RB	_	16	ADV
26	[	[	-LRB-	_	27	P
27	29	0	CD	_	9	PRN
28	]	]	-RRB-	_	27	P
29	can	can	MD	_	4	SUB
30	theoretically	theoretically	RB	_	29	ADV
31	result	result	VB	_	29	VC
32	in	in	IN	_	31	ADV
33	~	~	SYM	_	34	P
34	700,000	0	CD	_	37	NMOD
35	different	different	JJ	_	37	NMOD
36	allelic	allelic	JJ	_	37	NMOD
37	combinations	combination	NNS	_	32	PMOD
38	,	,	,	_	56	P
39	the	the	DT	_	41	NMOD
40	potential	potential	JJ	_	41	NMOD
41	number	number	NN	_	56	SBJ
42	of	of	IN	_	41	NMOD
43	allelic	allelic	JJ	_	44	NMOD
44	combinations	combination	NNS	_	42	PMOD
45	of	of	IN	_	44	NMOD
46	different	different	JJ	_	48	NMOD
47	recessive	recessive	JJ	_	48	NMOD
48	mutations	mutation	NNS	_	45	PMOD
49	and	and	CC	_	48	COORD
50	single	single	JJ	_	52	NMOD
51	nucleotide	nucleotide	NN	_	52	NMOD
52	polymorphisms	polymorphism	NNS	_	49	CONJ
53	genome	genome	NN	_	55	AMOD
54	-	-	HYPH	_	53	P
55	wide	wide	JJ	_	41	NMOD
56	is	be	VBZ	_	0	ROOT
57	currently	currently	RB	_	56	TMP
58	incalculable	incalculable	JJ	_	56	PRD
59	.	.	.	_	56	P

1	We	we	PRP	_	2	SBJ
2	suggest	suggest	VBP	_	0	ROOT
3	biallelic	biallelic	JJ	_	4	NMOD
4	effects	effect	NNS	_	2	OBJ
5	as	as	IN	_	2	ADV
6	a	a	DT	_	11	NMOD
7	previously	previously	RB	_	8	AMOD
8	underestimated	underestimate	VBN	_	10	AMOD
9	yet	yet	RB	_	10	AMOD
10	important	important	JJ	_	11	NMOD
11	variable	variable	NN	_	5	PMOD
12	in	in	IN	_	2	ADV
13	considering	consider	VBG	_	12	PMOD
14	genotype	genotype	NN	_	16	NMOD
15	–	–	HYPH	_	14	P
16	phenotype	phenotype	NN	_	17	NMOD
17	relationships	relationship	NNS	_	13	OBJ
18	from	from	IN	_	13	ADV
19	autosomal	autosomal	JJ	_	21	NMOD
20	recessive	recessive	JJ	_	21	NMOD
21	disease	disease	NN	_	18	PMOD
22	to	to	IN	_	18	PMOD
23	normal	normal	JJ	_	25	NMOD
24	phenotypic	phenotypic	JJ	_	25	NMOD
25	diversity	diversity	NN	_	22	PMOD
26	in	in	IN	_	13	LOC
27	mammals	mammal	NNS	_	26	PMOD
28	.	.	.	_	2	P

1	Extension	extension	NN	_	6	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	above	above	JJ	_	5	NMOD
5	concept	concept	NN	_	2	PMOD
6	implies	imply	VBZ	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	recessive	recessive	JJ	_	9	NMOD
9	mutations	mutation	NNS	_	10	SBJ
10	can	can	MD	_	7	SUB
11	enter	enter	VB	_	10	VC
12	evolutionary	evolutionary	JJ	_	13	NMOD
13	selection	selection	NN	_	11	OBJ
14	in	in	IN	_	11	ADV
15	F1	f0	NN	_	14	PMOD
16	provided	provide	VBN	_	11	ADV
17	that	that	IN	_	16	PMOD
18	the	the	DT	_	20	NMOD
19	second	$#ORD#$	JJ	_	20	NMOD
20	allele	allele	NN	_	21	SBJ
21	carries	carry	VBZ	_	17	SUB
22	a	a	DT	_	25	NMOD
23	different	different	JJ	_	25	NMOD
24	recessive	recessive	JJ	_	25	NMOD
25	alteration	alteration	NN	_	21	OBJ
26	.	.	.	_	6	P

1	Finally	finally	RB	_	5	ADV
2	,	,	,	_	5	P
3	our	our	PRP$	_	4	NMOD
4	data	datum	NNS	_	5	SBJ
5	highlight	highlight	VBP	_	0	ROOT
6	the	the	DT	_	7	NMOD
7	potential	potential	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	clinically	clinically	RB	_	10	AMOD
10	relevant	relevant	JJ	_	11	NMOD
11	alleles	allele	NNS	_	8	PMOD
12	previously	previously	RB	_	13	ADV
13	designated	designate	VBN	_	11	NMOD
14	as	as	IN	_	13	MNR
15	null	null	JJ	_	14	PMOD
16	,	,	,	_	11	P
17	with	with	IN	_	11	NMOD
18	little	little	JJ	_	22	NMOD
19	or	or	CC	_	18	COORD
20	no	no	DT	_	19	CONJ
21	detectable	detectable	JJ	_	22	NMOD
22	expression	expression	NN	_	17	PMOD
23	or	or	CC	_	22	COORD
24	activity	activity	NN	_	23	CONJ
25	,	,	,	_	7	P
26	to	to	TO	_	7	NMOD
27	nonetheless	nonetheless	RB	_	26	ADV
28	contribute	contribute	VB	_	26	IM
29	to	to	IN	_	28	ADV
30	phenotype	phenotype	NN	_	29	PMOD
31	.	.	.	_	5	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Methods	method	NNS	_	2	CONJ

1	Derivation	derivation	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	analysis	analysis	NN	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	mutant	mutant	JJ	_	6	NMOD
6	mice	mouse	NNS	_	4	PMOD
7	.	.	.	_	1	P

1	Generation	generation	NN	_	12	SBJ
2	of	of	IN	_	1	NMOD
3	XpdTTD	xpdttd	NN	_	11	NMOD
4	(	(	-LRB-	_	5	P
5	XPDR722W	xpdr0w	NN	_	3	PRN
6	)	)	-RRB-	_	5	P
7	and	and	CC	_	3	COORD
8	XpdTTD	xpdttd	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	KO	ko	NN	_	7	CONJ
11	mice	mouse	NNS	_	2	PMOD
12	has	have	VBZ	_	0	ROOT
13	been	be	VBN	_	12	VC
14	described	describe	VBN	_	13	VC
15	previously	previously	RB	_	14	TMP
16	[	[	-LRB-	_	19	P
17	21	0	CD	_	19	NMOD
18	,	,	,	_	19	P
19	22	0	CD	_	14	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	12	P

1	A	a	DT	_	3	NMOD
2	detailed	detailed	JJ	_	3	NMOD
3	description	description	NN	_	23	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	generation	generation	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	targeting	target	VBG	_	9	NMOD
9	constructs	construct	NNS	_	7	PMOD
10	for	for	IN	_	9	NMOD
11	Xpd†XPCS	xpd†xpcs	NN	_	14	NMOD
12	and	and	CC	_	11	COORD
13	Xpd †XP	xpd †xp	NN	_	12	CONJ
14	alleles	allele	NNS	_	10	PMOD
15	carrying	carry	VBG	_	14	NMOD
16	mutations	mutation	NNS	_	15	OBJ
17	encoding	encode	VBG	_	16	NMOD
18	the	the	DT	_	22	NMOD
19	G602D	g0d	NN	_	22	NMOD
20	and	and	CC	_	19	COORD
21	R683W	r0w	NN	_	20	CONJ
22	alterations	alteration	NNS	_	17	OBJ
23	will	will	MD	_	0	ROOT
24	be	be	VB	_	23	VC
25	provided	provide	VBN	_	24	VC
26	upon	upon	IN	_	25	ADV
27	request	request	NN	_	26	PMOD
28	.	.	.	_	23	P

1	Chimeric	chimeric	JJ	_	6	NMOD
2	mice	mouse	NNS	_	6	NMOD
3	and	and	CC	_	2	COORD
4	mouse	mouse	NN	_	5	AMOD
5	embryonic	embryonic	JJ	_	3	CONJ
6	fibroblasts	fibroblast	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	generated	generate	VBN	_	7	VC
9	according	accord	VBG	_	8	MNR
10	to	to	IN	_	9	PMOD
11	standard	standard	JJ	_	12	NMOD
12	procedures	procedure	NNS	_	10	PMOD
13	.	.	.	_	7	P

1	Haematoxylin	haematoxylin	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	eosin	eosin	NN	_	2	CONJ
4	staining	staining	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	performed	perform	VBN	_	5	VC
7	according	accord	VBG	_	6	MNR
8	to	to	IN	_	7	PMOD
9	standard	standard	JJ	_	10	NMOD
10	procedures	procedure	NNS	_	8	PMOD
11	.	.	.	_	5	P

1	Amino	amino	NN	_	2	NMOD
2	acid	acid	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	conducted	conduct	VBN	_	4	VC
6	as	as	IN	_	5	ADV
7	described	describe	VBN	_	6	SUB
8	in	in	IN	_	7	ADV
9	[	[	-LRB-	_	8	P
10	21	0	CD	_	8	PMOD
11	]	]	-RRB-	_	4	P
12	.	.	.	_	4	P

1	Blood	blood	NN	_	2	NMOD
2	values	value	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	analysed	analyse	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	Animal	animal	NN	_	9	NMOD
7	Blood	blood	NN	_	9	NMOD
8	Counter	counter	JJ	_	9	NMOD
9	Vet	vet	NN	_	5	OBJ
10	(	(	-LRB-	_	12	P
11	ABX	abx	NNP	_	12	NMOD
12	Diagnostix	diagnostix	NNP	_	9	PRN
13	,	,	,	_	12	P
14	Montpellier	montpellier	NNP	_	12	APPO
15	,	,	,	_	14	P
16	France	france	NNP	_	14	APPO
17	)	)	-RRB-	_	12	P
18	.	.	.	_	3	P

1	Radiographs	radiograph	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	taken	take	VBN	_	2	VC
4	,	,	,	_	2	P
5	and	and	CC	_	2	COORD
6	relative	relative	JJ	_	9	NMOD
7	bone	bone	NN	_	8	NMOD
8	mineral	mineral	NN	_	9	NMOD
9	density	density	NN	_	10	SBJ
10	was	be	VBD	_	5	CONJ
11	calculated	calculate	VBN	_	10	VC
12	as	as	IN	_	11	ADV
13	described	describe	VBN	_	12	SUB
14	in	in	IN	_	13	ADV
15	[	[	-LRB-	_	14	P
16	15	0	CD	_	14	PMOD
17	]	]	-RRB-	_	2	P
18	.	.	.	_	2	P

1	Mice	mouse	NNS	_	6	SBJ
2	used	use	VBN	_	1	NMOD
3	in	in	IN	_	2	ADV
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	in	in	IN	_	6	PRD
8	a	a	DT	_	13	NMOD
9	129Ola	0ola	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	C57BL6	c0bl0	NN	_	13	NMOD
12	mixed	mixed	JJ	_	13	NMOD
13	background	background	NN	_	7	PMOD
14	unless	unless	IN	_	6	ADV
15	noted	note	VBN	_	14	SUB
16	differently	differently	RB	_	15	ADV
17	.	.	.	_	6	P

1	All	all	DT	_	2	NMOD
2	experiments	experiment	NNS	_	5	SBJ
3	involving	involve	VBG	_	2	NMOD
4	mice	mouse	NNS	_	3	OBJ
5	were	be	VBD	_	0	ROOT
6	judged	judge	VBN	_	5	VC
7	and	and	CC	_	6	COORD
8	approved	approve	VBN	_	7	CONJ
9	by	by	IN	_	6	LGS
10	the	the	DT	_	12	NMOD
11	national	national	JJ	_	12	NMOD
12	committee	committee	NN	_	9	PMOD
13	for	for	IN	_	12	NMOD
14	genetic	genetic	JJ	_	15	NMOD
15	identification	identification	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	organisms	organism	NNS	_	16	PMOD
18	and	and	CC	_	12	COORD
19	the	the	DT	_	22	NMOD
20	animal	animal	NN	_	22	NMOD
21	ethical	ethical	JJ	_	22	NMOD
22	committee	committee	NN	_	18	CONJ
23	,	,	,	_	5	P
24	and	and	CC	_	5	COORD
25	were	be	VBD	_	24	CONJ
26	conducted	conduct	VBN	_	25	VC
27	according	accord	VBG	_	26	MNR
28	to	to	IN	_	27	PMOD
29	national	national	JJ	_	32	NMOD
30	and	and	CC	_	29	COORD
31	international	international	JJ	_	30	CONJ
32	guidelines	guideline	NNS	_	28	PMOD
33	.	.	.	_	5	P

1	UV	uv	NN	_	2	NMOD
2	sensitivity	sensitivity	NN	_	0	ROOT
3	,	,	,	_	2	P
4	UV	uv	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	UDS	uds	NN	_	17	NMOD
7	,	,	,	_	6	P
8	UV	uv	NN	_	10	NMOD
9	-	-	HYPH	_	8	P
10	RRS	rrs	NN	_	6	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	TFIIH	tfiih	NN	_	12	CONJ
14	incision	incision	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	excision	excision	NN	_	17	NMOD
17	activity	activity	NN	_	2	APPO
18	.	.	.	_	2	P

1	UV	uv	NN	_	2	NMOD
2	survival	survival	NN	_	12	NMOD
3	,	,	,	_	2	P
4	UV	uv	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	UDS	uds	NN	_	2	CONJ
7	,	,	,	_	6	P
8	and	and	CC	_	6	COORD
9	UV	uv	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	RRS	rrs	NN	_	8	CONJ
12	assays	assay	NNS	_	13	SBJ
13	were	be	VBD	_	0	ROOT
14	performed	perform	VBN	_	13	VC
15	as	as	IN	_	14	ADV
16	described	describe	VBN	_	15	SUB
17	previously	previously	RB	_	16	TMP
18	[	[	-LRB-	_	21	P
19	21	0	CD	_	21	NMOD
20	,	,	,	_	21	P
21	30	0	CD	_	14	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	13	P

1	For	for	IN	_	33	ADV
2	UV	uv	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	RRS	rrs	NN	_	1	PMOD
5	,	,	,	_	33	P
6	average	average	JJ	_	7	NMOD
7	values	value	NNS	_	33	SBJ
8	from	from	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	representative	representative	JJ	_	11	NMOD
11	experiment	experiment	NN	_	8	PMOD
12	containing	contain	VBG	_	11	NMOD
13	two	two	CD	_	14	NMOD
14	wt	wt	NN	_	32	NMOD
15	,	,	,	_	14	P
16	three	three	CD	_	19	NMOD
17	XpdTTD	xpdttd	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	TTD	ttd	NN	_	14	CONJ
20	,	,	,	_	19	P
21	two	two	CD	_	24	NMOD
22	XpdTTD	xpdttd	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	XPCS	xpcs	NN	_	19	CONJ
25	,	,	,	_	24	P
26	and	and	CC	_	24	COORD
27	one	one	CD	_	30	NMOD
28	XpdTTD	xpdttd	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	XP	xp	NN	_	26	CONJ
31	cell	cell	NN	_	32	NMOD
32	line	line	NN	_	12	OBJ
33	are	be	VBP	_	0	ROOT
34	presented	present	VBN	_	33	VC
35	.	.	.	_	33	P

1	The	the	DT	_	8	NMOD
2	~	~	SYM	_	3	P
3	48	0	CD	_	4	NMOD
4	%	%	NN	_	8	NMOD
5	UV	uv	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	UDS	uds	NN	_	8	NMOD
8	value	value	NN	_	18	SBJ
9	presented	present	VBN	_	8	NMOD
10	in	in	IN	_	9	ADV
11	this	this	DT	_	12	NMOD
12	study	study	NN	_	10	PMOD
13	for	for	IN	_	8	NMOD
14	XpdTTD	xpdttd	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	TTD	ttd	NN	_	17	NMOD
17	cells	cell	NNS	_	13	PMOD
18	differs	differ	VBZ	_	0	ROOT
19	from	from	IN	_	18	ADV
20	our	our	PRP$	_	23	NMOD
21	previously	previously	RB	_	22	AMOD
22	published	publish	VBN	_	23	NMOD
23	data	datum	NNS	_	19	PMOD
24	of	of	IN	_	23	NMOD
25	25	0	CD	_	26	NMOD
26	%	%	NN	_	29	NMOD
27	UV	uv	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	UDS	uds	NN	_	24	PMOD
30	[	[	-LRB-	_	31	P
31	21	0	CD	_	18	PRN
32	]	]	-RRB-	_	31	P
33	,	,	,	_	18	P
34	possibly	possibly	RB	_	35	PMOD
35	because	because	IN	_	18	PRP
36	of	of	IN	_	35	PMOD
37	the	the	DT	_	39	NMOD
38	high	high	JJ	_	39	NMOD
39	variability	variability	NN	_	36	PMOD
40	intrinsic	intrinsic	JJ	_	39	NMOD
41	to	to	IN	_	40	AMOD
42	the	the	DT	_	43	NMOD
43	assay	assay	NN	_	41	PMOD
44	or	or	CC	_	43	COORD
45	routine	routine	JJ	_	46	NMOD
46	variations	variation	NNS	_	44	CONJ
47	in	in	IN	_	43	NMOD
48	the	the	DT	_	51	NMOD
49	cell	cell	NN	_	50	NMOD
50	culture	culture	NN	_	51	NMOD
51	conditions	condition	NNS	_	47	PMOD
52	.	.	.	_	18	P

1	For	for	IN	_	11	ADV
2	the	the	DT	_	7	NMOD
3	incision	incision	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	excision	excision	NN	_	7	NMOD
6	activity	activity	NN	_	7	NMOD
7	assay	assay	NN	_	1	PMOD
8	,	,	,	_	11	P
9	recombinant	recombinant	JJ	_	10	NMOD
10	TFIIH	tfiih	NN	_	11	SBJ
11	was	be	VBD	_	0	ROOT
12	prepared	prepare	VBN	_	11	VC
13	and	and	CC	_	12	COORD
14	assayed	assay	VBN	_	13	CONJ
15	as	as	IN	_	12	ADV
16	described	describe	VBN	_	15	SUB
17	previously	previously	RB	_	16	TMP
18	[	[	-LRB-	_	19	P
19	27	0	CD	_	12	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	11	P

1	Comparative	comparative	JJ	_	2	NMOD
2	immunofluorescence	immunofluorescence	NN	_	0	ROOT
3	.	.	.	_	2	P

1	Latex	latex	NN	_	3	NMOD
2	bead	bead	NN	_	3	NMOD
3	labelling	labelling	NN	_	15	SBJ
4	and	and	CC	_	3	COORD
5	comparative	comparative	JJ	_	7	NMOD
6	immunofluorescence	immunofluorescence	NN	_	7	NMOD
7	analysis	analysis	NN	_	4	CONJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	p62	p0	NN	_	11	NMOD
11	subunit	subunit	NN	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	14	NMOD
14	TFIIH	tfiih	NN	_	12	PMOD
15	was	be	VBD	_	0	ROOT
16	performed	perform	VBN	_	15	VC
17	as	as	IN	_	16	ADV
18	described	describe	VBN	_	17	SUB
19	previously	previously	RB	_	18	TMP
20	[	[	-LRB-	_	23	P
21	16	0	CD	_	23	NMOD
22	,	,	,	_	23	P
23	17	0	CD	_	18	PRN
24	]	]	-RRB-	_	23	P
25	using	use	VBG	_	16	MNR
26	primary	primary	JJ	_	29	NMOD
27	mouse	mouse	NN	_	29	NMOD
28	embryonic	embryonic	JJ	_	29	NMOD
29	fibroblasts	fibroblast	NNS	_	25	OBJ
30	at	at	IN	_	25	ADV
31	passages	passage	NNS	_	32	NMOD
32	2	0	CD	_	30	PMOD
33	–	–	SYM	_	34	P
34	5	0	CD	_	32	NMOD
35	.	.	.	_	15	P

1	Two	two	CD	_	5	NMOD
2	or	or	CC	_	1	COORD
3	more	more	JJR	_	2	CONJ
4	cell	cell	NN	_	5	NMOD
5	lines	line	NNS	_	29	SBJ
6	per	per	IN	_	5	NMOD
7	genotype	genotype	NN	_	6	PMOD
8	(	(	-LRB-	_	9	P
9	except	except	IN	_	5	PRN
10	for	for	IN	_	9	PMOD
11	the	the	DT	_	15	NMOD
12	XpdTTD	xpdttd	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	†XP	†xp	NN	_	15	NMOD
15	cells	cell	NNS	_	10	PMOD
16	,	,	,	_	15	P
17	in	in	IN	_	24	ADV
18	which	which	WDT	_	17	PMOD
19	only	only	RB	_	22	NMOD
20	one	one	CD	_	22	NMOD
21	cell	cell	NN	_	22	NMOD
22	line	line	NN	_	23	SBJ
23	was	be	VBD	_	15	NMOD
24	used	use	VBN	_	23	VC
25	in	in	IN	_	24	ADV
26	repeated	repeat	VBN	_	27	NMOD
27	experiments	experiment	NNS	_	25	PMOD
28	)	)	-RRB-	_	9	P
29	were	be	VBD	_	0	ROOT
30	used	use	VBN	_	29	VC
31	,	,	,	_	29	P
32	and	and	CC	_	29	COORD
33	experiments	experiment	NNS	_	34	SBJ
34	were	be	VBD	_	32	CONJ
35	repeated	repeat	VBN	_	34	VC
36	2	0	CD	_	39	NMOD
37	–	–	HYPH	_	36	P
38	6	0	CD	_	36	QMOD
39	times	time	NNS	_	35	OBJ
40	per	per	IN	_	39	NMOD
41	genotype	genotype	NN	_	40	PMOD
42	.	.	.	_	29	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	very	very	RB	_	4	AMOD
4	grateful	grateful	JJ	_	2	PRD
5	to	to	IN	_	2	ADV
6	Steven	steven	NNP	_	7	NMOD
7	Bergink	bergink	NNP	_	5	PMOD
8	,	,	,	_	7	P
9	Koos	koos	NNP	_	10	NMOD
10	Jaspers	jasper	NNP	_	7	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	Bjorn	bjorn	NNP	_	14	NMOD
14	Schumacher	schumacher	NNP	_	12	CONJ
15	for	for	IN	_	2	PRP
16	thoughtful	thoughtful	JJ	_	17	NMOD
17	discussions	discussion	NNS	_	15	PMOD
18	and	and	CC	_	17	COORD
19	critical	critical	JJ	_	20	NMOD
20	reading	reading	NN	_	18	CONJ
21	of	of	IN	_	17	NMOD
22	the	the	DT	_	23	NMOD
23	manuscript	manuscript	NN	_	21	PMOD
24	and	and	CC	_	2	COORD
25	to	to	IN	_	24	GAP
26	Ruud	ruud	NNP	_	27	NMOD
27	Koppenol	koppenol	NNP	_	25	PMOD
28	and	and	CC	_	27	COORD
29	Tom	tom	NNP	_	31	NMOD
30	de	de	NNP	_	31	NMOD
31	Vries	vries	NNP	_	28	CONJ
32	for	for	IN	_	25	PRP
33	photography	photography	NN	_	32	PMOD
34	.	.	.	_	2	P

1	Author	author	NN	_	2	NMOD
2	contributions	contribution	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	JOA	joa	NNP	_	11	SBJ
2	,	,	,	_	1	P
3	JJ	jj	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	JHJH	jhjh	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	GTJvdH	gtjvdh	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	JRM	jrm	NNP	_	9	CONJ
11	conceived	conceive	VBD	_	0	ROOT
12	and	and	CC	_	11	COORD
13	designed	design	VBD	_	12	CONJ
14	the	the	DT	_	15	NMOD
15	experiments	experiment	NNS	_	11	OBJ
16	.	.	.	_	11	P

1	JOA	joa	NNP	_	21	SBJ
2	,	,	,	_	1	P
3	JJ	jj	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	JdW	jdw	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	FC	fc	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	DH	dh	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	MvdV	mvdv	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	WT	wt	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	JH	jh	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	WJvL	wjvl	NNP	_	15	CONJ
18	,	,	,	_	17	P
19	and	and	CC	_	17	COORD
20	JRM	jrm	NNP	_	19	CONJ
21	performed	perform	VBD	_	0	ROOT
22	the	the	DT	_	23	NMOD
23	experiments	experiment	NNS	_	21	OBJ
24	.	.	.	_	21	P

1	JOA	joa	NNP	_	25	SBJ
2	,	,	,	_	1	P
3	JJ	jj	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	JdW	jdw	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	FC	fc	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	DH	dh	NNP	_	7	CONJ
10	,	,	,	_	9	P
11	MvdV	mvdv	NNP	_	9	CONJ
12	,	,	,	_	11	P
13	JH	jh	NNP	_	11	CONJ
14	,	,	,	_	13	P
15	HBT	hbt	NNP	_	13	CONJ
16	,	,	,	_	15	P
17	WJvL	wjvl	NNP	_	15	CONJ
18	,	,	,	_	17	P
19	JME	jme	NNP	_	17	CONJ
20	,	,	,	_	19	P
21	JHJH	jhjh	NNP	_	19	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	JRM	jrm	NNP	_	23	CONJ
25	analyzed	analyze	VBD	_	0	ROOT
26	the	the	DT	_	27	NMOD
27	data	datum	NNS	_	25	OBJ
28	.	.	.	_	25	P

1	JdB	jdb	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	GTJvdH	gtjvdh	NNP	_	2	CONJ
4	contributed	contribute	VBD	_	0	ROOT
5	reagents	reagent	NNS	_	10	NMOD
6	/	/	HYPH	_	5	P
7	materials	material	NNS	_	10	NMOD
8	/	/	HYPH	_	7	P
9	analysis	analysis	NN	_	10	NMOD
10	tools	tool	NNS	_	4	OBJ
11	.	.	.	_	4	P

1	JOA	joa	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	JHJH	jhjh	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	JRM	jrm	NNP	_	5	CONJ
7	wrote	write	VBD	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	paper	paper	NN	_	7	OBJ
10	.	.	.	_	7	P

1	Funding	fund	VBG	_	0	ROOT
2	.	.	.	_	1	P

1	This	this	DT	_	2	NMOD
2	research	research	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	the	the	DT	_	8	NMOD
7	Netherlands	netherlands	NNP	_	8	NMOD
8	Organization	organization	NNP	_	5	PMOD
9	for	for	IN	_	8	NMOD
10	Scientific	scientific	NNP	_	11	NMOD
11	Research	research	NNP	_	9	PMOD
12	(	(	-LRB-	_	13	P
13	NWO	nwo	NNP	_	11	PRN
14	)	)	-RRB-	_	13	P
15	through	through	IN	_	11	NMOD
16	the	the	DT	_	17	NMOD
17	foundation	foundation	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	Research	research	NNP	_	21	NMOD
21	Institute	institute	NNP	_	18	PMOD
22	for	for	IN	_	21	NMOD
23	Diseases	disease	NNP	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	26	NMOD
26	Elderly	elderly	NNP	_	24	PMOD
27	,	,	,	_	8	P
28	as	as	RB	_	30	ADV
29	well	well	RB	_	30	ADV
30	as	as	IN	_	8	COORD
31	grants	grant	NNS	_	30	CONJ
32	from	from	IN	_	31	NMOD
33	the	the	DT	_	35	NMOD
34	National	national	NNP	_	35	NMOD
35	Institutes	institute	NNPS	_	32	PMOD
36	of	of	IN	_	35	NMOD
37	Health	health	NNP	_	36	PMOD
38	(	(	-LRB-	_	40	P
39	1PO1	0po0	NN	_	40	NMOD
40	AG17242–02	ag0–0	NN	_	35	PRN
41	)	)	-RRB-	_	40	P
42	,	,	,	_	35	P
43	National	national	NNP	_	44	NMOD
44	Institute	institute	NNP	_	35	CONJ
45	of	of	IN	_	44	NMOD
46	Environmental	environmental	NNP	_	48	NMOD
47	Health	health	NNP	_	48	NMOD
48	Sciences	science	NNP	_	45	PMOD
49	(	(	-LRB-	_	51	P
50	1UO1	0uo0	NN	_	51	NMOD
51	ES011044	es0	NN	_	44	PRN
52	)	)	-RRB-	_	51	P
53	,	,	,	_	44	P
54	European	european	NNP	_	55	NMOD
55	Commission	commission	NNP	_	44	CONJ
56	(	(	-LRB-	_	57	P
57	QRTL	qrtl	NN	_	55	PRN
58	-	-	HYPH	_	57	P
59	1999	0	CD	_	57	NMOD
60	–	–	HYPH	_	59	P
61	02002	0	CD	_	57	NMOD
62	)	)	-RRB-	_	57	P
63	,	,	,	_	55	P
64	and	and	CC	_	55	COORD
65	the	the	DT	_	68	NMOD
66	Dutch	dutch	NNP	_	68	NMOD
67	Cancer	cancer	NNP	_	68	NMOD
68	Society	society	NNP	_	64	CONJ
69	(	(	-LRB-	_	70	P
70	EUR	eur	NN	_	68	PRN
71	99	0	CD	_	70	NMOD
72	–	–	HYPH	_	71	P
73	2004	0	CD	_	70	NMOD
74	)	)	-RRB-	_	70	P
75	.	.	.	_	3	P

1	JRM	jrm	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	fellow	fellow	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	11	NMOD
7	Damon	damon	NNP	_	8	NMOD
8	Runyon	runyon	NNP	_	11	NMOD
9	Cancer	cancer	NNP	_	10	NMOD
10	Research	research	NNP	_	11	NMOD
11	Fund	fund	NNP	_	5	PMOD
12	(	(	-LRB-	_	13	P
13	DRG	drg	NN	_	11	PRN
14	1677	0	CD	_	13	NMOD
15	)	)	-RRB-	_	13	P
16	.	.	.	_	2	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	bp	bp	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	base	base	NN	_	4	NMOD
4	pair	pair	NN	_	0	ROOT

1	CS	c	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	Cockayne	cockayne	NNP	_	4	NMOD
4	syndrome	syndrome	NN	_	0	ROOT

1	E	e	NN	_	3	NMOD
2	[	[	-LRB-	_	3	P
3	number	number	NN	_	9	NMOD
4	]	]	-RRB-	_	9	P
5	-	-	HYPH	_	3	P
6	embryonic	embryonic	JJ	_	9	NMOD
7	day	day	NN	_	9	NMOD
8	[	[	-LRB-	_	9	P
9	number	number	NN	_	0	ROOT
10	]	]	-RRB-	_	9	P

1	kb	kb	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	kilobase	kilobase	NN	_	0	ROOT

1	NER	ner	NN	_	5	NMOD
2	-	-	HYPH	_	1	P
3	nucleotide	nucleotide	NN	_	4	NMOD
4	excision	excision	NN	_	5	NMOD
5	repair	repair	NN	_	0	ROOT

1	SEM	sem	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	standard	standard	JJ	_	4	NMOD
4	error	error	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	mean	mean	NN	_	5	PMOD

1	TFIIH	tfiih	NN	_	9	NMOD
2	-	-	HYPH	_	1	P
3	basal	basal	JJ	_	4	NMOD
4	transcription	transcription	NN	_	7	NMOD
5	/	/	HYPH	_	4	P
6	DNA	dna	NN	_	7	NMOD
7	repair	repair	NN	_	9	NMOD
8	factor	factor	NN	_	9	NMOD
9	IIH	iih	NN	_	0	ROOT

1	TTD	ttd	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	trichothiodystrophy	trichothiodystrophy	NN	_	0	ROOT

1	UV	uv	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	RRS	rrs	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	recovery	recovery	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	RNA	rna	NN	_	8	NMOD
8	synthesis	synthesis	NN	_	6	PMOD
9	after	after	IN	_	5	NMOD
10	ultraviolet	ultraviolet	JJ	_	11	NMOD
11	irradiation	irradiation	NN	_	9	PMOD

1	UV	uv	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	UDS	uds	NN	_	7	NMOD
4	-	-	HYPH	_	3	P
5	unscheduled	unscheduled	JJ	_	7	NMOD
6	DNA	dna	NN	_	7	NMOD
7	synthesis	synthesis	NN	_	0	ROOT
8	after	after	IN	_	7	NMOD
9	ultraviolet	ultraviolet	JJ	_	10	NMOD
10	irradiation	irradiation	NN	_	8	PMOD

1	wt	wt	NN	_	5	NMOD
2	-	-	HYPH	_	1	P
3	wild	wild	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	type	type	NN	_	0	ROOT

1	XP	xp	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	xeroderma	xeroderma	NN	_	4	NMOD
4	pigmentosum	pigmentosum	NN	_	0	ROOT

1	XPCS	xpcs	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	xeroderma	xeroderma	NN	_	4	NMOD
4	pigmentosum	pigmentosum	NN	_	0	ROOT
5	combined	combine	VBN	_	4	NMOD
6	with	with	IN	_	5	ADV
7	Cockayne	cockayne	NNP	_	8	NMOD
8	syndrome	syndrome	NN	_	6	PMOD

1	XPTTD	xpttd	NN	_	5	NMOD
2	-	-	HYPH	_	1	P
3	combination	combination	NN	_	5	NMOD
4	xeroderma	xeroderma	NN	_	5	NMOD
5	pigmentosum	pigmentosum	NN	_	0	ROOT
6	and	and	CC	_	5	COORD
7	trichothiodystrophy	trichothiodystrophy	NN	_	6	CONJ

1	Footnotes	footnote	NNS	_	0	ROOT

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	declared	declare	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	no	no	DT	_	8	NMOD
7	competing	compete	VBG	_	8	NMOD
8	interests	interest	NNS	_	9	SBJ
9	exist	exist	VBP	_	5	SUB
10	.	.	.	_	3	P

1	¤	¤	SYM	_	2	P
2	a	a	LS	_	6	NMOD
3	Current	current	JJ	_	4	NMOD
4	address	address	NN	_	6	NMOD
5	:	:	:	_	6	P
6	Institute	institute	NNP	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	Biotechnology	biotechnology	NNP	_	7	PMOD
9	,	,	,	_	6	P
10	University	university	NNP	_	6	APPO
11	of	of	IN	_	10	NMOD
12	Helsinki	helsinki	NNP	_	11	PMOD
13	,	,	,	_	10	P
14	Helsinki	helsinki	NNP	_	10	APPO
15	,	,	,	_	14	P
16	Finland	finland	NNP	_	14	APPO

1	¤	¤	SYM	_	2	P
2	b	b	LS	_	6	NMOD
3	Current	current	JJ	_	4	NMOD
4	address	address	NN	_	6	NMOD
5	:	:	:	_	6	P
6	Department	department	NNP	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	Molecular	molecular	NNP	_	11	NMOD
9	and	and	CC	_	8	COORD
10	Cell	cell	NNP	_	9	CONJ
11	Biology	biology	NNP	_	7	PMOD
12	,	,	,	_	6	P
13	University	university	NNP	_	6	APPO
14	of	of	IN	_	13	NMOD
15	California	california	NNP	_	16	NMOD
16	Berkeley	berkeley	NNP	_	14	PMOD
17	,	,	,	_	13	P
18	Berkeley	berkeley	NNP	_	13	APPO
19	,	,	,	_	18	P
20	California	california	NNP	_	18	APPO
21	,	,	,	_	20	P
22	United	united	NNP	_	23	NMOD
23	States	state	NNP	_	20	APPO
24	of	of	IN	_	23	NMOD
25	America	america	NNP	_	24	PMOD

1	¤	¤	SYM	_	2	P
2	c	c	LS	_	6	NMOD
3	Current	current	JJ	_	4	NMOD
4	address	address	NN	_	6	NMOD
5	:	:	:	_	6	P
6	Institute	institute	NNP	_	0	ROOT
7	for	for	IN	_	6	NMOD
8	Biomedical	biomedical	NNP	_	9	NMOD
9	Technology	technology	NNP	_	7	PMOD
10	,	,	,	_	6	P
11	University	university	NNP	_	6	APPO
12	of	of	IN	_	11	NMOD
13	Twente	twente	NNP	_	12	PMOD
14	,	,	,	_	11	P
15	Bilthoven	bilthoven	NNP	_	11	APPO
16	,	,	,	_	15	P
17	Netherlands	netherlands	NNP	_	15	APPO

